Molecular fingerprinting of VNUT-containing compartments in Neuro-2a cells by Jensen, Gabrielle
Molecular Fingerprinting of VNUT-containing 
Compartments in Neuro-2a Cells 
by 
Gabrielle Jensen 
B.Sc. (Biological Sciences), Simon Fraser University, 2018 
A.Sc. (Biology), Kwantlen Polytechnic University, 2015 
Thesis Submitted in Partial Fulfillment of the 
Requirements for the Degree of 
Master of Science 
in the 
Department of Biomedical Physiology and Kinesiology 
Faculty of Science 
 
© Gabrielle Jensen 2021 




Copyright in this work rests with the author. Please ensure that any reproduction  
or re-use is done in accordance with the relevant national copyright legislation. 
ii 
Declaration of Committee 
Name: Gabrielle Jensen 
Degree: Master of Science 
Title: Molecular Fingerprinting of VNUT-containing 
Compartments in Neuro-2a Cells 
Committee: Chair: Dawn Mackey 








Professor, Biomedical Physiology and Kinesiology 
Michael Silverman 
Committee Member 
Professor, Biological Sciences 
Tom Claydon 
Examiner 
Professor, Biomedical Physiology and Kinesiology 
iii 
Abstract 
Vesicular ATP release is involved in regulating biological processes like nociception, 
blood glucose, and vascular tone. ATP-containing vesicles are filled by the vesicular 
nucleotide transporter (VNUT) and are molecularly distinct from catecholaminergic 
vesicles of sympathetic neurons. This work sought to identify the molecular fingerprint of 
VNUT-containing vesicles. Fluorescence microscopy in Neuro-2a, HeLa, and HEK293 
cells showed VNUT being widely dispersed throughout the cells with a perinuclear 
enrichment. VNUT failed to colocalize with known markers of synaptic vesicles, 
lysosomes, dense cored vesicles, and catecholaminergic vesicles. Bioinformatic 
analyses of mammalian VNUT C-terminus identified a unique KDEL-like HEDL motif, as 
well as a lack of classic synaptic vesicle-targeting dileucine-like and tyrosine-based 
motifs. This work suggests that VNUT likely resides primarily in the Golgi-ER complex, a 
previously unconsidered location for what is thought to be a vesicle-associated 
translocase.  
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Chapter 1.  
 
Introduction 
1.1. Purinergic Signaling 
Vesicular ATP release has been demonstrated in a variety of cell types and tissues 
(Bodin & Burnstock, 2001; Burnstock, 2007; Meldrum & Burnstock, 1983), yet the 
molecular composition of primarily ATP-containing vesicles has not been characterized. 
With implications for several biological processes like vision, cognition, nociception, 
blood glucose regulation, bladder tone, and vascular tone (Bodin & Burnstock, 2001), 
this research aims to lay the groundwork for understanding the regulatory mechanisms 
of vesicular ATP release by characterizing the molecular constituents of purinergic 
vesicles. Identifying the molecular fingerprint of vesicular nucleotide transporter (VNUT)-
containing vesicles, particularly in comparison to vesicles containing other 
neurotransmitters, could provide additional insight into the molecular mechanisms 
underlying co-transmission and co-release. 
For the purposes of this research, co-transmission refers to the carefully regulated 
release of two or more neurotransmitters from different vesicle populations, while co-
release describes the release of different neurotransmitters from the same vesicle 
population. An example of co-transmission can be seen in the peripheral nervous 
system. Sympathetic nerves regulate vascular tone by releasing ATP and 
norepinephrine onto the adjacent smooth muscle lining of blood vessels, resulting in 
vasoconstriction. Each neurotransmitter is released in different proportions, allowing for 
fine tuned control of vascular tone. A greater proportion of ATP is released in response 
to lower frequency stimuli, while more norepinephrine is released after higher frequency 
stimuli (Todorov, Mihaylova-Todorova, Bjur, & Westfall, 1999). The release of 
norepinephrine can be sustained over a longer period of time than that of ATP (Todorov, 
Mihaylova-Todorova, Craviso, Bjur, & Westfall, 1996; Westfall, Todorov, Mihaylova-
Todorova, & Bjur, 1996). Both ATP release and the post-junctional response to ATP are 
short-lived (Todorov et al., 1999; Westfall et al., 1996), while norepinephrine-induced 
contractions are tonic in nature, unlike the phasic response to ATP (Sneddon & Westfall, 
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1984). The differences in release kinetics suggest that ATP and norepinephrine are 
regulated by co-transmission, although co-release has not been definitively ruled out.  
The vesicular nucleotide transporter (VNUT) is thought to be responsible for loading 
vesicles with ATP (Sawada et al., 2008). VNUT function is dependent on a positive 
internal membrane potential that is generated by the vesicular ATPase (V-ATPase) 
therefore, the V-ATPase must be a component of purinergic vesicles (Sawada et al., 
2008). Previous work in the Poburko lab attempted to identify whether ATP and 
norepinephrine were co-released from peripheral nerves of the rat tail artery by 
assessing colocalization of VNUT and the vesicular monoamine transporter (VMAT2), 
which loads vesicles with catecholamines such as norepinephrine (Wimalasena, 2011). 
Colocalization, indicated by both proteins being present on the same synaptic vesicle 
membrane, would suggest that ATP and norepinephrine are co-released. However, 
VNUT and VMAT2 were anti-colocalized in the peripheral nerves of rat tail artery 
(Kalkhoran et al., 2019). Vesicles containing the VMAT2 did associate with classic 
synaptic vesicle proteins like SV2a, synaptophysin, and synaptotagmin 1 (Kalkhoran et 
al., 2019). Additionally, my colleagues identified preferential association between 
VMAT2-containing puncta and the voltage-gated calcium channel CaV2.2, while VNUT 
associated with CaV2.3 (Kalkhoran et al., 2019). These results suggested that VNUT 
and VMAT2 resided within different vesicle populations, but the molecular components 
of VNUT-containing vesicles remained unclear.  
My thesis research sought to characterize the molecular fingerprint of a VNUT-
containing vesicle. The literature provided evidence for localization of VNUT to 
lysosomes, which might explain the lack of colocalization with synaptic vesicle markers 
seen in my colleagues’ research. Immunocytochemical analyses of several vesicle and 
lysosome markers did not colocalize with VNUT. Additional possible subcellular 
localizations were investigated by assessing the VNUT peptide sequence for known 
targeting motifs. Due to time constraints, I focused my study on the C-terminal region of 
VNUT, since the C-terminal tails of VMAT2, VAChT, and VGLUT2 are required for 
targeting these transporters to their respective vesicle populations (Colgan, Liu, Huang, 
& Liu, 2007; Haiyan Li, Santos, Park, Dobry, & Voglmaier, 2017; Varoqui & Erickson, 
1998).  
3 
1.1.1. ATP as a Neurotransmitter  
In 1929, ATP was discovered was identified and presumed to be involved in extracellular 
signaling, particularly with respect to muscle contraction (Bodin & Burnstock, 2001; 
Verkhratsky & Krishtal, 2009). A 1959 study identified ATP as being released from 
sensory neurons (Holton, 1959), officially implicating ATP as a neurotransmitter. The 
subsequent discovery of receptors that recognized ATP and its derivatives, ADP, AMP, 
and adenosine, as well as other nucleotides, birthed the field of purinergic signaling 
(Bodin & Burnstock, 2001).  
Purinergic receptors fall into two main classes, P1 and P2. P1 receptors recognize 
adenosine, while P2 receptors recognize ATP and ADP (Y. Moriyama, Hiasa, Sakamoto, 
Omote, & Nomura, 2017). The P2 receptor family further consists of metabotropic P2Y 
receptors and ionotropic P2X receptors. Both P2 receptor types are calcium sensitive 
and subsequently activate ATP release channels, like pannexin (Locovei, Scemes, Qiu, 
Spray, & Dahl, 2007; Pelegrin & Surprenant, 2006). Figure 1.1 summarizes the 
purinoceptors and their ligands, as well as their relationship with the Pannexin1 (Panx1). 
How the purinoceptors activate Panx1 secretion of ATP is not well understood.  
 
Figure 1.1 The cycle of ATP signaling via purine receptors and PanX1 
The P2X subgroup of purine receptors recognize ATP, while the G-protein coupled P2Y receptors 
recognize ATP and ADP. Adenosine (A) is the main ligand for P1 receptors. Upon activation by 
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their respective ligands, the P2 receptor activation initiates calcium influx via permeable channels. 
These receptors also activate Panx1 pannexin channels, although the details of Panx1 activation 
are unknown. Dotted lines indicate activation. Solid lines indicate direction of transport. In the 
synaptic cleft, ATP is hydrolyzed by ectonucleotidases. Created with BioRender.com. 
The idea of ATP being a neurotransmitter resulted in conflict. ATP is commonly 
described as cellular energy currency. Having such a critical role within the cell, a role as 
an extracellular messenger that was deliberately released seemed counter intuitive 
(Bodin & Burnstock, 2001; Verkhratsky & Krishtal, 2009). Indeed, one school of thought 
believed ATP could not be a neurotransmitter due to its critical intracellular presence 
(Burnstock, 2007; Verkhratsky & Krishtal, 2009). Evidence to support the contrary 
included the discovery of purinergic receptors, visualization of vesicles and measuring 
ATP release therefrom, and identification of non-adrenergic, non-cholinergic (NANC) 
transmission (Bodin & Burnstock, 2001; Burnstock, 2007; Burnstock, Cocks, Kasakov, & 
Wong, 1978; Verkhratsky & Krishtal, 2009). NANC transmission does not rely on 
acetylcholine or norepinephrine, but NANC transmitters are often released concurrently 
with acetylcholine or norepinephrine (Offermanns & Rosenthal, 2004) 
1.1.2. ATP in Sympathetic Neurons and Vesicle Release Kinetics 
Co-transmission allows cells to fine-tune post-junctional responses due to the different 
effects of transmitters. For example, post-junctional smooth muscle cells of the urinary 
bladder are more sensitive to acetylcholine after exposure to ATP, resulting in a stronger 
response to the acetylcholine (Burnstock, 2007). The release of acetylcholine from the 
pre-junctional motor nerves in the same neuromuscular junction is mediated by 
adenosine, a breakdown product of ATP (Verkhratsky & Krishtal, 2009). The effects of 
ATP can be regulated by itself as well as other transmitters. For example, the release of 
ATP from vascular sympathetic nerves is regulated by norepinephrine (Verkhratsky & 
Krishtal, 2009). The importance of regulating the relative amounts of co-released 
neurotransmitters is illustrated by the electrical stimulation of sympathetic nerves in the 
guinea pig vas deferens, resulting in altered ratios of ATP and norepinephrine released 
depending on the frequency of the electrical stimulus applied. At lower frequencies (8 
Hz), α2-adrenoceptors inhibit the amount of norepinephrine released with ATP, resulting 
in rapid yet short-lived post-junctional responses to ATP. As the stimulation frequency 
increases, α2-adrenoceptor inhibition of norepinephrine release is reduced. More 
norepinephrine is released, resulting in pre-junctional regulation to reduce ATP release. 
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Post-junctional responses to norepinephrine are tonic, slow to start, yet lasts longer than 
that of ATP (Todorov et al., 1999). By altering which neurotransmitter is released, when 
it is released, and how much is released, neurons can adjust post-junctional responses 
as needed. 
Despite the functional importance of co-transmission, the mechanism that coordinates 
the differential storage and release of neurotransmitters is not well understood. What is 
understood is that neurotransmitters are transported and stored in highly regulated 
intracellular vesicles. These vesicles are stored in specialized areas near the cell plasma 
membrane called active zones (Denker & Rizzoli, 2010). Active zones are the sites of 
vesicle fusion, neurotransmitter release, and re-uptake of the vesicle membrane 
components (Suedhof, 2012). Vesicles may fuse with the plasma membrane in three 
ways: full-collapse fusion, kiss-and-run, and compound exocytosis (L. G. Wu, Hamid, 
Shin, & Chiang, 2014). During complete fusion, the vesicle membrane fuses with the 
plasma membrane. Some transmembrane components mix with the plasma membrane 
components while others are retained in clusters for re-internalization. Some vesicles 
undergo a maturation process consisting of repeated fusion and retrieval from the 
plasma membrane, called vesicle recycling. Mature vesicles are re-loaded with 
transmitters by the action of vesicular transporters. Newly loaded vesicles are docked to 
the plasma membrane by cytoskeletal components and SNARE complexes in 
preparation for immediate release, forming the ready releasable pool (RRP) (Denker & 
Rizzoli, 2010). The vesicles of the RRP are fusion competent due to the presence of 
fusion chaperones such as syntaxin, SNAP-25/SNARE complexes, and Munc proteins 
(Suedhof, 2012). Proximity to the plasma membrane is facilitated by tethers between 
proteins of the vesicle and plasma membranes as well as scaffolding proteins like ELKS 
(Held & Kaeser, 2018). While proximity does help with physical fusion mechanics, 
scaffolds and tethers also help cluster vesicles around calcium channels allowing 
influxes of calcium to quickly bind to the calcium-depend fusion facilitator synaptotagmin-
1 (Held & Kaeser, 2018; Suedhof, 2012). In comparison, the recycling vesicle pool 
resides further away from the site of fusion and consists of 10-20% of synaptic vesicles; 
these vesicles fuse and release their contents in response to moderate stimuli (Denker & 
Rizzoli, 2010). High-frequency stimulation induces the release of the reserve vesicle 
pool, a collection of vesicles that must travel the furthest to fuse with the plasma 
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membrane. It is unclear what specific marker, if any, designates vesicles as fated to the 
RRP, the recycling pool, or the reserve pool (Denker & Rizzoli, 2010).  
Due to the speed of release in response to lower frequency stimuli, ATP is likely 
released from synaptic vesicles within the RRP. It is not clear if co-transmitters such as 
norepinephrine are released from a shared or separate RRP. In the guinea pig vas 
deferens, ATP-containing vesicles are released during low frequency stimuli (up to 8 Hz) 
and are depleted after 30 seconds. On the contrary, noradrenaline is released during 
higher frequency stimuli of greater than 8 Hz for up to 60 seconds before depletion 
(Westfall et al., 1996). Norepinephrine release is significantly impacted by reserpine, an 
inhibitor of norepinephrine vesicle loading, with 99% of initial release lost (Kirkpatrick & 
Burnstock, 1987). ATP release is unaffected by reserpine (Kirkpatrick & Burnstock, 
1987). Similarly, blockage of norepinephrine re-uptake and inhibition of α2-adrenoceptors 
with cocaine and phenoxybenzamine, respectively, did not reduce ATP release (Stjärne, 
2001). These results provide further evidence for the differential loading of ATP and 
norepinephrine, but it is not clear if vesicles containing the latter were incapable of fusion 
since vesicle loading was impeded, not fusion. However, these data in combination with 
the loss of co-release at higher stimulation frequency (Stjärne, 2001), the preferential 
association of norepinephrine- and ATP-containing vesicles with different isoforms of 
voltage-gated calcium channels (Kalkhoran et al., 2019; Smythe, Yamboliev, & 
Mutafova-Yambolieva, 2008), provide promising evidence of ATP and norepinephrine 
being sorted into and released from separate vesicle pools. 
1.1.3. Characterizing Different Vesicle Populations 
Neurotransmitters are associated with different vesicle proteins and vesicle populations, 
accordingly. Norepinephrine and related catecholamine transmitters are commonly 
found in dense core vesicles (Burnstock, 2009; Haiyan Li et al., 2005). The size and 
density of these vesicles can be seen on an electron micrograph. Dense core vesicles 
can be as large as 80-200 nm or similar in size to synaptic vesicles, about 45-60 nm 
(Merighi, 2018; Nagwaney et al., 2009). The high electron density of dense core vesicles 
is caused by chromogranins, which are soluble precursors of neuropeptides and may 
have a role in sorting catecholamines. Chromogranin A and B are associated with 
catecholaminergic vesicles as established by colocalization with the vesicular 
monoamine transporter 2 (VMAT2) (Kloukina-Pantazidou, Chrysanthou-Piterou, Havaki, 
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& Issidorides, 2013; Haiyan Li et al., 2005). VMAT2 is a transporter that loads 
catecholamines such as dopamine, serotonin, and norepinephrine into vesicles. VMAT2, 
and by association norepinephrine, is also associated with common synaptic vesicle 
proteins like synaptotagmin 1 (Syt1), synaptophysin, and synaptic vesicle glycoprotein-
2a (SV2a) (Freyberg et al., 2016; Kalkhoran et al., 2019; Haiyan Li et al., 2005). In 
contrast, the vesicular nucleotide transporter (VNUT), which loads ATP into cellular 
compartments, did not colocalize with Syt1, synaptophysin, or SV2a in sympathetic 
neurons of the rat tail artery (Kalkhoran et al., 2019). The lack of canonical vesicle 
protein association and the differences in release kinetics suggest that ATP resides in a 
different vesicle population from norepinephrine. Precedent for different synaptic vesicle 
pathways for co-released transmitters, including synthesis and recycling, is documented 
in midbrain and hippocampal neurons with the vesicular glutamate transporter (VGLUT) 
and VMAT2. VMAT2 was more dispersed across the plasma membrane than VGLUT, 
suggesting slower or perhaps less efficient recycling mechanics. Compared to VMAT2, 
VGLUT is sorted to a different vesicle population that is more readily released and 
undergoes faster endocytosis after an exocytotic event (Onoa, Li, Gagnon-Bartsch, 
Elias, & Edwards, 2010).  
The vesicle population to which ATP belongs is not well-understood. ATP can be 
present in catecholaminergic and cholinergic vesicles (Aberer, Stitzel, Winkler, & Huber, 
1979; Gualix, Pintor, & Miras-Portugal, 1999) but does not typically share vesicles with 
glutamate or γ-aminobutyric acid (GABA) (Pankratov, Lalo, Verkhratsky, & North, 2006). 
To add to the complexity, some reports claim that ATP is secreted from lysosomes in 
epithelial cells, glial cells, and neurons (Jung, Shin, Konishi, Lee, & Kiyama, 2013; J. Liu, 
Liu, & Yang, 2016; Oya et al., 2013). ATP secretion via lysosomes might explain the lack 
of association between VNUT and synaptic vesicle proteins. However lysosomal 
localization of VNUT might occur in a cell- or tissue-dependent manner. The canonical 
lysosome marker lysosome-associated membrane protein-1 (LAMP-1) did not colocalize 
with VNUT in microglia and cerebellar granule neurons (Imura et al., 2013; Menéndez-
Méndez et al., 2017). VNUT knockout studies in COS1 monkey fibroblast cells and 
C2C12 mouse myoblast cells support a critical role of VNUT in loading ATP into 
lysosomes (Zhong, Cao, Sun, & Dong, 2016). Conversely, other researchers provide 
evidence for ATP release from non-lysosomal compartments in epithelial cells, 
endocrine cells, and neurons (Aberer et al., 1979; Bjelobaba, Janjic, & Stojilkovic, 2015; 
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Y. Moriyama et al., 2017; Obermüller et al., 2005). The identification of VNUT-containing 
vesicles is complex due to the variety of compartments that may release ATP and as 
well as the mixed, perhaps cell-dependent localization of VNUT to lysosomes. 
For clarity, I will define several vesicle populations that I have investigated throughout 
my thesis work as well as any markers used to identify each vesicle population. 
Secretory vesicles of peripheral nerves are large vesicles that primarily contain peptides 
like vascular endothelial growth factor (VEGF). Another group of secretory 
compartments are lysosomes. With no clear distinction between traditional lysosomes 
and secretory lysosomes, the collective population of lysosomes are identified as 
containing LAMP-1. Synaptic vesicles are defined as small vesicles that contain synaptic 
vesicle associated proteins like SV2a, synaptophysin, or synaptotagmin. Within the 
context of peripheral nerves, two subcategories of synaptic vesicles are investigated: 
ATP-containing purinergic vesicles and norepinephrine-containing catecholaminergic 
vesicles. Localization of VNUT to synaptic vesicles, secretory vesicles, or lysosomes is 
not well characterized in N2a cells, with indirect evidence suggesting localization to 
vesicles (Gutiérrez-Martín et al., 2011; Menéndez-Méndez, Díaz-Hernández, & Miras-
Portugal, 2015). Various studies have characterized vesicular ATP release in N2a cells, 
but lack colocalization analyses to confirm VNUT localization to purinergic vesicles 
(Menéndez-Méndez et al., 2015; P. Y. Wu et al., 2009). If VNUT associates with 
secretory vesicles, typical markers of these vesicles should colocalize with VNUT. Two 
markers of secretory vesicles expressed in murine Neuro-2a neuroblastoma (N2a) cells 
are VEGF and CGA (Meister et al., 1999; Weng et al., 2017). An important note: CGA is 
not specific to a single vesicle population (i.e., catecholaminergic vesicles) as 
peptidergic vesicles also contain CGA (D’amico, Ghinassi, Izzicupo, Manzoli, & Di 
Baldassarre, 2014). If VNUT localizes to lysosomes, LAMP-1 should colocalize with 
VNUT. To account for the transient fusion and separation of lysosomes and endosomes, 
the endosome-associated protein EEA1 is a common early endosome marker that 
distinguishes colocalization of VNUT with lysosomes from that of endosomes. VNUT and 
synaptophysin have been studied in mouse retina photoreceptor cells, Neuro-2a 
neuroblastoma cells, and cerebellar granule neurons with colocalization being defined by 
partial overlap of each channel colour. (Menéndez-Méndez et al., 2015, 2017; S. 
Moriyama & Hiasa, 2016). For example, in mouse retinal tissues VNUT is stained with a 
red probe while synaptophysin is stained green with the resulting overlap producing a 
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yellow signal. While some partial overlap was observed in retinal tissue, the scale of 
these images did not show vesicular or organellar colocalization of VNUT and 
synaptophysin. Rather, these data demonstrated the co-expression of these proteins in 
retinal tissue (Menéndez-Méndez et al., 2015). In N2a cells and granule neurons, 
immunolabeling demonstrated punctate VNUT and synaptophysin signals, albeit slightly 
blurry. If VNUT and synaptophysin reside within synaptic vesicles, then all VNUT-
containing vesicles would colocalize with synaptophysin and vice versa. The data 
suggest otherwise, with few instances of overlapping puncta. The “most prominent” 
clusters of synaptophysin- and VNUT-containing are noted, but even these puncta do 
not demonstrate consistent overlap (Menéndez-Méndez et al., 2015). These data would 
benefit from further investigation of VNUT and synaptophysin colocalization using a 
blob-based analysis method (Fletcher, Scriven, Schulson, & Moore, 2010), as described 
later in this introduction and used in my research. VNUT colocalization with synaptic 
vesicle markers SV2a and synaptotagmin-1 has not been demonstrated in neurons, 
although the latter might be colocalized with VNUT in PC12 cells (Sawada et al., 2008). 
One goal of this thesis work is to provide additional and perhaps more conclusive data to 
determine the degree of colocalization between VNUT and markers of various vesicle 
populations, summarized in Table 1.1, in a neuron-like cell model. 
Table 1.1 Summary of Vesicle Subpopulation Markers 
 Small, synaptic vesicles  
(45-60 nm) 
Large, secretory vesicles  
(80-200 nm) 
Vesicle Subtype Purinergic Catecholaminergic Peptidergic Lysosomes Endosomes 
Chromogranin(s) 
Present? No Yes Yes No No 
Solute Carrier(s) VNUT VMAT1, VMAT2 VMAT1, VMAT2 VNUT(?) No 










1.2. Studying ATP Storage and Release 
ATP is released in three ways; exocytosis is the release of ATP from vesicles. Channel-
dependent release, such as through pannexin hemichannels, allow cells to release 
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cytosolic ATP. Finally, uncontrolled ATP release can occur via ruptures in the plasma 
membrane due to stress or damage (Bodin & Burnstock, 2001; Boudreault & 
Grygorczyk, 2002; Y. Moriyama et al., 2017; Murana et al., 2017; Sabirov, Dutta, & 
Okada, 2001). Figure 1.2 illustrates the three primary modes of ATP release. ATP 
release is primarily studied through measuring extracellular concentration of sequential 
media collections using the luciferin-luciferase bioluminescence assay. The amount of 
ATP released is related to the intensity of light emitted by the luciferin-luciferase reaction 
within a liquid sample (Marques & Esteves Da Silva, 2009). However, the assay lacks 
spatial and temporal resolution of release events and is unable to differentiate between 
vesicular and non-vesicular ATP release. 
 
Figure 1.2 Modes of ATP release 
In a healthy cell, left, ATP (orange) can be released from vesicles, or through hemichannels like 
pannexin (blue). Ruptures in the plasma membrane occur in cells that have sustained trauma, 
often resulting in cell death. The trauma can be physical or biological and result in the release of 
ATP in an uncontrolled manner. Created with BioRender.com. 
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Several fluorescent probes are used to study intracellular ATP compartmentalization. 
Quinacrine is a fluorescent dye that is recruited to acidic organelles including vesicles, 
endosomes, and lysosomes (Pierzynska-Mach, A Janowski & Dobrucki, 2014). 
Quinacrine staining is challenging to interpret for three reasons. First, acidic 
compartments swell over time when cells are exposed to quinacrine, likely due to stress 
from phototoxic species generation. Second, nucleic acid staining occurs with prolonged 
exposure during live cell imaging and readily in fixed cells (Pierzynska-Mach, A Janowski 
& Dobrucki, 2014). Although reported as a marker of ATP-containing vesicles (Akopova 
et al., 2012; Geisler et al., 2013; J. Liu et al., 2016), pH driven localization means there 
is little specificity for ATP-containing vesicles over vesicles containing other transmitters, 
like norepinephrine, or acidic compartments like lysosomes (Roy, Gagné, Fernandes, & 
Marceau, 2013). MANT-ATP is a fluorescent analogue of ATP. Like quinacrine, MANT-
ATP has been used to confirm VNUT localization to ATP-containing compartments 
(Imura et al., 2013), as well as demonstrating vesicular release of ATP from 
dopaminergic neurons in real time (Ho et al., 2015). Both fluorescent molecules exhibit 
strong colocalization with VNUT in dorsal root ganglia, microglia, C2C12 myoblast cells, 
retinal and cortex tissues (Cao et al., 2014; Ho et al., 2015; Imura et al., 2013; Jung et 
al., 2013). However, MANT-ATP indiscriminately accumulates in ATP-containing 
compartments including vesicles and lysosomes. Quinacrine and MANT-ATP are useful 
tools for studying intracellular ATP, but interpretating synaptic vesicle localization of 
VNUT is limited due to the non-specific accumulation of these probes. 
A new tool for studying real time ATP release, called the GRABATP1.0 sensor, was 
recently developed by and generously gifted from Yulong Li (Peking University). The 
GRABATP1.0 sensor is a GFP-conjugated, P2Y1 G-protein-coupled receptor that has been 
decoupled from its G-protein (Z. Wu et al., 2021). Instead of triggering a secondary 
messenger cascade, the GRABATP1.0 sensor fluoresces upon binding to ATP. The sensor 
has a half maximal effective concentration of 45 nM in neurons and is a promising tool 
for real-time imaging of ATP release (Z. Wu et al., 2021). 
12 
Due to the localization of the sensor to 
the plasma membrane, the sensor does 
not detect intracellular ATP. An 
advantage of the GRABATP1.0 sensor is 
the ability to visualize instances of ATP 
release in real time. See Figure 1.3 for 
an illustration of the workings of the 
GRABATP1.0 sensor, including activation 
upon ATP binding. In the same way that 
the GRABATP1.0 sensor is a powerful new 
tool for recording extracellular ATP, 
studying subcellular vesicle-like pools of 
ATP was made possible by the 
discovery of VNUT. 
1.2.1. The Vesicular Nucleotide 
Transporter 
The field of purinergic signaling gained powerful molecular tools to study ATP 
localization, such as immunostaining and expression vectors, when the Moriyama lab 
identified the vesicular nucleotide transporter (VNUT) as the protein that loads ATP into 
vesicles (Sawada et al., 2008). VNUT is encoded by the SLC17A9 gene of the solute 
carrier 17 family. The SLC17 family is a group of anion transporters that includes the 
vesicular glutamate transporters (VGLUT1-3) and sialin (Rudnick, 2008; Sawada et al., 
2008). Table 1.2 lists the gene and protein names of each SLC17A family member. 
In order of efficacy, VNUT preferentially transports ATP, UTP, GTP, ITP, ADP, and AMP 
(Y. Moriyama et al., 2017). Like the other SLC17A transporters, VNUT function depends 
on the positive luminal membrane potential that is established by the H+ electrochemical 
gradient generated by the vesicular ATPase (V-ATPase) (Y. Moriyama et al., 2017; 
Omote & Moriyama, 2013; Rudnick, 2008; Sawada et al., 2008). The V-ATPase inhibitor 
bafilomycin severely impairs mechanically-induced ATP release from primary cultures of 
rat hippocampal astrocytes and mouse cortical astrocytes (Coco et al., 2003; Xiong, 
Sun, Teng, Jin, & Zhou, 2018) as well as ionomycin-induced ATP release from primary 
cultures of rat cortical microglia (Imura et al., 2013). As a consequence of driving protons 
Figure 1.3 Activation of the GRABATP1.0 
sensor in response to ATP 
The GRABATP1.0 sensor is a genetically encoded 
probe that detects exogenous ATP. The diffusion 
of ATP upon release can be observed by the 
sequential activation of neighbouring sensors. 
Created with BioRender.com. 
13 
into the vesicle lumen, the V-ATPase also establishes an inside acidic pH gradient, 
which is a component of neurotransmitter/proton antiport in the SLC18A family of 
transporters (Y. Moriyama et al., 2017; Omote & Moriyama, 2013; Rudnick, 2008; 
Sawada et al., 2008). Unlike the SLC18A family members, VNUT function is not 
dependent on pH (Sawada et al., 2008). 
Table 1.2 Summary of SLC17A family protein names 
Gene Name Gene-based Protein Name Protein Common Name Abbreviation used in 
Thesis 
SLC17A1 Solute Carrier Family 17, Member 1 
Sodium/phosphate 
cotransporter 1 NPT1 
SLC17A2 Solute Carrier Family 17, Member 1 
Sodium/phosphate 
cotransporter 3 NPT3 
SLC17A3 Solute Carrier Family 17, Member 1 
Sodium/phosphate 
cotransporter 4 NPT4 
SLC17A4 Solute Carrier Family 17, Member 1 
Sodium/phosphate 
cotransporter homolog NPT2 
SLC17A5 Solute Carrier Family 17, Member 1 Silain Sialin 
SLC17A6 Solute Carrier Family 17, Member 1 
Vesicular Glutamate 
Transporter 2 VGLUT2 
SLC17A7 Solute Carrier Family 17, Member 1 
Vesicular Glutamate 
Transporter 1 VGLUT1 
SLC17A8 Solute Carrier Family 17, Member 1 
Vesicular Glutamate 
Transporter 3 VGLUT3 




Inhibitors of VNUT include Evans blue, diisothiocyanatostilbene disulfonic acid (DIDS), 
and atractyloside (Geisler et al., 2013; Gualix et al., 1999; Y. Moriyama et al., 2017; Oya 
et al., 2013; Yin et al., 2019). While these compounds do inhibit VNUT, they are not 
specific to VNUT. For example, Evans blue prevents glutamate uptake by allosterically 
inhibiting AMPA and kainate receptors as well as the excitatory amino acid transporter 
and vesicular glutamate transporters. Clodronate is an anti-osteoporotic drug that is 
used to treat osteoporosis and neuropathic pain. In 2017, clodronate was found to inhibit 
pain by inhibiting VNUT through competition with the chloride binding site (Y. Moriyama 
& Nomura, 2017). With a half maximal inhibitory concentration of 15.6 nM and no 
apparent off-target inhibition of other SLC transporters, clodronate is currently the most 
selective inhibitor of VNUT (Kato et al., 2017; Y. Moriyama & Nomura, 2017).  
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VNUT has a critical role in ATP release, illustrated by several studies using VNUT 
deficient mice (Imura et al., 2013; Y. Moriyama et al., 2017; Y. Moriyama & Nomura, 
2017). Mice that do not express SLC17A9 experience severely impaired ATP release 
from neurons, neuroendocrine, and microglial cells (Kato et al., 2017). Dorsal horn 
neurons are involved in peripheral nerve injury pain perception, which is lost in 
SLC17A9-/- mice. General pain sensation, such as tail- or paw-flicks, remains intact 
(Masuda et al., 2016), but inflammatory responses such as edema are significantly 
reduced compared to wild-type mice (Kato et al., 2017). VNUT deficient mice do not 
release ATP from adrenal chromaffin cells in response to high K+. This lack of ATP 
release causes a subsequent decrease in noradrenaline secretion because purinergic 
P2Y12 and P2X4-7 receptors regulate vesicular catecholamine release (Sakamoto et al., 
2014). In the islets of Langerhans (pancreatic β cells) of SLC17A9-/- mice, glucose-
stimulated ATP release is lost while glucose-stimulated insulin secretion is 1.5-fold 
greater than in wild-type mice (Sakamoto et al., 2014). VNUT deficient mice have 
enhanced glucose tolerance. Blood glucose readings are approximately 100 mg/dL less 
than those of  wild-type mice between 30 and 120 minutes after oral administration of 
glucose, indicating a role in ATP release in blood glucose homeostasis (Sakamoto et al., 
2014). Hippocampal neurons isolated from SLC17A9-/- mice do not release ATP in 
response to high K+ (Miras-Portugal et al., 2019). Similarly, hippocampal astrocytes are 
less responsive to the anti-depressant fluoxetine, which stimulates ATP release causing 
reduced depression-like behaviour in mice. Conversely, over-expression of VNUT 
improved the therapeutic effects of fluoxetine (Kinoshita et al., 2018; Miras-Portugal et 
al., 2019). These results point to a regulatory role of VNUT-mediated ATP release in 
depression. Although not explicitly related to VNUT deficient mice, a study on 
glaucomatous mice identified a positive correlation between SLC17A9 expression and 
glaucoma progression. As VNUT expression and ATP release increased, the glaucoma 
became more severe (Miras-Portugal et al., 2019; Pérez de Lara et al., 2015). At the 
organism level, SLC17A9-/- mice appear to be healthy. This puzzling observation 
suggests that VNUT-dependent ATP release is not life-sustaining or else the lack of 
SLC17A9 expression may stimulate compensational upregulation of ATP release 
channels, such as pannexins, to rescue ATP release (Mihara, Uchida, Koizumi, & 
Moriyama, 2018; Y. Moriyama et al., 2017).  
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VNUT-mediated ATP release has also been demonstrated using cultured cell lines. RNA 
interference studies support a critical role for VNUT in ATP release with ~50% reduction 
in N2a cells (Menéndez-Méndez et al., 2015) and PC12 cells (Sawada et al., 2008) and 
nearly abolished release in hippocampal primary culture (Larsson et al., 2012). The role 
of VNUT in ATP release in microglia and PC12 cells appears to be dependent on 
plasmalemmal depolarization and subsequent activation of voltage-gated calcium 
channels, inferring that VNUT-mediated ATP release is vesicular (Imura et al., 2013; 
Sawada et al., 2008). ATP release in response to elevated intracellular Ca2+ may 
suggest a vesicular mechanism of release. Knocking down VNUT in microglia reduced 
ATP release in response to ionomycin, a Ca2+ ionophore, by approximately 68% (Imura 
et al., 2013). In microglia, Ca2+-dependent VNUT-mediated ATP release is regulated by 
the SNARE complex. Botulinum A is a neurotoxin that inhibits SNAP-25, a key 
component of the core SNARE complex (Smythe et al., 2008). In the presence of 
botulinum A, ionomycin-triggered ATP release was reduced by approximately 32% 
(Imura et al., 2013). The Ca2+ chelator BAPTA-AM also impaired vesicular ATP release, 
as did the vesicle transport inhibitor brefeldin A (Imura et al., 2013). These results all 
implicate VNUT in vesicular ATP release and presumably its localization to vesicles. 
In addition to strong evidence for vesicular ATP release, there is also evidence for VNUT 
localization to lysosomes. Lysosomes isolated from COS1 monkey kidney fibroblast cells 
took up less ATP when exposed to VNUT inhibitors DIDS and Evans Blue. As previously 
discussed, these inhibitors are not specific to VNUT, thus interpreting these results is 
limited. However, inhibitors of connexin and pannexin hemichannels carbenoxolone and 
niflumic acid did not reduce ATP uptake into the lysosome-containing fractions of kidney 
fibroblast-like cells (Zhong et al., 2016). VNUT shRNA expression in C2C12 murine 
myoblast cells significantly impacted ATP uptake into lysosome lysates, inducing a 10-
fold decrease in ATP uptake compared to the scrambled shRNA control (Zhong et al., 
2016). Further evidence in support of VNUT localization to lysosomes include studies 
using optic nerve head astrocytes and retinal epithelial cells (Beckel et al., 2018), 
cochlear marginal cells (J. Liu et al., 2016), cerebellar granule neurons (Menéndez-
Méndez et al., 2017), Schwann cells (Shin, Lee, & Jung, 2012), and human epithelial 
kidney cells (Cao et al., 2014). These studies highlight the complexity of VNUT 
localization studies as well as assessing lysosomal and vesicular ATP release.  
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1.2.2. VNUT: A Comparison in Structure and Targeting 
The secondary structure of VNUT is based on homology to other SLC17A family 
members (Sawada et al., 2008). In addition to providing a basis for predicting the 
structure of VNUT, the vesicular glutamate transporters and sialin might provide a clue 
to the subcellular localization of VNUT as these transporters localize to synaptic vesicles 
in neurons. The peptide sequences of VGLUT1-3 contain a synaptic vesicle targeting 
dileucine motif that is preceded by an acidic residue: [D/E]XXXLL (Haiyan Li et al., 
2017), where X can be any amino acid. The dileucine motif is also present in synaptic 
vesicle proteins synaptobrevin and synaptotagmin-1 (Colgan et al., 2007; Prado & 
Prado, 2002). SLC18A family members VMAT1-2 and the vesicular acetylcholine 
transporter (VAChT) also have dileucine motifs of EEKMAIL and SERDVLL, 
respectively, which are thought to participate in internalization and vesicle targeting 
(Colgan et al., 2007; Prado & Prado, 2002; Varoqui & Erickson, 1998). The dileucine 
motif is often found on the cytosolic C-terminus of synaptic vesicle associated proteins. 
This motif recruits adaptor proteins, which subsequently recruit clathrin to the vesicle.  
In addition to the three-wild card dileucine-like motif, a two-wild card [D/E]XXLL motif 
and a tyrosine-based YXXθ motif facilitate internalization of clathrin-dependent cargo at 
the plasma membrane through recognition by adaptor protein-2 (AP-2) (Pandey, 2009; 
Prado & Prado, 2002). Additionally, the NPXY internalization motif is typically found on 
the C-terminal domain of cell surface proteins like the low density lipoprotein receptor 
(Bonifacino & Traub, 2003) and is recognized by adaptor proteins and clathrin 
(Bonifacino & Traub, 2003; Pandey, 2009). Adaptor protein-clathrin interaction is integral 
to vesicle protein sorting and vesicle trafficking (Schmid, 1997). In contrast to the 
VGLUTs, VMATs, and VAChT, the presence of dileucine-like motifs and other known 
targeting motifs, which will be discussed in the next section, have not been identified in 
VNUT. 
1.2.3. Vesicle Sorting and Membrane Targeting 
Identification of targeting sequences is achieved via mutational studies where segments 
of a protein are removed or replaced with inert residues and the resultant functional 
changes are observed. A general motif can be deduced in some instances, such as the 
nuclear localization sequence (NLS) that allows targeted proteins to enter the nucleus. 
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However, sequence variation between species and/or proteins result in generalized 
motifs. General rules are established, such as the peroxisomal targeting sequence 
(PTS) containing clusters of basic residues (Gould, Keller, & Subramani, 1987), or the 
numerous functional variants of the ER-targeting KDEL-based motif (Raykhel et al., 
2007). General rules can also be shared by different motifs. For example, basic residues 
also occur in NTSs (Kalderon, Roberts, Richardson, & Smith, 1984; Lange et al., 2007). 
For this reason, trafficking studies are required to confirm the dependence of protein 
localization on a particular motif.  
Protein sorting to lysosomes appears to be driven by the tyrosine motif YXXθ, where θ 
can be any hydrophobic amino acid (Bonifacino & Traub, 2003). LAMP-1 is a canonical 
marker of lysosomes and has an 11-amino acid C-terminal tail containing the YXXθ 
motif. A CD44 and LAMP-1 C-terminus fusion protein resulted in targeting of the cell 
surface protein to lysosomes. This experiment identified the C-terminus of LAMP-1 as 
being necessary for lysosomal targeting (Guarnieri, Arterburn, Penno, Cha, & August, 
1993). However, lysosomal localization appears to be driven by a modified variant of this 
motif. Isolated and purified LAMP-1 from mice livers lacked two C-terminal residues 
predicted from the cDNA sequence. Instead of the predicted octameric sequence 
SHAGYQTI, the isolated peptide contained six residues: SHAGYQ (Guarnieri et al., 
1993). Proteolytic modification of the YXXθ motif might explain the differential targeting 
of LAMP-1 and VAChT. In VAChT, the intact YXXθ motif is necessary and sufficient for 
targeting to synaptic vesicles and is also required for internalization (Colgan et al., 2007; 
Varoqui & Erickson, 1998). It is unclear which targeting motifs are present within VNUT 
or if those motifs are modified, but motif modifications or splice variants might explain the 
differential trafficking of VNUT to different membranes. 
For completeness, since cells do not only contain vesicular or lysosomal membranes to 
which proteins can be sorted, I will describe some additional targeting sequences. Di-
lysine endoplasmic reticulum (ER) and Golgi retention motifs, such as KKXX or 
[K/H]DEL, are typically found on the C-terminal tail of soluble resident proteins (Banfield, 
2011; Teasdale, Jackson, & Johnson, 1996). The lysine residues of the former motif 
cannot be substituted for other amino acids. Replacement of either lysine residues with 
similarly basic arginine or histidine residues does not rescue the motif (Teasdale et al., 
1996). The critical role of lysine residues in targeted sorting of Golgi proteins is well 
characterized in yeast, where Golgi proteins are missorted to lysosome-like structures 
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(Banfield, 2011). While the ER and Golgi work closely to synthesize proteins for 
secretion, they are functionally different with different molecular components. The 
[K/H]DEL motif allows escaped ER residents to be retrieved from the Golgi network via 
the action of the KDEL receptor. Relative to the ER, the acidic pH of the Golgi (pH ~6.5) 
creates ideal binding conditions for the KDEL receptor. Retrograde transport of the cargo 
to the ER exposes the receptor to a less acidic pH~7, allowing the receptor to release its 
cargo. Other explanations for differences in targeting between the Golgi and ER include 
transmembrane domain structure for Golgi targeting and differences in peripheral 
binding proteins (Banfield, 2011; Teasdale et al., 1996). Further, [F/L][L/I/V]XX[R/K] is a 
Golgi-specific targeting sequence that is recognized by peripheral Golgi protein GOLPH3 
(Banfield, 2011). In yeast, changes to this sequence prevents recognition by peripheral 
Golgi proteins, resulting in proteins being sorted to lysosome-like structures and 
degraded (Banfield, 2011). It is worth noting that mammalian glycosyltransferases lack 
the [F/L][L/I/V]XX[R/K] motif and instead require phosphatidylinositol 4 phosphate (PI4P)-
binding of GOLPH3 for retention to the Golgi (Banfield, 2011). 
 
A nuclear localization sequence (NLS) is a motif that allows nuclear import of proteins 
containing these sequences by NLS receptors. NLSs can be monopartite or bipartite, 
indicating the number of sequence segments within the entirety, and are typically 
clusters of basic amino acids. An example of a monopartite sequence is PKKKRKV of 
the SV40 large T antigen. An example of a bipartite sequence is 
KRPAATKKAGQAKKKK of nucleoplasmin, wherein two sequence segments are 
underlined (Lange et al., 2007). 
 
A mitochondrial targeting sequence (MTS) allows protein transport to mitochondria as 
well as navigation through the mitochondrial import pathway. For example, COX4 
encodes a subunit of cytochrome c oxidase, which is involved in the electron transport 
chain. This mitochondrial protein undergoes nuclear transcription. To enter the 
mitochondria, mitochondrial preprotein receptors called Translocases of the Outer 
Mitochondrial membrane (TOM) recognize N-terminal amphipathic helices (M. Li et al., 
2010). The COX4 subunit requires the N-terminal sequence 
MLSLRQSIRFFKPATRTLCSSRYLLA for mitochondrial targeting and TOM-mediated 
import (“Intracellular transport: 4.2 Peptide signal sequences,” 2020).  
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Like NTSs and MTSs, peroxisome targeting sequences (PTSs) do not have 
characterized motifs. Instead, specific sequences are known. For example, the 
LIKAKKGGKSKL sequence at the carboxyl terminus of firefly luciferase is perhaps the 
best-known PTS (Gould et al., 1987). Generally, peroxisomal membrane proteins have a 
PTS with a transmembrane segment that is preceded by a cluster of basic amino acid 
residues (Van Ael & Fransen, 2006). Nuclear, mitochondrial, and peroxisomal 
sequences are not identifiable by distinct unique motifs, making the study of these 
sequences difficult.  
A comparative study of lysosomal, peroxisomal, mitochondrial, nuclear, and vesicular 
signaling motifs within VNUT and related transporters remains to be reported. While the 
secondary structure of VNUT was predicted using homology comparisons within the 
SLC17A family (Sawada et al., 2008), these comparisons did not include targeting 
motifs. The evolutionary conservation of the VNUT peptide sequence was briefly 
explored across ten species (Sawada et al., 2008). However, this initial comparison 
would benefit from a comprehensive expansion that includes multiple representatives of 
each Class of Kingdom Animalia. Combined with a targeting motif analysis of the C-
termini, this data could provide insight into the evolution-driven changes in VNUT and 
perhaps changes in function because of novel mutations. These aspects of the VNUT 
peptide sequence are explored in Chapter 4. 
1.3. Analyzing Colocalization 
The use of fluorescence microscopy to label and observe the subcellular localization of 
two or more proteins of interest in relation to each other is a common method of 
ascribing the degree of colocalization between said proteins. Although a useful tool for 
observing organellar localization patterns of chosen probes, fluorescence microscopy 
cannot determine functional relationships or interactions between proteins (Dunn, 
Kamocka, & McDonald, 2011). Perhaps even less well defined is the threshold of 
colocalization at which one can claim that two probes are sufficiently overlapping to be 
considered residents of the same cellular compartment and thus colocalized.  
Colocalization can describe two main relationships between probes: co-occurrence and 
correlation (Dunn et al., 2011). Co-occurrence is the spatial overlap of the probes while 
correlation refers to the relative amount of signal. In the case of VNUT, there might be 
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one to two molecules per vesicle, which contains considerably more ATP. In this 
example, VNUT and ATP co-occur. The absolute amount of VNUT and ATP do not 
affect colocalization analysis because these molecules present a high degree of 
covariance. Most ATP blobs should contain a VNUT blob, and the relative fluorescent 
intensities of these probes should be positively correlated. A common visual evaluation 
of colocalization consists of two-channel images presented side-by-side with a final 
merged image. Side-by-side and merged images can create intuitive, easy-to-follow 
figures to illustrate colocalization (or lack thereof) but they do not sufficiently quantify 
colocalization. Visual evaluation is prone to error as differences in signal intensity can 
affect the interpretation of the merged image. Quantification of colocalization should 
accompany merged channel images to allow more accurate and less biased 
interpretation of data (Dunn et al., 2011). An example of a quantifiable analysis is a 
scatterplot, which illustrates the co-variance of the signal intensity of each probe using 
the Pearson’s Correlation Coefficient. The theory of the Pearson Correlation Coefficient 
is straightforward and intuitive, but the execution requires careful consideration of the 
many limitations. The coefficient describes the co-variance of two probes by defining the 
x and y axes of a scatterplot as the signal intensities of each probe. In the case of 
colocalization, the resulting dots exhibit a positive correlation along a linear regression 
(Bolte & Cordelières, 2006). If the ratio between the probe intensities co-vary equally, 
the coefficient approaches one. Otherwise, the coefficient approaches negative one in 
instances of negative correlations of co-variance or minimal colocalization, and zero if no 
correlations can be made (Bolte & Cordelières, 2006). The Pearson Correlation 
Coefficient is limited by its susceptibility to over-represent the covariance between 
probes in whole fields of view or when regions of interest (ROIs) are not accurate (Dunn 
et al., 2011). Further, intra- and extracellular background pixels (noise), bleed through of 
one probe into the emission spectra of the other probe, or different probe ratios within 
the sample will falsely contribute to the representation of pixels for which the intensities 
are low, skewing the data towards larger values of variance (Bolte & Cordelières, 2006; 
Dunn et al., 2011).  
Other methods of quantifying colocalization include the Manders Overlap Coefficient and 
fractional overlap. The Manders Overlap Coefficient is related to the Pearson’s 
Correlation Coefficient except it measures pixel intensity while largely ignoring 
differences in probe intensity (Dunn et al., 2011). The ImageJ colocalization tool JaCoP 
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uses the Manders Overlap Coefficient (Dunn et al., 2011). A better measure of spatial 
overlap is the fractional overlap, which measures the amount of overlap between probes 
after the minimum fluorescent values (i.e., background grey levels) have been 
subtracted from each signal (Dunn et al., 2011). 
Tools for assessing colocalization are available via the ImageJ plugins Coloc 2 and 
JaCoP (“Colocalization Analysis,” 2020). Coloc 2 performs pixel intensity correlation 
analyses based on several statistical principles of colocalization (including those 
discussed above) while JaCoP is a compiled set of tools like common colocalization 
indicators and visualizations. Additional colocalization resources, which are used in my 
research, are ImageJ macros that identify puncta using user-defined parameters and 
then calculate relative distances between puncta, named the Recursive ImageJ Particle 
Analyzer (RIPA) and Multi-Image Nearest Neighbour Colocalization (MINER), 
respectively (Kalkhoran et al., 2019; Poburko, n.d.). The RIPA macro allows user input of 
parameters that best describe the probe signal such as circularity, solidity, upper and 
lower threshold limits, and minimum and maximum area, to draw ROIs. RIPA helps 
reduce the influence of intensity differences between signal and background, resulting in 
unbiased ROI selection. 
MINER is a nearest neighbour analysis tool that recognizes the ROIs generated by RIPA 
and records multiple characteristics of each punctum based on user input. Users can tell 
MINER which channel contains the reference puncta and how many other channels are 
being analyzed relative to the reference, denoted as nearest neighbour (NN) channels. 
The intensity of each ROI is fitted to a Gaussian curve along the major and minor axis 
and the resultant full-width half-max value is recorded. The distance of each NN puncta 
is measured relative to the perimeter and/or center of the reference channel puncta, as 
per user preference (Kalkhoran et al., 2019). All output files can then be imported to 
statistical analysis software such as JMP. Together, MINER and RIPA allow a semi-
automatic, high-throughput workflow. 
1.4. Mouse Neuroblastoma-2a Cells 
The neuroblastoma Neuro-2a (N2a) cell line is derived from the neural crest and can be 
differentiated into neuron-like cells (Tremblay et al., 2010) that are easy to maintain 
compared to primary neuronal cultures. This cell line is capable of transfection and 
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grows rapidly in culture (Shastry, Basu, & Rajadhyaksha, 2001). N2a cells have been 
used extensively to study neuronal differentiation, cytoskeletal stability, axonal growth, 
neurodegenerative disorders, and signaling pathways (Gutiérrez-Martín et al., 2011; S. 
Kim et al., 2013; Menéndez-Méndez et al., 2015; Namsi et al., 2018; Swayne, Sorbara, 
& Bennett, 2010; Tremblay et al., 2010; Wicki-Stordeur, Dzugalo, Swansburg, Suits, & 
Swayne, 2012; P. Y. Wu et al., 2009; Xu et al., 2018).  
In the context of studying purinergic signaling, N2a cells are able to release ATP via 
pannexin channels and vesicular-like mechanisms alike (Gutiérrez-Martín et al., 2011; 
Menéndez-Méndez et al., 2015; Swayne et al., 2010; Xu et al., 2018). Although not 
selective for ATP, Pannexin1 (Panx1) pores are the main mediator for channel-
dependent ATP release (Dahl, 2015) and are expressed in N2a cells (Wicki-Stordeur et 
al., 2012). The channel undergoes conformational changes to allow ATP release in 
response to mechanistic changes to the plasma membrane, hypoxic conditions, high 
extracellular K+, and purinergic receptor activation (Dahl, 2015). Activated metabotropic 
P2Y and ionotropic P2X receptors mediate cytosolic calcium levels (Dahl, 2015; 
Menéndez-Méndez et al., 2015). The resultant increase in intracellular calcium activates 
pannexin channels, although the mechanism of calcium activated Panx1 activation is not 
well understood. N2a cells express P2X1, P2X3, P2X4, and P2X7, but only the P2X7 
receptor is functional (Gómez-Villafuertes et al., 2009). Co-immunoprecipitation of P2X7 
and Panx1 in HEK cells highlights the close physical receptor-channel relationship 
(Pelegrin & Surprenant, 2006), while electrophysiological recordings and fluorescence 
microscopy in 1321N1 human astrocytoma cells provide evidence of a close functional 
relationship (Locovei et al., 2007). In addition to Panx1 mediated release, N2a cells are 
thought to release ATP from vesicles (Gutiérrez-Martín et al., 2011; Menéndez-Méndez 
et al., 2015).  
Vesicular fusion and neurotransmitter release requires SNARE complexes, which 
consist of several vesicle membrane and plasma membrane associated proteins. The 
alpha helical domains of these proteins twist into each other, pulling the vesicle 
membrane into close proximity to the plasma membrane (Yoon & Munson, 2018). 
Additional regulatory factors like the calcium sensor synaptotagmin and cytoskeleton 
associated tethers like ELKS mediate the proximity of the two membranes such that 
fusion occurs in response to an influx of calcium (Held & Kaeser, 2018; Yoon & Munson, 
2018). The SNARE complex inhibitor N-ethylmaleimide (NEM) drastically reduced 
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ionomycin-induced ATP release (Gutiérrez-Martín et al., 2011), providing evidence that 
N2a cells release ATP using vesicular mechanisms. Since VNUT is thought to load 
vesicles with ATP, knocking down VNUT should inhibit vesicular ATP release by 
preventing vesicle filling. Compared to cells overexpressing VNUT and a scrambled 
shRNA construct, N2a cells that were co-transfected with VNUT shRNA and the VNUT 
expression construct exhibited approximately 50% decrease in luminescence using the 
luciferin-luciferase assay (Menéndez-Méndez et al., 2015). These data support a VNUT-
mediated vesicular release of ATP from N2a cells. However, Panx1-mediated ATP 
release accounts for approximately 40% of KCl-induced ATP release (Wicki-Stordeur et 
al., 2012). Like synaptic release, Panx1 channels are calcium-activated. Inhibition of 
pannexin channels should result in only vesicular release while inhibition of VNUT and/or 
SNARE complexes should result in channel-dependent release. If VNUT is localized to 
synaptic vesicles, the application of the inhibitor clodronate should result in a similar 
reduction of ATP release as NEM inhibition of SNARE complexes. Finally, inhibition of 
basal release from Panx1 with probenecid and vesicular release using NEM and/or 
clodronate should abolish most ATP release in response to calcium ionophores such as 
ionomycin and A23187. 
While endogenous VNUT expression is low in N2a cells (Miras-Portugal et al., 2019), 
overexpression can be induced by transfecting the cells with exogenous expression 
constructs. VNUT overexpression changes the morphology of the cells, resulting in 
stunted neurite growth. Contrarily, neuritogenesis is increased when VNUT expression is 
knocked down (Menéndez-Méndez et al., 2015). The effect of overexpressed VNUT is 
presumably due to the increased ATP release (Menéndez-Méndez et al., 2015), 
subsequently increasing the activation of P2X7 receptors, which in turn inhibit neurite 
formation (Gómez-Villafuertes et al., 2009). These results demonstrate the functionality 
of both endogenous and overexpressed VNUT in N2a cells. 
Finally, previous work to develop fluorescently labeled, pH-sensitive VNUT and VMAT2 
reporters for studying ATP and catecholamine corelease was facilitated by the relatively 
quick culture time and robust post-transfection survival of the N2a cells (B. Kim, 2019). 
These characteristics, in addition to the expression of purinergic signaling components, 
combined with previous working knowledge of these cells point to the N2a cell line being 
an advantageous model for this research.  
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1.5. Thesis Hypotheses 
The overarching hypothesis of this research was that VNUT localization to a molecularly 
unique population of purinergic vesicles is driven by synaptic vesicle targeting motifs. 
This hypothesis was elaborated through two sub-hypotheses that are tested in their 
respective Aims. Aim 1 hypothesized that VNUT is localized to a population of purinergic 
synaptic vesicles that is distinct from catecholaminergic synaptic vesicles. This 
hypothesis was tested using fluorescent microscopy-based colocalization analyses to 
identify the molecular fingerprint of VNUT-containing vesicles, discussed in Chapter 3. 
Aim 2 hypothesized that a signaling motif that is responsible for targeting VNUT to 
synaptic vesicles resides in the C-terminal domain. Bioinformatic analyses of VNUT and 
other solute carriers were performed to answer this question and are described in 
Chapter 4. Initially, a third aim was developed to test the hypothesis that VNUT-
mediated, Ca2+-dependent ATP release from N2a cells is vesicular. Some experimental 
troubleshooting was completed and is described in Appendix A, but this hypothesis 
could not be tested due to COVID-19-related complications. 
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Chapter 2.  
 
General Methods 
2.1. Cell Culture 
2.1.1. N2a Cell Maintenance and Differentiation 
Neuro-2A (N2a) neuroblastoma cells (American Type Culture Collection CCL-131) are 
cancer cells that can be differentiated into postganglionic-like phenotypes resembling 
dopaminergic neurons. The N2a cells were maintained in growth media (GM) consisting 
of Dulbecco’s Modified Eagle Medium (DMEM) with high glucose and sodium pyruvate 
(4.5 g/L D-glucose, L-glutamine, 110 mg/L sodium pyruvate, ThermoFisher Scientific, cat 
# 10569), supplemented with 10% fetal bovine serum (FBS, Seradigm LIFE SCIENCE, 
cat# 97068-085) and 1X antibiotic-antimycotic (ThermoFisher Scientific, cat# 15240-
062), in cell culture treated 75 cm2 flasks (ThermoFisher Scientific, cat# FB012937). 
Cells grown in GM were typically round with few neurite-like extensions. The spherical 
cell bodies of in Figure 2.1, image A and inset, illustrate the proliferative phenotype 
observed when the cells are grown in growth media. Differentiation was induced via 
serum starvation using a retinoic acid differentiation media (DM). DM was prepared 
using the same DMEM supplemented with 0.1% FBS and 5 µM retinoic acid (Millipore-
Sigma, cat# R2625). The differentiated cells had smaller cell bodies and elongated 
neurites with occasional varicosity-like swellings (Fig 2.1B). Unless otherwise stated, all 
culture wear is tissue culture treated. Cells were trypsinized using TrypLE 
(ThermoFisher Scientific, cat# 12604013) incubated at 37°C for 3 minutes. When not in 
use during experiments or imaging, live cells were stored in a humidified cell culture 
incubator at 37°C with 5% CO2 and 95% air. 
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Figure 2.1 Proliferative and differentiated phenotypes N2a cells 
Phase contrast images were taken at 20X magnification after a three-day incubation in GM (A) or 
DM (B). Yellow-bounded regions are enlarged in the insets. Scale bar = 100 µm. 
N2a cells were seeded onto autoclaved #1 12 mm glass coverslips (ThermoFisher 
Scientific, cat# 12-545-80). Prior to cell culture, coverslips were aseptically transferred 
into a 24-well plate (VWR, cat# 10861-558). Approximately 100 µL of 10 µg/mL laminin 
in PBS (Corning via VWR, cat # 354232) was applied to the coverslips and allowed to 
cure at room temperature within the biosafety cabinet during cell harvesting and 
maintenance, about 20 minutes. The excess laminin was aspirated, GM was added to 
the wells and the cells were seeded down at 10-20 K cells per well. Note: Autoclaved 
coverslips were stored at room temperature in a sterile container.  
2.1.2. Transfection 
One day after seeding, cells were transfected with fluorescently labeled expression 
constructs at a 1:2 ratio of DNA to jetPRIME reagent using the jetPRIME DNA 
transfection kit and protocol from Polyplus (cat# 114-07). For example, 0.5 µg of DNA 
and 1 µL jetPRIME reagent was used to transfect one well of a 24-well plate. After 
application of the transfection mixture, cells were incubated at 37°C for four hours, 
followed by careful aspiration of the transfection media and replacement with fresh 
warmed GM. Cells recovered from transfection for one day prior to subsequent steps 
such as differentiation. See Table 2.1 for a list of expression constructs used. The 
LAMP-1-GFP and CGA-GFP constructs were gifted from SFU researcher Michael 
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Silverman. The GRABATP1.0 and VAMP2-mCherry constructs were gifted from Yulong Li 
of Peking University, China. 
Table 2.1 Expression constructs used  
Construct Name Probe Source Cat #  
GRABATP1.0 GFP (green) Li Lab, Peking University Patent Pending 
LAMP-1-GFP GFP (green) Silverman Lab, SFU Plasmid #16290 
LAMP-1-RFP RFP (red) AddGene.org Plasmid #1817 
CGA-GFP GFP (green) Silverman Lab, SFU n/a 
VAMP2-mCherry mCherry (red) Li Lab, Peking University n/a 
 
2.2.  Immunocytochemistry 
2.2.1. Immunostaining Workflow 
After three days of retinoic acid-induced differentiation, the cells were fixed using 4% 
paraformaldehyde (PFA) in PBS (Electron Microscopy Sciences, cat# 15710) for 15 
minutes, then washed three times with PBS for 2 minutes each. All incubation times 
occurred in the dark (i.e., a drawer) at room temperature unless otherwise stated. Cell 
were permeabilized with 0.1% Triton-X 100 (Millipore-Sigma, T8787) in PBS for 15 
minutes, followed by three PBS washes and a one-hour incubation in blocking solution 
(4% normal goat serum (NGS) (Millipore-Sigma, cat# NS02L) in PBS). Primary 
antibodies were diluted in the blocking solution, applied the diluted antibodies to the 
cells, and incubated overnight at 4°C. The next day, a 20-minute wash with 1 µg/mL 
Hoechst-33342 (Invitrogen Molecular Probes, cat# H3570) was followed by two PBS 
washes of 5 minutes each. Secondary antibodies were diluted in blocking solution, 
applied to the cells, and allowed to incubate for one hour. After three five-minute PBS 
washes, cells were post-fixed with 4% PFA for 15 minutes then washed three times with 
PBS for two minutes per wash. Coverslips were mounted onto glass slides using 
ProLong Glass Antifade Mountant (ThermoFisher Scientific, cat# P36984), cured 
overnight, and stored until imaging. Unmounted coverslips were stored in PBS at 4°C 
until use. Table 2.2 summarizes all antibodies used. Figure 2.2 illustrates all three 
experimental workflows, ICC-only (Fig 2.2A), transfection-only (Fig 2.2B), and hybrid 
ICC and transfection (Fig 2.2C). 
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Figure 2.2 Workflow for immunocytochemistry-based, transfection-based, and 
hybrid experiments 
A: Immunocytochemical preparation of cells for colocalization analysis. Although only one antigen 
is show in the figure, VNUT and one or two other antigens were stained at the same time. B: Co-
transfection experiments were used to corroborate immunocytochemical findings. In these 
experiments, LAMP-1-RFP was co-transfected with an N-terminal EGFP tagged VNUT or a C-
terminal EGFP tagged VNUT. C: Hybrid experiments were used to assess VNUT colocalization 
with VAMP2-mCherry or LAMP-1-GFP. This figure shows a secondary antibody with a green 
fluorophore, which was been used with VAMP2-mCherry. Not shown is a red fluorophore-




Table 2.2 Antibodies used  
Poburko Lab ID Target Species Isotype(s) Source, Cat # Dilution 
CGA Chromogranin A Mouse IgG1 Silverman Lab, Invitrogen (MA5-13096) 100X 
LAMP-1 LAMP-1 Mouse IgG2a Silverman Lab, Millipore Sigma (AMAB91170) 100X 
Synapsin Synapsin Mouse IgG1 Silverman Lab 200X 
Syp Synaptophysin Mouse IgG1 Abcam (AB8049) 200X 
Syt 1 Synaptotagmin 1 Mouse IgG2a Abcam (AB13259) 200X 
Syt 2 Synaptotagmin 2 Mouse IgG1 Santa Cruz (SC-136089) 200X 
Syt 5 Synaptotagmin 5/9 Mouse IgG2a Santa Cruz (SC-398837) 200X 
Syt 7 Atto Synaptotagmin 7 Mouse IgG2b StressMarq Biosciences (SMC-424) 200X 
SV2a SV2a Mouse IgG1 Abcam (AB49572) 200X 
ELKS ELKS Mouse IgG2a Millipore Sigma (E4531) 200X 
VMAT2 (D-4) VMAT2 Mouse IgG1 Santa Cruz Biotech (SC-3902285) 100X 
SLC17A9 (T-12), 
lot G1812 VNUT Rabbit Polyclonal 
Santa Cruz Biotech (SC-
86313) 200X 
SLC17A9 (T-12), 
lot J1215 VNUT Rabbit Polyclonal 
Santa Cruz Biotech (SC-
86313) 200X 
SCL17A9, ANT-
085 VNUT Rabbit Polyclonal 
Alomone Labs (ANT-
085) 2000X 
gArb555 Rabbit IgG Goat Polyclonal Invitrogen (A21429) 1000X 
647 IgG2a Mouse IgG2a Goat IgG2a Invitrogen (A21241) 1000X 
647 IgG1 Mouse IgG1 Goat IgG1 Invitrogen (A21240) 500X 
AF647 GaR Rabbit IgG Goat Polyclonal Invitrogen (A21244) 1000X 
gArb 488 Rabbit IgG Goat Polyclonal Invitrogen (A11034) 1000X 
555 IgG2a Mouse IgG2a Goat IgG2a Invitrogen (A21137) 500X 




2.3. Fixed Cell Imaging 
Fluorescent microscopy was done using a CFI Plan Apo Lambda 100X 1.45 NA 
objective on a Nikon Ti-E scope and attached Zyla 5.5 CMOS camera as previously 
described (Kalkhoran et al., 2019). Images were acquired at z-steps of 200 nm, about 11 
steps per image, to capture the depth of the cell body, neurites, and varicosities. All 
channels of a multi-coloured image were acquired at each z-step to ensure axial 
alignment.  
2.4. Image Analysis 
2.4.1. ImageJ/FIJI 
All image data was processed using ImageJ/FIJI (Schindelin et al., 2012). Fixed cell 
image stacks were compressed into a single z-plane through the Extended Depth of 
Field plugin (Aguet et al., 2008). Cell parts (e.g., neurites, somas, varicosities) were 
hand-traced and labeled. The RIPA macro generates ROIs through a series of 
thresholds, bounding each punctum based on user inputs such as fluorescent intensity 
relative to background, puncta size in pixels, puncta circularity, and puncta solidity, 
Figure 2.3 (Kalkhoran et al., 2019). Prior to analysis, images were preprocessed with a 
10-pixel rolling ball background subtraction and a 1-pixel radius two-dimensional 
Gaussian blur. If necessary, conjoined ROIs were separated using a unsharp mask 
radius of 0.8 pixels. Images were watershed on the final loop of RIPA, then the final 
ROIs were drawn. All input parameters were saved in the output RIPA folder, allowing 
repeat iterations.  
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Figure 2.3 RIPA bounding of ROIs based on user input 
RIPA-drawn ROIs are shown around puncta in each channel of a three-channel image containing 
immunolabeled VNUT (green), LAMP-1 (red), and VMAT2 (purple). Lower right image shows the 
hand-traced cell parts (yellow). The arrow indicates the terminal varicosity in which RIPA 
bounded puncta ROIs are shown. While RIPA will bound all ROIs in an image through multiple 
steps of thresholding, only the ROIs that are within a cell part are analyzed. This excludes most 
instances of background fluorescence from analysis. RIPA-drawn ROIs were bounded using 
conservative input parameters (0.7 ≤ circularity ≤ 1; 0.7 ≤ solidity ≤ 1; 9 ≤ area ≤ 100 pixels; 
exclude 5 pixels from edge of image). Scale bar = 5 µm unless otherwise stated. 
MINER analysis followed, which fitted the RIPA-drawn ROIs with a Gaussian fit to 
identify the full-width half-max of the major and minor axes (Kalkhoran et al., 2019). The 
nearest neighbor analysis then identified puncta that are closest to puncta from the 
reference channel, as selected by the user, within each cell part. Figure 2.4 exemplifies 
the FWHM calculations, as well as the identification of nearest neighboring (NN) LAMP-1 
and VMAT2 puncta to the VNUT reference puncta. 
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Figure 2.4 MINER workflow and outputs 
Top: Graphs show the change in fluorescent intensity of puncta along the path of the white line in 
the two-channel image. The FWHM of each punctum is calculated using the average of the 
FWHM values along the major and minor axes (white) of each punctum. Bottom: The VNUT 
reference punctum was assessed for NN puncta. For images containing multiple NN channels, 
such as LAMP-1 and VMAT2, each reference punctum is assigned an NN puncta for each NN 
channel. Image contrasts were scaled by puncta. Original images were not saturated. Scale bar = 
500 nm. 
The MINER macro was validated as a tool for colocalization analysis. In this validation, 
the LAMP-1 and VMAT2 channels of a previous colocalization analysis image were 
separated out of the image, isolating the VNUT channel and corresponding ROIs. This 
VNUT image was copied, and the puncta were randomized using the Poburko lab macro 
RandomizeByROIsV1.5.4. This macro uses the ImageJ/FIJI random number generator 
to assign the ROIs new (x,y) co-ordinates within a boundary ROI. Instead of using cell 
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part ROIs, the MINER validation test and the randomization trial (described in the next 
paragraph) used whole cell ROIs that were generated by thresholding the images to 
create tight cell outline. I wanted to minimize expanding the cell ROI area in which the 
VNUT puncta would be randomized. Hand tracing is prone to increasing the cell ROI 
size, which would then underestimate the frequency of colocalization. An example of cell 
ROI generation and subsequent randomization of VNUT ROIs within the cell boundary is 
shown in Figure 2.5. The image containing the randomized puncta was then merged 
with the original image as an additional channel. The resultant two-channel image 
contained the randomized VNUT puncta that were pseudocoloured magenta and the 
original, green VNUT puncta. The MINER macro was used to analyze this image using 
the original arrangement of VNUT puncta as the reference channel. The reference 
puncta were assessed for having nearest neighbouring (NN) randomized VNUT puncta 
or original VNUT puncta channel within their perimeter or touching their periphery as 
described in the previous colocalization analysis. 
The likelihood of random colocalization compared to experimentally observed 
colocalization was quantified using a randomization trial. VNUT puncta from 8 cells were 
scrambled throughout the cell boundary ROIs using the RandomizeByROIsV1.5.4 
macro. The VMAT2 and LAMP-1 puncta were unchanged. The MINER macro was used 
to analyze the frequencies of colocalization between the randomized or original VNUT 
reference puncta and their assigned NN LAMP-1 and VMAT2 puncta. These frequencies 
were compared to those of the original analyses. 
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Figure 2.5 Randomization of VNUT puncta 
Top: The ImageJ thresholding tool was used to generate cell outlines that were tighter than the 
hand-drawn cell part ROIs. Scale bar = 20 µm. Bottom: The ROIs and the pixels contained within 
them (square zoom, left) were randomized within the cell boundary. The outlines of the 
randomized ROIs are overlayed on the original imaging (square zoom, right). Scale bar = 2.5 µm. 
The randomized coordinates were saved for each ROI and these ROIs were treated as an 
additional channel in subsequent randomization analyses. 
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2.4.2. JMP and Statistical Analysis 
I analyzed my data using JMP software (JMP®, Version 15. SAS Institute Inc., Cary, NC, 
1989–2021). Colocalization was calculated between the assessed markers and VNUT 
by measuring puncta size and the distance from the perimeter of the reference puncta to 
the center of the nearest neighbour (NN) puncta. Colocalized puncta were defined as 
reference puncta that contained their NN puncta within their periphery (i.e., overlapped 
such that the center of the NN puncta was within the bounds of the reference). 
Touching puncta were defined when the NN center and the perimeter of a reference 
ROI was less than the half-width at half-maximal intensity (HWHM) of the NN puncta. 
Puncta were defined as not touching if the distance between the reference punctum 
perimeter was greater than the HWHM of the NN punctum. Figure 3.3 in Section 3.2 
illustrates the physical relationships defined above. The reported mean values for 
fraction of within, touching, and not touching puncta were calculated from the percent of 
reference puncta from each category out of the total population of reference puncta. 
Statistical significance testing of different degrees of colocalization for each marker 
between cell parts was assessed using an ANOVA. Where significant differences were 
detected, a Tukey honestly significant differences (HSD) post hoc test was used to 
identify which cell part means were significantly different. The Student’s T Test was used 
to identify significant differences between means of randomized VNUT puncta and the 
original puncta arrangement in the randomization trial. 
Reversed MINER analyses were used to assess the relative proportion of colocalization 
between markers and VNUT. The analysis workflow was the same as described above 
except the marker was the reference channel and VNUT was the NN channel.  
2.4.3. Adobe Illustrator and Figure Building 
Figures were built by importing JMP graphs into Adobe Illustrator, where I consolidated 
data for each marker as appropriate. I finalized formatting, spacing, sizing, fonts, and 
colours for consistency and readability.   
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2.4.4. Microbiology 
Expression constructs were transformed into DH10β (ThermoFisher Scientific, Cat# 
EC0113) or NEB5α Escherichia coli (New England BioLabs, cat# C2987H) for 
amplification. The plasmids were extracted using the PureYield Plasmid Midiprep 
System (Promega, cat# A2392) and stored at -20°C until transfection. Bacterial glycerol 
stocks were prepared using a 1:1 solution of LB Broth and 40% glycerol in water and 
stored at -80°C. I followed the AddGene protocol for glycerol stocks, including the 
preceding instructions “Inoculating an Overnight Liquid Culture,” which can be found at 
https://www.addgene.org/protocols/create-glycerol-stock/.  
2.4.5. Bioinformatic Analysis of VNUT 
GenBank sequences for VNUT, VMAT2, VAChT, VGLUT1-3, and sialin were retrieved 
en masse from NCBI, encompassing approximately 800 sequences from kingdom 
Animalia with representatives from Classes Mammalia, Aves, Reptilia, Amphibia, 
Chondrichthyes, Actinopterygii, Hyperoartia, Bivalvia, Trematoda, and Insecta. An in-
house, regex-based motif searching R script was used to analyze the peptide sequences 
for signaling sequences or motifs. The R script can be found on GitHub: 
https://github.com/dpoburko/bioInformaticsTools/blob/master/motifSearch.R. Positive 
motif matches were listed in an output Excel file, which were then compiled into JMP for 
analysis and graphing. VNUT sequences were compared to SLC17A and SLC18A family 
members using the R script. Comparisons between VNUT and other solute carriers 
across all Classes were visualized in JMP. 
Alignment analyses of amino acid and nucleic acid sequences were completed using 
CLC Genomics Workbench. Structural comparisons between human transporters were 
built with the Constrained Consensus Topology prediction server (CCTOP), CLC, and 
the secondary structure visualization tool Protter. CCTOP was used to predict 
transmembrane domains, while Protter and CLC were used to illustrate secondary 
structure and amino acid sequences, respectively. 
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Chapter 3.  
 
Inconclusive VNUT Localization to Vesicle-Like 
Compartments 
3.1. Rationale 
The subcellular localization of VNUT varies depending on cell type. Evidence for 
localization to lysosomes includes the reduction of ATP uptake into lysosomes isolated 
from COS1 cells when exposed to non-specific inhibitors of VNUT DIDS and Evans Blue 
(Cao et al., 2014; Zhong et al., 2016). Since DIDS and Evans blue inhibit other 
transporters, it is unclear how much of the reduction in ATP uptake can be attributed to 
VNUT. Inhibitors of connexin and pannexin hemichannels, carbenoxolone and niflumic 
acid, did not reduce ATP uptake into lysosome fractions (Cao et al., 2014; Zhong et al., 
2016). VNUT shRNA expression in C2C12 cells significantly decreased ATP uptake into 
lysosome lysates while overexpression of GFP-tagged VNUT resulted in faster uptake of 
ATP (Cao et al., 2014). Studies of primary cortical astrocytes also suggest VNUT is 
localized to lysosomes via immunocytochemistry and live-cell imaging using 
LysoTracker (Oya et al., 2013), although data derived from pH-sensitive dyes requires 
careful interpretation due to non-specific accumulation. For example, LysoTracker 
accumulates in acidified compartments and as such is sold as a lysosome marker. 
However, vesicles and endosomes are also acidic organelles that can be stained with 
LysoTracker (S. Li et al., 2014; Moreno, Ramalho-Santos, Chan, Wessel, & Schatten, 
2000). A study using astrocytes provides what is arguably the most direct evidence of 
ATP release from lysosomes (Zhang et al., 2007). Instead of relying on the 
bioluminescence assay or pH-sensitive probes, extended incubation of astrocytes with 
the AM1-43 dye resulted in selective staining of lysosomes, confirmed by colocalization 
with lysosomal membrane markers LAMP-1 and CD-63. Exocytosis-induced lysosomal 
de-staining was observed in response to ATP as well as chemically induced hypoxia 
with potassium cyanide (KCN). The calcium chelator BAPTA-AM inhibited de-staining 
while ionomycin increased AM1-43 de-staining (Zhang et al., 2007). To demonstrate 
lysosomal exocytosis of ATP, the cells were stained with GFP-conjugated lysosomal 
marker CD63 and MANT-ATP to confirm MANT-ATP localization to lysosomes. The 
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subsequent MANT-ATP de-staining in response to KCN provides strong evidence of 
lysosomal exocytosis of ATP (Zhang et al., 2007).  
Microglia cells provide strong evidence of vesicular ATP release (Imura et al., 2013). 
Ionomycin-induced ATP release is significantly reduced in the presence of the calcium 
chelator BAPTA-AM, the vesicle trafficking inhibitor brefeldin A, the V-ATPase inhibitor 
bafilomycin, and the SNARE complex inhibitor botulinum A (Imura et al., 2013). These 
results support vesicular ATP release. VNUT knockdown via siRNA reduced ATP 
release in response to ionomycin and ATP by approximately 32% and 50%, respectively  
(Imura et al., 2013). Colocalization of quinacrine and MANT-ATP to VNUT-RFP puncta 
was observed in murine MG5 cells using total internal reflection fluorescence (TRIF) 
microscopy. Quinacrine and MANT-ATP de-staining was observed in response to 
ionomycin and ATP. Immunostaining for LAMP-1 and VNUT did not corroborate the 
lysosomal localization of VNUT as these puncta were distinctly anti-colocalized (Imura et 
al., 2013). These data strongly point to VNUT localization to purinergic vesicles and the 
vesicular release of ATP. N2a cells are able to release ATP via pannexin channels and 
SNARE complexes (Gutiérrez-Martín et al., 2011; Menéndez-Méndez et al., 2015; Xu et 
al., 2018). Lysosomal release of ATP has not been demonstrated in N2a cells.  
3.2. Assessing the Subcellular Localization of VNUT 
In Aim 2 of my thesis, I sought to quantify colocalization between VNUT and markers of 
exocytotic compartment(s) such as synaptic vesicles, secretory vesicles, and secretory 
lysosomes, with the goal of generating a molecular fingerprint of VNUT-containing 
vesicles. Briefly, immunocytochemistry and transfection techniques visualized 
fluorescent probes for VNUT and the vesicle population markers. After image 
acquisition, processing, and analysis, I quantified colocalization by categorizing nearest 
neighbouring (NN) marker puncta into three groups, as described two paragraphs below 
this one and illustrated in Figure 3.3. Possible vesicle population markers were 
discussed in Chapter 1, Section 1.2.3, but I will take a moment to review the markers 
that I studied as shown in Figure 3.1. Due to the possibility of VNUT associating with 
lysosomes, LAMP-1 colocalization with VNUT was assessed. Chromogranin A (CGA) 
was used as a marker of secretory vesicles, while VMAT2 was used to identify 
catecholaminergic synaptic vesicles. ELKS was used as an active zone marker. 
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Synaptic vesicle proteins synapsin, SV2a, synaptophysin, and synaptobrevin (VAMP2) 
were used as markers of synaptic vesicles. 
  
Figure 3.1 Identifying the molecular fingerprint of VNUT-containing vesicles 
Each of the assessed markers are shown within their associated membranes. ELKS, a soluble 
scaffolding protein that is concentrated in active zones, is shown as a red gradient in the cartoon 
at upper left. The upper right cartoon depicts the predicted molecular architecture of a VNUT-
containing vesicle. Created with Biorender.com. 
In addition to the previously mentioned synaptic vesicle proteins, I analyzed the 
frequency of overlap of four calcium-sensitive synaptotagmin isoforms with VNUT: Syt1, 
Syt2, Syt5 (also known as Syt 9), and Syt 7. Isoforms 1, 2, and 5/9 reside in synaptic 
vesicle membranes and mediate vesicle fusion in a calcium-dependent manner 
(Maximov, 2009). Syt7 has a role in mediating asynchronous release of 
neurotransmitters as well as the replenishment of synaptic vesicles during tonic 
transmission (H. Liu et al., 2014). The anti-Syt7 antibody was non-specific, as shown in 
Figure 3.2, thus no Syt7 data was acquired. A fifth isoform, Syt4, is associated with 
secretory vesicles (Dean et al., 2009; Mori & Fukuda, 2011), the Golgi apparatus (Arthur, 
Dean, Pagratis, Chapman, & Stowell, 2010; Ibata, Fukuda, Hamada, Kabayama, & 
Mikoshiba, 2000), and retrograde signaling (Yoshihara, Adolfsen, Galle, & Littleton, 
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2005). Syt4 is expressed in N2a cells (data not shown) but was not tested for 
colocalization with VNUT due to incompatible antibody species.  
I will outline some general notes for analyzing the characteristics of each vesicle marker. 
First, puncta size was calculated from the average of the major and minor FWHM values 
of fluorescent puncta. When calculating puncta 
size, I included all data regardless of whether 
the VNUT reference puncta had unique 
nearest neighbour (i.e., vesicle marker) puncta. 
In some cases, one NN puncta might be the 
closest puncta in the NN channel to multiple 
reference puncta. In our analyses, a NN 
puncta was only allowed to be assigned to its 
closest puncta in the reference channel. The 
more distant reference puncta were designated 
as not having a NN puncta.  
Second, when performing the colocalization 
analysis, I characterized reference puncta into 
three groups: reference puncta that do not 
touch a NN punctum, reference puncta that 
touch a NN punctum, and reference puncta 
that contain their NN puncta within their periphery as drawn by RIPA. Figure 3.3 
illustrates example arrangements of puncta from each group described above.  
Lastly, colocalization data were assessed using an ANOVA comparison, followed by a 
Tukey HSD post hoc test. Statistically significant data are denoted in the figures of this 
chapter by an asterisk. Only significant comparisons, defined as p<0.05, are annotated.  
Figure 3.2 Anti-Syt7 antibody shows 
non-specific binding 
This is a representative image showing the 
extracellular staining of the anti-Syt7 
antibody, shown in magenta. Anti-VNUT 
staining is largely restricted to the cells and 
is shown in green. Scale bar = 20 µm. 
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Figure 3.3 Categorization of nearest neighbouring puncta based on degree of 
colocalization with reference puncta 
The nearest neighbour (NN) punctum is r2epresented by the left sphere (pink) while the reference 
punctum is on the right (green) of each pairing. The Gaussian fit of the fluorescent signal from the 
NN punctum is illustrated above the corresponding sphere, under which the half-width, half-max 
(HWHM) value of the NN puncta is illustrated by a pink line. The distance to the center of the NN 
punctum is measured from the perimeter of the reference punctum. 
3.2.1. Validation of Semi-Automatic, High-Throughput Colocalization 
Analysis using MINER in N2a Cells 
VNUT Self-Colocalization Trial 
To test the accuracy of the MINER colocalization analysis, I analyzed the frequency of 
colocalization between two arrangements of VNUT puncta within an N2a cell. Using the 
original puncta as the reference channel, I analyzed the frequency of reference puncta 
that had an NN randomized or original puncta within their perimeter or were touching 
their NN puncta using the MINER macro. Panel B in Figure 3.4 shows the MINER 
output, which highlights the reference and NN puncta in relation to each other. The 
resultant analysis illustrated the accuracy with which MINER detected 98% of original 
NN puncta as residing within their reference puncta (Fig 3.4D), indicated in Table 3.1. 
The average distance from the reference perimeter to the center of the assigned original 
NN puncta was -76 nm (Figure 3.4C). Throughout this thesis, this is the only negative 
mean Distance From Perimeter (dFromP) value reported. Since the original NN puncta 
were not moved, the 2% of “other” puncta (i.e., reference puncta that did not touch their 
NN puncta) indicates the error rate of the MINER analysis method (Table 3.1). 
Moreover, the fraction of reference puncta containing their nearest neighbouring 
randomized VNUT puncta within their periphery was 10% with an average distance from 
perimeter (dFromP) of 291+/-233 nm (Table 3.1). These data suggest that the NN 
puncta were sufficiently randomized throughout the cell by the ROI-randomizing macro 
in ImageJ/Fiji.  
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Table 3.1 Results of VNUT self-colocalization analysis 
NN Puncta Within Touching Other dFromP (nm) 
Original 97.7 0 2.3 -75.6 (86.9) 




Figure 3.4 Validation of MINER via VNUT self-colocalization analysis 
A: This cartoon illustrates the original arrangement of the VNUT puncta within the N2a cell (green 
dots). The purple borders indicate that these puncta were analyzed as NN puncta in a self-
analysis and correspond to the purple boxplot in C and the purple dots in D and E. The VNUT 
puncta in the randomized arrangement (pink dots) are the NN puncta that were analyzed using 
the original puncta as the reference channel. The analysis of these puncta is colour coded in 
panels C, D, and E as a pink boxplot and pink dots, respectively. B: The MINER output shows all 
analyzed ROIs. The reference ROIs are highlighted with yellow outlines, the randomized VNUT 
ROIs are outlined in magenta, and the magenta lines connect NN puncta to their nearest 
reference puncta. Grey boxes highlight reference puncta not assigned to an NN puncta. Scale bar 
= 0.5 µm. C: Numbers above each boxplot refer to n, number of puncta; diamonds illustrate 95% 
confidence interval of mean; bar indicates median value. D,E: Numbers above each dot indicate 
the N, number of cells; NN, nearest neighbour. C,D,E: O, original; R, randomized. 
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Assessing Colocalization of Randomized VNUT Puncta with LAMP-1 and 
VMAT2 in N2a Cells 
I sought to develop thresholds at which I could deem a protein to be colocalized with 
VNUT. Due to difficulties developing and acquiring an shRNA-based negative control 
condition, my next best option was to use the acquired data to create a randomized 
control condition. The randomization of ROIs is described in Section 2.4.1. The 
randomized VNUT puncta of 8 cells were assessed in parallel to the original images, 
using the RIPA and MINER macros as previously described. The distances from the 
perimeter of the VNUT reference puncta to the centers of the nearest neighbouring 
LAMP-1 and VMAT2 puncta were compared. The frequencies of reference puncta 
containing their NN puncta within their perimeter and touching their NN puncta were also 
compared. The Student’s T test was used to test for significant differences between the 
mean frequency of reference puncta containing NN within periphery for the randomized 
and original VNUT puncta, Figure 3.5B. Similarly, the differences in mean frequency of 
reference randomized or original VNUT puncta touching their NN puncta was tested (Fig 
3.5C). Significant differences are denoted by an asterisk (*) in Figure 3.5B and C.  
The average distances from the perimeter of the original VNUT puncta to the centers of 
the NN puncta were 162 (± 155) nm for LAMP-1 and 167 (±154) nm for VMAT2. The gap 
widened when the VNUT puncta were randomly arranged throughout the cells, with the 
perimeter of the VNUT puncta being an average of 183 (± 155) nm and 196 (± 158) nm 
away from the centers of LAMP-1 and VMAT2 NN puncta (Fig 3.5A). The fraction of 
reference puncta containing their LAMP-1 NN puncta within their perimeter was, on 
average, 11.7% for the original VNUT puncta and 8.0% for the randomized VNUT 
puncta (Fig 3.5B). Similarly, the average fraction of reference puncta that had their 
VMAT2 NN puncta within their periphery was 10.3% for the randomized VNUT puncta 
and 14.0% for the original VNUT puncta (Fig 3.5B). The randomized reference puncta 
had a lower average frequency of touching their LAMP-1 NN puncta (12.5%) compared 
to the original VNUT reference puncta (15.6%), Figure 3.5C. For VMAT2, the original 
reference puncta touched their NN puncta an average of 9.2% of the time, which 
dropped to 6.3% when the reference puncta were randomized (Fig 3.5C). Tables 3.2 
and 3.3 summarize the randomization trial data, with standard deviations in brackets. 
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Figure 3.5 Characterization of colocalization between randomized and non-
randomized VNUT puncta and LAMP-1 and VMAT2 puncta 
A: Top-most numbers refer to cell number; stacked pair of numbers above each set of four 
boxplots refer to n, number of puncta; diamonds illustrate 95% confidence interval of mean; bar 
indicates median value. B,C: NN, nearest neighbour (i.e., LAMP-1 or VMAT2); numbers above 
each boxplot refer to N, number of cells analyzed; dots indicate mean value; bar indicates median 
value. A-C: O, original arrangement of VNUT puncta as seen in ICC images; R, randomized 
VNUT puncta that were randomly shuffled within each cell using an ImageJ plugin; LAMP-1 data 
is shown on the left-hand side of each pairing (A) and on the leftmost graphs (B,C) in purple; 
VMAT2 data is shown on the right-hand side of each pairing (A) and on the rightmost graphs 
(B,C) in pink. 
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Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 Cell 6 Cell 7 Cell 8 Average 
Within LAMP-1 Original 12.2% 11.1% 11.4% 13.0% 11.6% 11.9% 11.4% 11.0% 11.7%   
Randomized 10.6% 9.4% 9.1% 7.0% 7.5% 7.2% 7.2% 5.7% 8.0%  
VMAT2 Original 12.2% 12.9% 14.4% 16.7% 12.7% 14.5% 14.6% 13.7% 14.0%   
Randomized 11.0% 11.7% 11.7% 10.7% 8.5% 8.4% 10.1% 10.0% 10.3%            
 
Touching LAMP-1 Original 16.1% 15.4% 15.9% 16.5% 16.3% 13.0% 15.8% 15.6% 15.6%   
Randomized 13.5% 13.8% 13.9% 11.1% 12.3% 10.2% 12.3% 12.8% 12.5%  
VMAT2 Original 7.6% 9.1% 9.2% 9.5% 10.8% 8.1% 9.5% 9.5% 9.2%   
Randomized 5.9% 7.5% 7.6% 5.0% 6.1% 6.5% 5.9% 6.1% 6.3% 
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3.2.2. Analysis of VNUT Colocalization with LAMP-1 
To test VNUT localization to lysosomes, I assessed the degree of colocalization between 
VNUT and LAMP-1. In case of non-specific recongition of off-target proteins by the 
LAMP-1 or VNUT antibodies, I also assessed the colocalization of VNUT N- or C-
terminally-conjugated EGFP construct that was co-transfected with a LAMP-1-RFP 
construct. Figure 3.6 shows typical, punctate patterning of the immunolabeled LAMP-1 
and VNUT as well as the exogenously expressed LAMP-1-RFP and EGFP-conjugated 
VNUTs alike. In the soma, VNUT puncta are primarily localized to the perinuclear space, 
while larger and brighter LAMP-1 puncta surround the periphery of the cell body as 
indicated by the arrow (Fig 3.6C). The neurites and varicosities exhibited some overlap 
between VNUT and LAMP-1 (arrow), although most of the VNUT-containing puncta 
appeared to be anti-colocalized with the LAMP-1 puncta (Fig 3.6F). Exogenous 
expression of LAMP-1-RFP and VNUT-EGFP resulted in punctate fluorescence similar 
to LAMP-1 and VNUT immunostaining, although the puncta seemed to aggregate at the 
perinuclear space to a greater extent than the immunostained counterparts (Fig 3.6I). 
Overlap of the overexpressed VNUT-EGFP and LAMP-1-RFP (arrows) occurred more 
often than with the immunostaining counterparts, perhaps due to accumulation of the 
exogenous constructs in the endoplasmic reticulum or Golgi (Fig 3.6J-L).  
Across all cell parts, the average distance of LAMP-1 puncta from the perimeter of 
VNUT reference puncta was 146 nm (Fig 3.6M). On average, LAMP-1-RFP NN puncta 
were 107 nm from the perimeter of their VNUT-EGFP reference puncta. The whole-cell 
average frequency of VNUT reference puncta that contained their NN LAMP-1 puncta 
within their periphery was 12.1%. Statistically significant differences were seen between 
soma (10.6%), neurites (14.2%), and terminal varicosities (10.7%) (Fig 3.6N). VNUT-
EGFP reference puncta contained their LAMP-1-RFP NN puncta slightly more often than 
their immunolabeled counterparts, with a whole cell average of 15.6%. Significant 
differences were seen in the means of neurites (10.8%), varicosities (15.1%), and 
terminal varicosities (23.5%), with the latter housing the highest fraction of NN-
containing VNUT-EGFP puncta (Fig 3.6N). The fraction of VNUT reference puncta 
touching their assigned NN puncta tended to increase from soma to terminal varicosities, 
but these differences did not reach statistical significance. The average fraction of 
LAMP-1-adjacent VNUT reference puncta was 16.4%, while the average fraction of 
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LAMP-1-RFP-touching VNUT-EGFP puncta was 8.7% (Fig 3.6O). The highest fraction of 
VNUT-EGFP and NN LAMP-1-RFP touching occurred in neurites at 12.3%.  
Reversing the MINER analysis such that LAMP-1 or LAMP-1-RFP were the reference 
channels and VNUT or VNUT-EGFP served as the NN channels resulted in similar 
distances from perimeter values to VNUT or VNUT-EGFP being the reference. The 
average distances of LAMP-1 and LAMP-1-RFP to native and exogenous VNUT NN 
puncta were 139 nm and 101 nm, respectively (Fig 3.6P). Similar to panel N, the 
differences between the fraction of LAMP-1 or LAMP-1-RFP reference puncta containing 
their NN pucnta within their perimeter did not reach statistical significance. The average 
fraction of LAMP-1 and LAMP-1-RFP having the center of an NN VNUT or VNUT-EGFP 
puncta within their periphery was 15.3% and 12.5%, respectively (Fig 3.6Q). The fraction 
of NN VNUT-EGFP puncta that touched their reference LAMP-1-RFP puncta averaged 
out to 7.3% with statistically significant differences in means detected between soma 
(11.1%) and collectively neurites and terminal varicosities (4.9%) (Fig 3.6R). The 
average size of LAMP-1 and LAMP-1-RFP puncta were 286 nm and 327 nm, 
respectively. Across all analyses for VNUT-LAMP-1 colocalization, including the LAMP-
1-GFP and immunostained VNUT hybrid experiment shown in Figure 3.7 (below), the 
average size of VNUT-containing puncta was 255 nm (Fig 3.6S). 
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Figure 3.6 Immunostaining for LAMP-1 and exogenously expressed LAMP-1-RFP do not colocalize with VNUT 
A-C,G-I: Scale bar = 20 µm. D-F,J-L: Scale bar = 5 µm. M,P,S: Numbers above each boxplot refer to n, number of puncta; diamonds 
illustrate 95% confidence interval of mean; bar indicates median value. N,O: NN, nearest neighbour (i.e., LAMP-1 or LAMP-1-RFP). Q,R: 
Ref, refers to reference protein (i.e., LAMP-1 or LAMP-1-RFP). N,O,Q,R: Numbers above each boxplot refer to N, number of cell parts 
analyzed; dots indicate mean value; bar indicates median value. S: VNUT is represented by the green boxplots on the left of each pairing; 




An additional assessment of VNUT localization to lysosomes used a LAMP-1-GFP 
expression construct in conjuction with immunostaining for VNUT, resulting in a hybrid 
probe experiment (Fig 3.7). The accumulation of LAMP-1-GFP to the perinuclear region, 
as indicated by the arrow (Fig 3.7A), was similar to LAMP-1-RFP (seen in Figure 3.6G-I). 
In contrast, VNUT exhibited a consistently punctate pattern of fluorescence throughout 
the cell. Some LAMP-1-GFP puncta trafficked to neurites and, like LAMP-1-RFP, 
occaisonal fluorescent overlap was visible with VNUT (Fig 3.7D-F). Similar to the LAMP-
1 and LAMP-1-RFP analyses, LAMP-1-GFP puncta were largely anti-colocalized with 
antibody-labeled VNUT.  
Compared to the LAMP-1 and LAMP-1-RFP counterparts, the average distance between 
the center of LAMP-1-GFP NN puncta and the perimeter of the reference VNUT puncta 
was slightly larger at 160 nm (Fig 3.7J). An average frequency of 7.9% of VNUT puncta 
contained their NN LAMP-1-GFP puncta within their periphery and 9.4% of VNUT puncta 
were touching their NN LAMP-1-GFP puncta (Fig 3.7K,L).  
When LAMP-1-GFP served as the reference channel and VNUT as the nearest 
neighbouring channel in a reverse MINER analysis, the average distance from LAMP-1-
GFP perimeter of VNUT puncta was 99 nm (Fig 3.7M). The average fraction of LAMP-1-
GFP reference puncta containing their NN VNUT puncta was 24.7%, likely due to the 
decreased density of LAMP-1-GFP compared to VNUT puncta. An average of 8.7% of 
LAMP-1-GFP-containing blobs touched their NN VNUT-containing blobs (Fig 3.7N,O). 
The average size of LAMP-1-GFP puncta was 295 nm (Fig 3.7P), which was 
comparable to the sizes of the LAMP-1 (286 nm) and LAMP-1-RFP (327 nm) puncta.  
The difference in frequency of reference puncta containing their NN puncta in the VNUT 
reference and reverse MINER experiments indicate that LAMP-1-GFP puncta contained 
a NN VNUT puncta more often than VNUT puncta reference puncta contained a NN 
LAMP-1-GFP puncta. This could be due to the size difference between the VNUT and 
LAMP-1-GFP puncta. Since the LAMP-1-GFP puncta are larger than the VNUT puncta, 
it is conceivable that the centers of VNUT puncta would be detected within the periphery 
of the LAMP-1-GFP puncta, but not vice versa. However, the LAMP-1/VNUT and LAMP-
1-RFP/VNUT-EGFP colocalization analyses are based on at least three independent 
replicates. The anti-VNUT/LAMP-1-EGFP colocalization results are based on one 
replicate; conclusions regarding these experiments should be weighed accordingly.
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Figure 3.7 Quantification of colocalization between immunolabeled VNUT and exogenously expressed LAMP-1-GFP 
and VAMP-mCherry 
A-C: Scale bar = 20 µm. D-I: Scale bar = 5 µm. J,M,P: Numbers above each boxplot refer to n, number of puncta; diamonds illustrate 95% 
confidence interval of mean; bar indicates median value. K,L: NN, nearest neighbour (i.e., LAMP-1-GFP or VAMP-mCherry). N,O: Ref, 
refers to reference protein (i.e., LAMP-1-GFP or VAMP-mCherry). K,L,N,O: Numbers above each boxplot refer to N, number of cell parts 
analyzed; dots indicate mean value; bar indicates median value. P: VNUT is represented by the green boxplots on the left of each pairing; 
LAMP-1-GFP and VAMP-mCherry are represented by pink boxplots on the right of each pairing. J-P: S, soma; N, neurite; V, varicosity; Vt, 
terminal varicosity.
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3.2.3. Analysis of VNUT Colocalization with Synaptic Vesicle Markers  
VNUT localization to synaptic vesicles was assessed using synaptic vesicle markers 
synaptobrevin (VAMP2), SV2a, synaptophysin, synaptotagmins, synapsin, and the 
active zone protein ELKS. Colocalization data for genetically encoded VAMP-mCherry 
and immunolabeled VNUT is shown in Figure 3.7. Visually, VAMP-mCherry and VNUT 
exhibited partial overlap (Fig 3.7A-I). The average distance between puncta was 228 nm 
(Fig 3.7J), which was smaller than the average size of VAMP-mCherry puncta, 326 nm 
(Fig 3.7P). On average, 2.8% of VNUT puncta contained their NN VAMP-mCherry 
puncta within their periphery (Fig 3.7K,L). Reference VNUT puncta touched their NN 
VAMP-mCherry puncta with an average frequency of 5.4%.  
In a reversed MINER analysis, the average distance between VAMP-mCherry reference 
puncta and NN VNUT was 142 nm (Fig 3.7M). On average, 18% of VAMP-mCherry 
reference puncta contained a NN VNUT puncta within their periphery, while 9.4% were 
touching their NN VNUT puncta (Fig 3.7N,O). These data indicate that VAMP-mCherry 
puncta contained or touched a VNUT puncta more often than VNUT puncta contained or 
touched a VAMP-mCherry puncta, suggesting that a small proportion of VNUT-
containing compartments are synaptic vesicles. 
Like VNUT, immunostaining for SV2a and synaptophysin resulted in punctate staining 
(Fig 3.8A-F). Clusters of VNUT and SV2a puncta were observed in neurites and 
varicosities, with several instances of fluorescent overlap as indicated by the arrows (Fig 
3.8A-C). Conversely, synaptophysin puncta did not exhibit many instances of visual 
overlap with VNUT although the few instances of fluorescence overlap were observed in 
neurites (Fig 3.8D-F). The average distance between the centers of SV2a and 
synaptophysin puncta from the VNUT perimeter was 77 nm and 121 nm, respectively 
(Fig 3.8G). The average frequency of SV2a-containing VNUT puncta was 16.90%, with 
statistically significant differences in means detected between soma (10.68%) and 
neurites and varicosities, collectively (19.97%). For synaptophysin, this average was 
14.56% (Fig 3.8H). SV2a and synaptophysin puncta touched their VNUT reference 
puncta with average frequencies of 10.25% and 13.33%, respectively.  
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In a reversed MINER analysis, the calculated average distance between VNUT NN 
puncta and their reference SV2a or synaptophysin puncta was 102 nm and 129 nm, 
respectively (Fig 3.8J). Further, SV2a puncta contained their VNUT NN puncta within 
their periphery 26.6% of the time, with significant differences reported between the soma 
(15.4%) and all other cell parts combined (30.3%). Synaptophysin puncta contained their 
VNUT NN puncta within their perimeter less frequently, with a whole cell average of 
15.1% of the time (Fig 3.8K). VNUT NN puncta touched their reference SV2a and 
synaptophysin puncta more often than they resided within these markers. The average 
frequency of VNUT-containing puncta touching SV2a and synaptophysin was similar at 
20.0% and 20.3%, respectively (Fig 3.8L).  
In terms of size, SV2a puncta were 314 nm across while synaptophysin puncta were 267 
nm across. The average puncta size for VNUT from all synaptic vesicle protein analyses, 
including VAMP-mCherry (Fig 3.7), was 258 nm (Fig 3.8M).  
Synaptic vesicle-associated synaptotagmin isoforms 1, 2, and 5 (also known as Syt 9 by 
homology) were used to further assess VNUT localization to synaptic vesicles, Figure 
3.9. Some instances of partial fluorescent overlap between VNUT and Syt1 were 
observed, (Fig 3.9A-C). In contrast to the small puncta of Syt1, Syt2 puncta formed 
larger clusters that exhibited moderate fluorescent overlap with VNUT. These instances 
of overlap tended to occur most often in varicosities (Fig 3.9D-F). Visually, fluorescent 
overlap between Syt5/9 and VNUT was sparse, suggesting Syt5/9 was anti-colocalized 
to VNUT (Fig 3.9G-I). The average distances of the NN Syt1, 2, and 5 puncta from their 
VNUT reference puncta were 124 nm, 142 nm, and 136 nm, respectively (Fig 3.9J).  
The respective average fractions of Syt1 and Syt5 puncta that resided within their 
VNUT-containing reference puncta were 15.4% and 11.1%, respectively, but did not 
significantly differ between the soma and neurites or varicosities. Although the analysis 
of Syt2 reported a comparable average of 13.0% of VNUT puncta containing their NN 
puncta, statistically significant differences were detected between varicosities (19.4%) 
and terminal varicosities (6.3%) (Fig 3.9K). In order, the average frequencies at which 
Syt1, 2, and 5 touched their VNUT reference puncta were 18.5%, 13.8%, and 10.4% 
(Fig 3.9L). 
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In their respective reversed MINER analyses, the average distance from Syt1, 2, or 5 as 
reference puncta to their NN VNUT puncta was 138 nm, 169 nm, and 173 nm, 
respectively (Fig 3.9M). The average fraction of reference puncta containing their VNUT 
NN puncta within their periphery was 9.7% for Syt1, 9.8% for Syt2, and 11.5% for Syt5 
(Fig 3.9N), while the average frequency at which VNUT touched these reference puncta 
was 13.1%, 17.7%, and 17.9% (Fig 3.9O).
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Figure 3.8 Colocalization analysis of synaptic vesicle markers SV2a and synaptophysin with VNUT via ICC 
A-F: Scale bar = 5 µm. G,J,M: Numbers above each boxplot refer to n, number of puncta; diamonds illustrate 95% confidence interval of 
mean; bar indicates median value. H,I: NN, nearest neighbour (i.e., SV2a or synaptophysin). K,L: Ref, refers to reference protein (i.e., 
SV2a or synaptophysin). H,I,K,L: Numbers above each boxplot refer to N, number of cell parts analyzed; dots indicate mean value; bar 
indicates median value. M: VNUT is represented by the green boxplots on the left of each pairing; SV2a and synaptophysin are 






Figure 3.9 Colocalization analysis of immunocytochemical staining for synaptotagmin isoforms 1, 2, 5 and VNUT 
A-I: Scale bar = 5 µm. J,M,P: Numbers above each boxplot refer to n, number of puncta; diamonds illustrate 95% confidence interval of 
mean; bar indicates median value. K,L: NN, nearest neighbour (i.e., Syt1, Syt2, or Syt5). N,O: Ref, refers to reference protein (i.e., Syt1, 
Syt2, or Syt5). K,L,N,O: Numbers above each boxplot refer to N, number of cell parts analyzed; dots indicate mean value; bar indicates 
median value. P: VNUT is represented by the green boxplots on the left of each pairing; synaptotagmin isoforms are represented by pink 
boxplots on the right of each pairing. J-P: S, soma; N, neurite; V, varicosity; Vt, terminal varicosity. 
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The synaptotagmin-containing puncta were similar in size. Syt1 puncta averaged out to 
289 nm, Syt2 to 287 nm, and Syt 5 to 263 nm. Across all synaptotagmin analyses, the 
average size of VNUT puncta was 285 nm (Fig 3.9P). 
The last assessed synaptic vesicle markers were ELKS and synapsin. These proteins 
participate in vesicle docking. Colocalization of VNUT with ELKS or synapsin would 
suggest the VNUT-containing vesicle is fusion competent. However, ELKS and VNUT 
puncta were anti-colocalized (Fig 3.10A-C). Instances of fluorescent overlap was 
observed only in instances of diffuse ELKS staining (see arrows). Minimal fluorescent 
overlap was observed between synapsin and VNUT (Fig 3.10D-F). The average 
distances from the perimeter of VNUT reference puncta to the center of their NN ELKS 
or synapsin puncta was 135 nm and 153 nm, respectively (Fig 3.10G). Reference puncta 
contained ELKS NN puncta within their periphery 18.9% of the time on average, with 
significant differences reported between the soma (15.2%) and neurites (22.5%). VNUT 
reference puncta had an average of 13.2% of NN synapsin puncta within their periphery 
(Fig 3.10H). The average fraction of VNUT-touching ELKS or synapsin puncta was 
14.6% and 19.6%, respectively (Fig 3.10I).  
In their respective reversed MINER analyses in which ELKS and synapsin were the 
reference channels and VNUT was the NN channel, the average distances from the 
reference perimeter to the center of the VNUT NN puncta were 129 nm and 146 nm, 
respectively (Fig 3.10J). Across all cell parts, an average of 11.9% of ELKS reference 
puncta contained their VNUT NN puncta within their perimeter. Significant differences in 
mean colocalization between different cell parts were detected between the soma 
(9.8%), neurites (14.2%), and terminal varicosities (7.0%) as well as between the soma 
and varicosities (16.6%). The average frequency of synapsin reference puncta 
containing their VNUT NN puncta was 8.0% (Fig 3.10K). The average frequencies of 
VNUT puncta touching either ELKS or synapsin puncta were 11.5% and 8.4%, 
respectively (Fig 3.10L).  
ELKS-containing puncta were slightly smaller than synapsin puncta, with an average 
size of 287 nm, while the average synapsin punctum was 314 nm across. For these 
analyses, the average size of VNUT-containing puncta was 243 nm. 
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Figure 3.10 Colocalization analysis of synaptic vesicle-associated proteins ELKS nd synapsin with VNUT as 
visualized with ICC 
A-F: Scale bar = 5 µm. G,J,M: Numbers above each boxplot refer to n, number of puncta; diamonds illustrate 95% confidence interval of 
mean; bar indicates median value. H,I: NN, nearest neighbour (i.e., ELKS or synapsin). K,L: Ref, refers to reference protein (i.e., ELKS or 
synapsin). H,I,K,L: Numbers above each boxplot refer to N, number of cell parts analyzed; dots indicate mean value; bar indicates median 
value. M: VNUT is represented by the green boxplots on the left of each pairing; ELKS and synapsin are represented by pink boxplots on 
the right of each pairing. G-M: S, soma; N, neurite; V, varicosity; Vt, terminal varicosity.
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3.2.4. Analyzing VNUT Colocalization with Chromogranin A 
VNUT localization to large, secretory vesicles was assessed by measuring the degree 
and frequency of overlap between VNUT- and chromogranin A-containing puncta. Data 
collected from this analysis is shown in Figure 3.11. Both immunolabeled CGA and 
VNUT exhibited a punctate pattern of fluorescence. Visually, some instances of overlap 
were seen (arrow), but most of the VNUT-containing puncta did not appear to contain a 
CGA puncta (Fig 3.11A-C). Similar to the immunostaining, CGA-GFP expression 
resulted in punctate signals (Fig 3.11D-F). The mean distance of immunolabeled CGA 
puncta from the perimeter of VNUT reference puncta was 143 nm, 94 nm, 115 nm, and 
115 nm within soma, neurites, varicosities, and terminal varicosities, respectively. Across 
all cell parts, the average distance from VNUT perimeter was 117 nm (Fig 3.11G). The 
whole-cell mean fraction of VNUT reference puncta containing their nearest 
neighbouring CGA puncta within their periphery was 12.7%. An average of 7.4% of 
reference puncta contained their NN CGA-GFP puncta within their periphery (Fig 3.11H). 
The average fraction of CGA puncta touching VNUT blobs was 15.4%, with statistically 
significant differences detected between neurites (12.7%) and terminal varicosities 
(17.3%). An average of 9.0% of CGA-GFP puncta touched VNUT-containing blobs 
across all cell parts (Fig 3.11I).  
In their respective reverse MINER analyses, the average distance from perimeter of the 
CGA or CGA-GFP reference puncta to the center of the VNUT NN puncta was 101 nm 
and 158 nm, respectively (Fig 3.11J). The average frequency of CGA puncta containing 
a NN VNUT puncta within their perimeter was 21.0%. Soma and terminal varicosities 
reported statistically significant differences with 18.9% of CGA blobs containing a VNUT 
blob in the soma and 26.1% in terminal varicosities. The average fraction of VNUT 
puncta within CGA-GFP puncta was 15.2% (Fig 3.11K). An average of 14.7% and 
22.1% of CGA and CGA-GFP reference puncta were touching their VNUT NN puncta 
(Fig 3.11L).  
The average size of CGA and CGA-GFP puncta were 336 nm and 267 nm, respectively, 
while the average size of VNUT-containing puncta was 266 nm across both analyses.
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Figure 3.11 Quantification of colocalization between chromogranin A and exogenously expressed chromogranin A-
GFP with VNUT 
A-F: Scale bar = 5 µm. G,J,M: Numbers above each boxplot refer to n, number of puncta; diamonds illustrate 95% confidence interval of 
mean; bar indicates median value. H,I: NN, nearest neighbour (i.e., CGA or CGA-GFP). K,L: Ref, refers to reference protein (i.e., CGA or 
CGA-GFP). H,I,K,L: Numbers above each boxplot refer to N, number of cell parts analyzed; dots indicate mean value; bar indicates 
median value. M: VNUT is represented by the green boxplots on the left of each pairing; CGA and CGA-GFP are represented by pink 
boxplots on the right of each pairing. G-M: S, soma; N, neurite; V, varicosity; Vt, terminal varicosity.
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3.2.5. VNUT does not Colocalize with the Catechomamine Transporter 
VMAT2 
Previous work in rat tail artery suggested different molecular fingerprints between VNUT-
containing purinergic vesicles and VMAT2-containing catecholaminergic vesicles. I 
tested this hypothesis by measuring the frequency of overlap between VNUT- and 
VMAT2-containing puncta (Fig 3.12). Immunostaining of VMAT2 and VNUT resulted in 
small puncta indicative of vesicles or clusters thereof (Fig 3.12A-C). Visually, few 
instances of overlap were observed, one of which is indicated with an arrow (Fig 3.12D-
F). The segregation of VNUT and VMAT2 blobs in the images suggested that these 
proteins were organized by in an anti-colocalized manner. Averaged across all cell parts, 
the distance from the perimeter of VNUT reference puncta to the center of nearest 
neighbouring VMAT2 puncta was 146 nm (Fig 3.12G).  
The average fraction of VNUT reference puncta containing their VMAT2 NN puncta 
within their perimeter was 11.1%, which breaks down to 10.9% for soma, 12.7% for 
neurites, 9.5% for varicosities, and 11.2% in terminal varicosities. Neurites and 
varicosities had statistically significant differences in means (Fig 3.12H). The mean 
frequency of VNUT puncta that touched their VMAT2 NN puncta was 16.1% across all 
cell parts. Within each cell part, the mean frequency of touching puncta was 15.9% in 
soma, 17.9% in neurites, 15.9% in varicosities, and 14.7% in terminal varicosities, with 
statistically significant differences in means between neurites and terminal varicosities 
(Fig 3.12I).  
In a reverse MINER analysis with VMAT2 as the reference channel, the distance from 
the perimeter of VMAT2 to the center of the nearest neighbouring VNUT puncta was 
almost double the distance from perimeter for VNUT as the reference, with an average 
of 289 nm (Fig 3.12J). In order of soma to terminal varicosity, the average fraction of 
reference VMAT2 puncta containing their VNUT NN puncta within their periphery was 
15%, 19.1%, 15.8%, and 16.7%, with an overall average of 16.7% (Fig 3.12K). The 
average fraction of reference puncta that touched their VNUT NN puncta was 16% for 
soma, 15.8% in neurites, 15.9% in varicosities, and 14.9% in terminal varicosities (Fig 
3.12L). The overall average of VNUT-touching VMAT2 puncta was 15.7%. 
The average size of VMAT2 puncta was 305 nm. The average size of VNUT-containing 
puncta was 266 nm (Fig 3.12 M).
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Figure 3.12 Lack of colocalization between VMAT2 and VNUT 
A-C: Scale bar = 20 µm. D-F: Scale bar = 5 µm. G,J,M: Numbers above each boxplot refer to n, number of puncta; diamonds illustrate 
95% confidence interval of mean; bar indicates median value. H,I: NN, nearest neighbour (i.e., VMAT2). K,L: Ref, refers to reference 
protein (i.e., VMAT2). H,I,K,L: Numbers above each boxplot refer to N, number of cell parts analyzed; dots indicate mean value; bar 
indicates median value. M: VNUT is represented by the green boxplots on the left of each pairing; VMAT2 is represented by pink boxplots 
on the right of each pairing. G-M: S, soma; N, neurite; V, varicosity; Vt, terminal varicosity. 
The next four pages summarize all data pertaining to the colocalization analyses of each marker with VNUT in N2a cells. A 
graphical representation of the data is shown in Figure 3.13, followed by a series of tables (Table 3.4-3.9) that are a 
numerical summary of the colocalization analyses data. The values in each table are flanked by parentheses, which indicate 




Figure 3.13 Summary of colocalization analyses in N2a cells 
Each row of graphs illustrates the frequency of the corresponding degree of colocalization noted on the y-axis. The markers are labeled along the 
top and are grouped by vesicle population, from left to right: lysosomes (LAMP-1; LAMP-1-GFP; LAMP-1-RFP), synaptic vesicles (Syt1, 2, and5; 
SV2a; Synaptophysin; VAMP-mCherry; Synapsin; ELKS), catecholaminergic vesicles (VMAT2), and secretory vesicles (CGA; CGA-GFP). The 
values indicating a high degree of colocalization from the VNUT-self colocalization trial are shown (dotted lines) as well as the range of values that 
correspond to colocalization of LAMP-1/VMAT2 with VNUT due to random chance (grey bars). The numbers at the top of the graph denote n, 
number of cell parts. S, soma; N, neurite; V, varicosity; Vt, terminal varicosity. 
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Table 3.4 Distance from perimeter of VNUT reference puncta to center of NN puncta (in nm) 
NN Puncta Soma Neurite Varicosity Terminal Varicosity Average 
CGA 143.3 (160) 94.3 (169.3) 115.2 (169) 115 (163.6) 117 (165.5) 
CGA-GFP 147.4 (156.1) 126.6 (158.8) 161.2 (150.6) 136.7 (155.7) 143 (155.3) 
LAMP-1 156.5 (153.3) 134.2 (159) 140.4 (160) 152.4 (156) 145.9 (157) 
LAMP-1-GFP 162.1 (162.8) 113.8 (173.6) 166.6 (172.4) 196.4 (161.2) 159.7 (167.5) 
LAMP-1-RFP 112.9 (195.6) 136 (183.4) 63.5 (184.5) 115.3 (227.1) 106.9 (197.7) 
ELKS 143.5 (165.6) 122.2 (183.2) 127.5 (171.5) 148.2 (189.1) 135.4 (177.3) 
Synapsin 174.2 (153.2) 127.8 (169) 139.5 (147.4) 169.8 (173.1) 152.8 (160.7) 
SV2a 115.4 (170.5) 54.9 (171.5) 73.6 (190.1) 64.3 (184.3) 77 (179.1) 
Synaptophysin 140.3 (169.3) 96.6 (185.1) 143.4 (180) 103.1 (170.2) 120.8 (176.1) 
VAMP-mCherry 190.8 (150.7) 246.5 (163.8) --- 245.4 (136.2) 227.6 (150.2) 
Syt1 145.8 (162.4) 116.9 (166.7) 110.8 (173.8) 122.2 (180.6) 123.9 (170.9) 
Syt2 153 (168.7) 129.9 (169.4) 146.9 (171.8) 136.4 (169.5) 141.6 (169.8) 
Syt5 149 (165.9) 125.6 (174.1) 152.8 (183.8) 115.3 (182.4) 135.7 (176.5) 




Table 3.5 Distance from reference puncta perimeter to center of NN VNUT puncta from reversed MINER analyses (in nm) 
NN Puncta Reference Puncta Soma Neurite Varicosity Terminal Varicosity Average 
VNUT CGA 127.8 (169.5) 75.6 (181.4) 101.4 (176.2) 98.3 (170.6) 100.8 (174.4) 
VNUT CGA-GFP 164.4 (158.8) 148.6 (165.2) 168 (142.7) 150.8 (165.4) 157.9 (158) 
VNUT LAMP-1 147.9 (156.2) 131.2 (162.2) 137.8 (162.7) 137.9 (163.4) 138.7 (161.1) 
VNUT LAMP-1-GFP 199.4 (177.9) 42.1 (180.9) --- 56 (220.3) 99.2 (193.1) 
EGFP-N-VNUT LAMP-1-RFP 131 (188.9) 107.9 (187.1) 136.7 (187.3) 71.7 (217.5) 111.8 (195.2) 
VNUT-C-EGFP LAMP-1-RFP 123.9 (190) 100.7 (187.7) 69.7 (198) 64.6 (190.2) 89.7 (191.5) 
VNUT ELKS 151.9 (162.5) 117.2 (168.8) 119.8 (176.1) 127.1 (172.9) 129 (170.1) 
VNUT Synapsin 163.8 (155.2) 130.7 (166.1) 138 (155.2) 151.3 (183.6) 145.9 (165) 
VNUT SV2a 148.8 (161.1) 90.9 (163) 87.9 (174.2) 80.8 (184) 102.1 (170.6) 
VNUT Synaptophysin 153.5 (161.6) 114.7 (169) 126.9 (168.7) 119.4 (168.6) 128.6 (167) 
VNUT VAMP-mCherry 136.7 (173.4) 153.2 (184.8) --- 136.6 (180.5) 142.2 (179.6) 
VNUT Syt1 158.9 (157.9) 123.7 (162.2) 146.1 (159) 125.3 (175.3) 138.5 (163.6) 
VNUT Syt2 182.3 (155.2) 156.1 (155.3) 166.8 (160.1) 170.2 (175.8) 168.9 (161.6) 
VNUT Syt5 165.2 (165) 170.7 (157.3) 206.5 (175.1) 151.1 (153.1) 173.4 (162.6) 
VNUT VMAT2 136 (164.7) 112.2 (178.3) 139 (171.4) 119 (166.8) 126.5 (170.3) 
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Table 3.6 Fraction of VNUT reference puncta with NN puncta within their periphery 
 
Table 3.7 Fraction of reference puncta with NN VNUT puncta within their perimeter 
from reverse MINER analysis 
Reference Puncta Soma Neurite Varicosity Terminal Varicosity Average 
CGA 18.9 (5.4) 21.2 (16.8) 18 (16.8) 26.1 (21.3) 21 (15.1) 
CGA-GFP 17.5 (8.1) 17.6 (15.4) 9.3 (5.6) 16.5 (9.9) 15.2 (9.7) 
LAMP-1 13 (3.5) 16.7 (8.2) 16 (6.8) 15.4 (10.8) 15.3 (7.3) 
LAMP-1-GFP 6.4 (8.4) 17.6 (25) --- 50 (70.7) 24.7 (34.7) 
LAMP-1-RFP 12.8 (13.8) 10.2 (16.2) 14.4 (24.7) 12.7 (15.2) 12.5 (17.5) 
ELKS 9.8 (2.3) 14.2 (6.3) 16.6 (11.3) 7 (8.6) 11.9 (7.1) 
Synapsin 6.6 (2.8) 8.3 (6.2) 6.2 (1.7) 10.8 (5.8) 8 (4.1) 
SV2a 15.4 (5.9) 25.8 (11.6) 30 (7.8) 35.2 (17.9) 26.6 (10.8) 
Synaptophysin 13.3 (3.9) 19.2 (11.6) 13.4 (9.5) 14.5 (13.6) 15.1 (9.7) 
VAMP-mCherry 20.9 (2) 16.7 (1.6) --- 16.7 (0) 18.1 (1.8) 
Syt1 9.8 (4.6) 9.9 (8.2) 7.3 (8.1) 12 (7.7) 9.7 (7.1) 
Syt2 9.8 (4.8) 9.6 (7.1) 9.7 (6.5) 10.2 (9.6) 9.8 (7) 
Syt5 14.6 (4.1) 10.1 (6.9) 9.1 (11.7) 11.9 (11.4) 11.5 (8.5) 
VMAT2 15 (3.5) 19.1 (8.5) 15.8 (7.2) 16.7 (9.2) 16.7 (7.1) 
 
NN Puncta Soma Neurite Varicosity Terminal Varicosity Average 
CGA 10.8 (3.1) 13.1 (11.6) 12.9 (11.4) 13.7 (12.5) 12.7 (9.7) 
CGA-GFP 3.6 (3.4) 6.5 (6) 9.2 (6.7) 10.2 (5.8) 7.4 (5.5) 
LAMP-1 10.6 (3.1) 14.2 (7.4) 13 (5.4) 10.7 (7.1) 12.1 (5.8) 
LAMP-1-GFP 5.3 (2.1) 9.8 (6.5) 14.4 (14.4) 2.1 (3.8) 7.9 (6.7) 
LAMP-1-RFP 13.1 (9.3) 10.8 (11.8) 15.1 (12.5) 23.5 (12.8) 15.6 (11.6) 
ELKS 15.2 (4.5) 22.5 (9.1) 18.3 (8.6) 19.8 (20.3) 18.9 (10.6) 
Synapsin 10.4 (3.9) 15.2 (7.7) 11.5 (7.5) 15.8 (9.8) 13.2 (7.2) 
SV2a 10.7 (5.3) 20.5 (9.2) 19.4 (9.6) 17 (9.6) 16.9 (8.4) 
Synaptophysin 11.8 (4.5) 16.8 (9.8) 13.2 (11.4) 16.4 (13.7) 14.6 (9.8) 
VAMP-mCherry 2.9 (1.6) 2.8 (0.4) --- --- 2.8 (1) 
Syt1 14.1 (2.3) 14.8 (7.3) 15.2 (7.5) 17.6 (11.7) 15.4 (7.2) 
Syt2 12.3 (4.9) 13.9 (8.8) 19.4 (16.8) 6.3 (7.5) 13 (9.5) 
Syt5 9.1 (3.2) 8 (5.5) 13.9 (12.9) 13.5 (9.8) 11.1 (7.8) 
VMAT2 10.9 (3.3) 12.7 (7.1) 9.5 (4.4) 11.2 (7.2) 11.1 (5.5) 
66 
Table 3.8 Average puncta size, FWHM, of NN puncta (in nm) 
NN Puncta Soma Neurite Varicosity Terminal Varicosity Average 
CGA 311.6 (96.4) 338.5 (75.6) 339.9 (84.4) 355.7 (102.1) 336.4 (89.6) 
CGA-GFP 257.9 (66.4) 271.9 (62.2) 261 (87.2) 278.9 (87.8) 267.4 (75.9) 
LAMP-1 272 (93.6) 293.8 (94.9) 287.8 (91.7) 289.5 (94.4) 285.8 (93.6) 
LAMP-1-GFP 297.5 (130.2) 313.8 (114.7) 291.6 (120.5) 276 (89.5) 294.7 (113.7) 
LAMP-1-RFP 306.7 (150) 346 (135.3) 324.7 (126.7) 331.6 (147.8) 327.3 (139.9) 
ELKS 251 (126.2) 301 (135.2) 292.8 (145.3) 302.7 (131.8) 286.9 (134.6) 
Synapsin 290.4 (113) 341.2 (114.7) 264.8 (84.7) 359 (130.7) 313.8 (110.8) 
SV2a 285.3 (88.2) 314.3 (82.2) 315.2 (81.7) 340.9 (98.8) 313.9 (87.7) 
Synaptophysin 249.6 (82.4) 271.7 (86.7) 282.6 (84.3) 264.6 (77.2) 267.1 (82.7) 
VAMP-mCherry 301.8 (120.3) 322 (119.9) --- 354 (101.7) 326 (114) 
Syt1 264 (94.2) 293.5 (96.1) 287.3 (101.2) 311.9 (91.3) 289.2 (95.7) 
Syt2 272 (88.5) 288.7 (85.5) 292.1 (82.7) 294.4 (77.9) 286.8 (83.7) 
Syt5 276.7 (102.4) 259.5 (71.2) 253.4 (67.7) 261 (73.3) 262.7 (78.7) 
VMAT2 293 (97) 317.7 (96.8) 309.7 (87.8) 301.1 (84.1) 305.4 (91.4) 
 
Table 3.9 Average puncta size, FWHM, of VNUT puncta (in nm) 
NN Puncta Soma Neurite Varicosity Terminal Varicosity Average 
CGA 242.3 (72.7) 267.3 (68.3) 263.8 (70.4) 263 (98.2) 259.1 (77.4) 
CGA-GFP 251.3 (91.3) 297.6 (94.1) 284.2 (86.2) 258.6 (90.9) 272.9 (90.6) 
LAMP-1 249.7 (88.8) 271.4 (82.2) 263.4 (83.7) 262.2 (88.3) 261.7 (85.7) 
LAMP-1-GFP 225.8 (86.8) 246.1 (96.3) 249.4 (127.8) 254.9 (79.8) 244.1 (97.7) 
LAMP-1-RFP 278.8 (122.1) 245.4 (89.5) 276.4 (106.7) 231.5 (85.5) 258 (101) 
ELKS 258.4 (73.7) 273.7 (57.5) 272.5 (74.9) 294.1 (112) 274.7 (79.5) 
Synapsin 211.3 (69.8) 227.6 (72.8) 179.2 (58) 225.9 (59.6) 211 (65) 
SV2a 265.5 (85.2) 313.3 (86.1) 302.1 (87.3) 317.7 (77.4) 299.7 (84) 
Synaptophysin 275.2 (79.3) 307 (70.7) 308.5 (92.2) 299 (69.1) 297.5 (77.8) 
VAMP-mCherry 178.2 (101.8) 168.6 (98.2) --- 183.5 (71.3) 176.8 (90.4) 
Syt1 261.5 (80.9) 283.3 (89.7) 289.9 (66) 286.4 (72.4) 280.3 (77.2) 
Syt2 269.6 (74.7) 297.3 (71.8) 291 (68.2) 288.2 (60.4) 286.5 (68.8) 
Syt5 268.8 (75.8) 296.9 (72.9) 286.6 (59.4) 301.4 (86.8) 288.4 (73.7) 




3.3. VNUT does not Colocalize with LAMP-1 in HEK293 and 
HeLa Epithelial Cell Lines 
After observing infrequent colocalization between VNUT and LAMP-1 in N2a cells, I 
assessed whether the N2a cells were an ideal model for VNUT colocalization analysis. 
Since several researchers have reported lysosomal localization of VNUT, perhaps VNUT 
localization to lysosomes is characteristic of epithelial cells. I used human epithelial 
kidney 293 (HEK293) cells and HeLa human cervical cancer cells to test this working 
theory. The cells were gifted from SFU researchers T. Claydon and J. Guttman, 
respectively, and were given to me ready for fixing. Immunostaining, imaging, and 
analysis was performed in the same manner as for the N2a cells, described in Section 
2.2.1. To distinguish epithelial cell extensions and swellings from N2a neurites and 
varicosities, I named these cell parts projections and nodes, respectively, Figure 3.14. 
Representative images and data pertaining to HEK- and HeLa-based experiments are 
shown in Figure 3.15.  
 
Figure 3.14 Annotated N2a and epithelial cell parts 
The N2a cell (left) and HEK cell (right) have been annotated with their respective cell parts. HeLa 
cell parts were identified using the same method shown for HEK cells. Scale bar = 20 µm. Insets 
show original images without overlaid cell part tracings. N2a cell darkest to lightest blue: Soma, 
neurite, varicosity, terminal varicosity. HEK cell darkest to lightest blue: Soma, projection, node, 
terminal node. Created with BioRender.com.  
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Figure 3.15 LAMP-1 and VNUT are anti-colocalized in epithelial cells 
A-F: Scale bar = 5 µm. G,J,M: Numbers above each boxplot refer to n, number of puncta; diamonds illustrate 95% confidence interval of 
mean; bar indicates median value. H,I: NN, nearest neighbour (i.e., LAMP-1). K,L: Ref, refers to reference protein (i.e., LAMP-1). H,I,K,L: 
Numbers above each boxplot refer to N, number of cell parts analyzed; dots indicate mean value; bar indicates median value. M: VNUT is 
represented by the green boxplots on the left of each pairing; LAMP-1 is represented by pink boxplots on the right of each pairing. G-M: S, 
soma; P, projection; N, node; Nt, terminal node.
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Like the N2a cells, immunolabeling VNUT and LAMP-1 resulted in punctate staining in 
both epithelial cell lines. Unlike the N2a cells in which LAMP-1 puncta were concentrated 
at the cell periphery and VNUT aggregated in the soma, the puncta were evenly 
distributed throughout the cell (Fig 3.15A-F). HEK cells exhibited infrequent overlap 
between LAMP-1 and VNUT fluorescent probes, as indicated by the arrow (Fig 3.15C).  
HeLa cells also exhibited minimal fluorescent overlap between VNUT and LAMP-1 (Fig 
3.15F).  
The average distance between the VNUT reference puncta perimeter to the center of 
their LAMP-1 NN puncta was 179 nm in HEK cells and 172 nm in HeLa cells (Fig 
3.15G). VNUT-containing blobs had a LAMP-1 NN blob within their perimeter at similar 
average frequencies of 16.4% in HEK cells and 17.9% in HeLa cells. Statistically 
significant differences in means were detected between the projections (18.4%) and 
terminal nodes (14.2%) of HEK cells (Fig 3.15H). VNUT puncta touched their LAMP-1 
NN puncta with an average frequency of 14.2% and 16.9% in HEK and HeLa cells, 
respectively (Fig 3.15I).  
Reversing the MINER analysis such that LAMP-1 was the reference channel and VNUT 
was the NN channel reduced the average distance between puncta to 143 nm in HEK 
cells and 160 nm in HeLa cells. In HEK and HeLa cells, the average frequency of LAMP-
1 puncta containing their VNUT NN puncta residing within their periphery was 13.1% 
and 10.9%, respectively. Statistically significant differences were reported between 
nodes (13.9%) and combined soma and projections (12.7%) in HEK cells, while HeLa 
cells reported a significant difference between soma (9.7%) and projections (12.1%) (Fig 
3.15K). The average fraction of LAMP-1 puncta that touched their assigned NN VNUT 
puncta was 17.2% and 16.8% in HEK and HeLa cells, respectively. The soma and 
terminal nodes of HeLa cells reported statistically significant differences in means with 
an average of 15.1% puncta touching in soma and 18.6% in terminal nodes (Fig 3.15L).  
The average size of LAMP-1 puncta was 243 nm in HEK cells and 281 nm in HeLa cells. 
The epithelial LAMP-1 puncta were slightly smaller than their N2a counterparts, which 
had an average size of 303 nm. In comparison, the average size of VNUT-containing 
puncta in both epithelial cell lines were similar to N2a cells. HEK cells reported an 
average VNUT puncta size of 257 nm and HeLa cells 280 nm (Fig 3.15M), while the 
collective average size of VNUT puncta in N2a-based LAMP-1 analyses was 255 nm. 
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Tables 3.10-3.13 summarize the data I analyzed during my colocalization analyses in 
HEK and HeLa cells, with standard deviations in parentheses. 
Table 3.10 Summary of physical data from HEK and HeLa colocalization analysis 
Distance from VNUT 
Perimeter (nm) Cell Type Soma Projection 
Terminal 
Node Average 
 HEK 177.9 (172.5) 170.6 (173.3) 187.1 (171.2) 178.5 (172.3) 
 HeLa 177.5 (173.4) 164.2 (176.7) 174.2 (178.2) 171.9 (176.1) 
LAMP-1 FWHM (nm) Cell Type     
 HEK 244.9 (85.9) 240.4 (76.8) 244.4 (97.5) 243.3 (86.7) 
 HeLa 265.3 (80.1) 287.4 (92) 289 (87.2) 280.6 (86.4) 
VNUT FWHM (nm) Cell Type     
 HEK 255.4 (77.5) 262.3 (72.5) 252.2 (75.7) 256.6 (75.2) 
 HeLa 274 (72.6) 282.9 (71.2) 281.7 (68) 279.5 (70.6) 
 
Table 3.11 Summary of physical data from HEK and HeLa reverse MINER 
colocalization analysis 
Distance from Ref 
Perimeter (nm) Cell Type Soma Projection Node 
Terminal 
Node Average 














LAMP-1 FWHM (nm) Cell Type      





 HeLa 286.1 (79.4) 
297.6 
(87) 
--- 295.4 (77.4) 293 (81.3) 
VNUT FWHM (nm) Cell Type      





 HeLa 251.8 (72.8) 
271 
(82.9) 






Table 3.12 Degree of colocalization between VNUT reference puncta and LAMP-1 
NN puncta in HEK and HeLa cells 
 Cell Type Soma Projection Terminal Node Average 
Within HEK 16.5 (3.3) 18.4 (3.3) 14.2 (5.2) 16.4 (3.9) 
 HeLa 16.9 (3) 18.3 (4.8) 18.5 (3.6) 17.9 (3.8) 
      
Touching HEK 13.8 (3.1) 15.1 (3.2) 13.7 (5.9) 14.2 (4.1) 
 HeLa 15.5 (1.9) 16.9 (3.8) 18.4 (6.4) 16.9 (4) 
 
Table 3.13 Degree of colocalization between LAMP-1 reference puncta and VNUT 
NN puncta in reverse MINER analysis in HEK and HeLa cells 
 Cell 
Type Soma Projection Node 
Terminal 
Node Average 
Within HEK 12.6 (2.6) 12.7 (4.1) 13.9 (5.3) --- 13.1 (4) 
 HeLa 9.7 (1.4) 12.1 (3.5) --- 10.8 (4.4) 10.9 (3.1) 
       
Touching HEK 16.4 (2) 15.9 (4.6) 19.4 (6.1) --- 17.2 (4.2) 
 HeLa 15.1 (1.7) 16.6 (3) --- 18.6 (7.2) 16.8 (4) 
 
3.4. Possible VNUT Localization to the ER-Golgi Complex 
Despite VNUT failing to colocalize with the tested markers, a distinct pattern of 
localization was observed. Puncta containing immunolabeled and genetically encoded 
VNUT were capable of trafficking out to neurites and varicosities. However, large 
clusters of high-intensity VNUT signal were consistently seen in the perinuclear region of 
the soma, Figure 3.16. Similar localization patterns were also observed in other 
experiments in the Poburko lab. Experiments validating pH sensitive fluorescent probes 
VMAT2-pHuji and VNUT-pHluorin for visualizing the release of catecholaminergic- and 
ATP-containing vesicles, respectively, were tested in N2a cells, shown in Figure 3.17.  
72 
  
Figure 3.16 Perinuclear localization of VNUT in N2a cells 
Images were taken at 100X oil magnification. The leftmost image shows immunolabeled VNUT 
and LAMP-1, while the center and rightmost images show exogenous N-terminal and C-terminal 
conjugated VNUT-EGFP expression vectors, respectively. The VNUT-EGFP vectors were co-
transfected with LAMP-1-RFP. In all three images, the VNUT probe is shown in green. The 
LAMP-1 probes are shown in red. Perinuclear regions are indicated by arrows. Scale bar = 10 
µm. 
These constructs are similar in composition and function. The cartoon in Figure 3.17 
demonstrates the conditions required for quenching and dequenching the pHluorin 
construct. Although not shown, the pHuji construct works in a similar manner for 
catecholaminergic vesicles. Conjugation of the fluorescent proteins on a luminal loop of 
each transporter causes the pH sensitive fluorescent proteins to be quenched in acidic 
compartments, such as synaptic vesicles, lysosomes, and endosomes. Exposure to less 
acidic pH levels, like the extracellular space during a vesicle fusion event, dequenches 
the probes. The resulting fluorescent signal is maintained for the duration of exposure of 
externalization. These genetically encoded transporters were conjugated to red (pHuji) 
and green (pHluorin) fluorescent proteins to allow simultaneous imaging of VMAT2 and 
VNUT, respectively (Fig 3.17B).  
The pH sensitive VNUT and VMAT2 constructs illustrate the different release kinetics 
and pH responses of their respective compartments, illustrated by manipulating 
extracellular and intracellular pH using saline solutions buffered with 2-(N-
morpholino)ethanesulfonic acid (MES), sodium butyrate (Na.butyrate), or ammonium 
chloride (NH4Cl) (Sankaranarayanan, De Angelis, Rothman, & Ryan, 2000). Reminiscent 
of my own experiments, compartments labeled with the VNUT-pHluorin probe were 
primarily clustered in the perinuclear space. Based on the pH dependent excitation and 
emission spectra of pHluorin (Miesenböck, De Angelis, & Rothman, 1998), these puncta 
appear to have a slightly acidic or near-neutral pH (Fig 3.17B). VNUT-pHluorin was not 
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quenched in response to MES buffered saline (pH 5.5) but was quenched in the 
presence of 20 mM sodium butyrate (Fig 3.17B). This membrane permeable, weak acid 
decreases the cytosolic pH of rat crypt cells (Diener, Helmle-Kolb, Murer, & Scharrer, 
1993) and was used to reversibly decrease luminal pH. The VNUT-pHluorin probe 
exhibited moderately increased fluorescence in response to NH4Cl solution (Fig 3.17B). 
NH4Cl dissociates into the weak base NH4+, followed by the membrane permeable gas 
NH3 (Lazarenko, DelBove, Strothman, & Zhang, 2017) that increases cytosolic and 
luminal pH. These results indicate the VNUT-pHluorin-containing compartments are not 
readily externalized, are localized to the perinuclear space, and have a pH that is not 
compatible with synaptic vesicles. Conversely, the VMAT2-pHuji construct was localized 
to highly acidic compartments that were capable of externalization. Externalized VMAT2-
pHuji probe fluoresced when exposed to HEPES buffered saline solution (pH 7.4). 
Extracellular acidification using MES buffered saline quenched the VMAT2-pHuji probe. 
Further, the VMAT2-pHuji probe experienced a robust response to NH4Cl, while 
intracellular acidification with sodium butyrate did not cause further quenching (Fig 
3.17B). These results are indicative of VMAT2 localization to synaptic vesicles, while 
VNUT seems to localize to perinuclear organelles bearing similar pH and morphologies 
to the ER/Golgi complex.  
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Figure 3.17 VNUT-pHluorin construct localizes to ER/Golgi complex 
A: In the cartoon, ATP molecules are represented by blue squares, VNUT-pHluorin is shown by 
the grey bar (VNUT) with the black or green circle representing quenched and unquenched 
pHluorin, respectively. The thick grey curve is the plasma membrane while the thin grey circles 
are synaptic vesicles. B: Traces are normalized to the fluorescence change of the pH-sensitive 
probes relative to the range of intensity. The response of VMAT2-pHuiji is shown in purple while 
the response of VNUT-pHluorin is shown in green. The stimuli and duration of exposure are 
noted by the black trace along the x-axis. From left to right, the images below the traces show the 
2-channel merge of VNUT-pHluorin and VMAT2-pHuiji, the isolate channel for VNUT-pHluorin, 
and the isolated channel for VMAT2-pHuji. Scale bar = 5 µm. Traces and images were provided 
courtesy of Lara Gastaldello and Damon Poburko from the Poburko lab (unpublished data). 
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Chapter 4.  
 
Bioinformatic Study of VNUT and SLC17 and SLC18 
Transporter Families 
4.1. Structural Comparison of VNUT and other Solute 
Carrier Transporters 
4.1.1. Studying VNUT Structure 
This chapter describes my comparative study of the VNUT C-terminus with the C-termini 
of other solute carriers of the 17 and 18 families. The study began by corroborating the 
secondary structure of VNUT, which allowed the identification of the predicted 
transmembrane domains. The predicted C-terminal domain of VNUT was assessed for 
common targeting motifs, which could hint to the subcellular localization of VNUT. Figure 
4.1 illustrates some of the motifs for which VNUT was assessed.  
 
Figure 4.1 An overview of common C-terminal targeting motifs 
Purple: low density lipoprotein receptor with NPXY internalization motif. Red: LAMP-1 with YXXθ 
lysosome targeting sequence. Grey: ER resident with KDEL receptor recognition motif. Green: 
Solute carrier with dileucine-like internalization and/or synaptic vesicle targeting motif (@X{2,3}θ). 
Pink: VAChT with tyrosine motif (YXXθ). Partially created with BioRender.com. 
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In addition to discovering that VNUT is encoded by the SLC17A9 gene, Sawada and 
colleagues analyzed homologies between members of the SLC17A family to identify 
possible transmembrane domains (Sawada et al., 2008). I sought to validate their 
prediction to provide an updated prediction of C-terminal domain length from the last 
predicted transmembrane domain. Additionally, our lab was interested in comparing the 
cytosolic loops of the SLC17A family members to guide optimal insertion of pH sensitive 
probes into VNUT without impeding function or trafficking. Finally, the structural data 
acquired via this thesis can be used as a foundation to future bioinformatics-based 
studies of the conservation, or lack thereof, in the cytosolic domains of VNUT. 
I first sought to assess the online constrained topology prediction software (CCTOP). 
CCTOP provides a consensus of ten topology prediction methods to provide a best 
guess estimate of the transmembrane domains within a protein (Dobson, Reményi, & 
Tusnády, 2015a, 2015b). I compared the predicted secondary structure of VNUT with 
the homology-based predictions made by Sawada (Sawada et al., 2008) and SWISS-
MODEL, an interactive modeling server that predicts secondary structures based on 
homology to solved protein structures within the repository. The SWISS-MODEL method 
used the VGLUT2 transporter of Rattus norvegicus (SWISS-MODEL ID: Q9JI12) as the 
reference model for homology-based predictions of the VNUT secondary structure. 
Figure 4.2 illustrates the VNUT transmembrane domains as predicted by Sawada, 
CCTOP, and SWISS-MODEL. 
The CCTOP prediction corroborates the initial SLC17-based homology performed by 
Sawada and colleagues (Sawada et al., 2008). Unexpectedly, the VGLUT2-based 
SWISS-MODEL method predicted ten transmembrane domains in VNUT. This is odd 
given there are 12 transmembrane domains in the related SLC17A family member 
VGLUT2. However, the ten transmembrane domains in the unsolved VNUT structure 
correspond to CCTOP-predicted domains within a few amino acid residues (Fig 4.3). 
The protein sequences of human VNUT (NCBI accession Q9BYT1.2) and R. norvegicus 
VGLUT2 (NCBI accession Q9JI12.1) were also aligned using CLC Genomics 
Workbench. The alignment showed 21.53% sequence identity in CLC whereas the 
SWISS-MODEL repository reports 26.20% sequence identity. This discrepancy can be 
explained by ten C-terminal residues in the VNUT sequence (VDLSSTHEDL) that are 
ignored by the VGLUT-based model. Conversely, entering the VGLUT2 Fasta sequence 
into CCTOP resulted in twelve transmembrane domains that closely coincide with the 
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solved secondary structure in the SWISS-MODEL repository (Fig 4.3). Further, the 
CCTOP topology prediction method was validated using 170 test sequences with 
predictions as accurate as 95% (Dobson et al., 2015a). Of the two independent methods 
of assessing topology, the CCTOP method was chosen to predict and compare the 
secondary structure of VNUT and other solute carriers of the 17A and 18A families. 
 
Figure 4.2 Predicting VNUT structure 
Top: Transmembrane domains as predicted by Sawada are shown with yellow fill. SWISS-
MODEL homology model-based TMDs are outlined in red. Physical arrangement as shown was 
predicted by CCTOP software. Bottom: Structural illustration of VNUT from SWISS-MODEL 




Figure 4.3 Structural prediction of human VNUT based on the VGLUT2 transporter of the Norway rat 
Top: Alignment shows VGLUT2 and VNUT protein sequences. The transmembrane domains as predicted by CCTOP are highlighted in yellow. Transmembrane domains predicted by the SWISS-MODEL are highlighted in blue. The first and 
tenth CCTOP-predicted domains are missing from the SWISS-MODEL prediction. Bottom left: SWISS-MODEL quality estimate information illustrates poor model quality. The star at far right shows how the model performs compared to the 
repository. Bottom right: Human VNUT (Q9BYT1) and rat VGLUT2 (Q9JI12) schematics with transmembrane domains shown in blue blocks (arrow, correspond to blue highlighting in alignment). 
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When comparing primary amino acid sequences of VNUT, SLC17A, and SLC18A 
transporters, the VNUT sequence is consistently shorter regardless of organism Class, 
Figure 4.4. In Class Mammalia, the N-terminus varies greatly in length, from 15 amino 
acids in White-throated Capuchin monkeys to 132 amino acids in Bison (Fig 4.5A). 
Conversely, the C-terminal domain is consistently comprised of 13 amino acids after the 
last predicted transmembrane domain (Fig 4.5A). These 13 amino acids are highly 
conserved in mammals (Fig 4.5B). 
 
Figure 4.4 Comparison of transporter sequence lengths 
The numbers under the common names of each transporter reports the average sequence length 
across 7 analyzed Classes of chordate animals. Error bars indicate the standard deviation 




Figure 4.5 Comparison of N- and C-terminal lengths of VNUT in mammals 
A. Blue dots in the left graph shows the variation of sequence length across 39 mammals. The N-terminus is indicated in the schematic 
(blue arrow). The right graph shows high level of sequence length conservation in C-terminus (black dots), which is indicated in the protein 
structure schematic by a black arrow. N refers to the number of accession numbers. Some species had multiple accession numbers. For 
example, there are 28 species listed for the C-terminal analysis, yet 30 sequences were analyzed. Homo sapiens had three separate 
accession numbers that were analyzed. B. The C-terminal domain is highly conserved at the amino acid level. To the left of each 
sequence is the common name of the animal, followed by the accession number(s). The last transmembrane domain is highlighted within 
several sequences. The numbers at the end of each sequence denotes the total number of amino acids shown for each sequence.  
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In addition to identifying general structural differences in VNUT and the other 
transporters, I wanted to assess possible targeting motifs within VNUT. Chapter 1, 
Sections 1.3.2 and 1.3.3 explain in greater detail some of the known targeting motifs for 
synaptic vesicles, lysosomes, Golgi, ER, and nucleus. Known targeting motifs of other 
transporters and synaptic vesicle proteins are typically found in the C-terminal domain. 
For example, the C-terminal domain of VAChT is necessary and sufficient for targeting 
to synaptic vesicles. In PC12 cells, a chimera protein consisting of the plasmalemmal 
Tac protein conjugated with the VAChT C-terminus is redirected to synaptic vesicle-like 
vesicles (Colgan et al., 2007). VAChT and VMAT2 chimeras in which the C-terminal tails 
were swapped resulted in each recombinant protein being targeted as dictated by the C-
terminus (Varoqui & Erickson, 1998).  In the VGLUT transporters, C-terminal dileucine-
like motifs are important for targeting to synaptic vesicles (Haiyan Li et al., 2017). 
Similarly, synaptic vesicle proteins synaptotagmin, synaptophysin, and synaptobrevin 
contain dileucine-like motifs in their C-termini (Prado & Prado, 2002). Due to the 
importance of the C-terminus for other transporters and synaptic vesicle proteins, as well 
as the high degree of conservation amongst mammalian VNUT C-termini, the motif 
analysis was focused on the C-terminal domain. 
4.1.2. Comparison of Targeting Motifs in SLC Transporter Proteins 
I assessed 295 chordate VNUT sequences for targeting motifs identified from primary 
literature. I compared the motifs in the C-terminus of VNUT to 493 chordate sequences 
for SLC17A5-8 and SLC18A1-3. Figure 4.6 illustrates the workflow for assessing the 
presence of targeting motifs within these transporters. SLC17A1-4 were excluded from 
the motif analysis for two reasons. One, topology predictions suggest SLC17A2 and 
SLC17A3 have 11 transmembrane domains, while SLC17A4 has eight. Comparing 
VNUT to transporters with 12 transmembrane regions allows more direct comparisons to 
be made when interpreting the importance of each motif. Further, biochemical properties 
like transport dynamics, localization, function and inhibition of SLC17A1-4 are less well-
known compared to sialin, the VGLUTs, VAChT, and VMAT2 (Omote & Moriyama, 2013; 
Reimer, 2013; Wimalasena, 2011). 
Although I hypothesized that VNUT is localized to synaptic vesicles, I examined the C-
terminus for additional motifs such as those that target proteins to lysosomes, 
peroxisomes, endosomes, internalization at the plasma membrane, the Golgi apparatus, 
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the endoplasmic reticulum (ER), and the nucleus. Since the three- and two-wild card 
dileucine-like motifs may be involved in synaptic vesicle and/or internalization trafficking 
(Pandey, 2009; Prado & Prado, 2002), both motifs were combined into a shared 
@X{2,3}θθ motif. Residue labeling is based on normalized nomenclature (Aasland et al., 
2002). For example, the θ symbol represents a hydrophobic reside. An exception was 
made for acidic residues, which are represented by the @ symbol. The { } brackets 
denote a variable number of the preceding letter. In the @X{2,3}θ motif, the minimum 
and maximum number of wild card residues is two and three, respectively. A compiled 
list of motifs and target membranes can be found in Tables 4.1 and 4.2, where the 
former lists motifs found within the C-terminal tail of VNUT and the latter lists absent 
motifs. 
 
Figure 4.6 Method for acquiring and analyzing SLC 17 and 18 transporter 
sequences for targeting motifs 
The VNUT Genpept files of 800 animals were downloaded en masse into one file from NCBI. This 
file was separated into a separate .txt file per accession number. These .txt files were used for 
alignment analysis. Since most animal models in which VNUT might be studied are chordate 
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animals, the chordate .txt files were selected for motif analysis. This was done using an R script 
to scan the taxonomy data of each .txt file. All motif searches were compiled into a JMP 
spreadsheet. The separation of the original Genpept file containing 800 accession numbers into 
.txt files and the regex-based motif searching were both performed using R scripts. 
VNUT does not have a peroxisome, trans-Golgi network (TGN), NPXY internalization, or 
nuclear targeting motifs in the C-terminus of 16 Classes of animals (Fig 4.7). For most of 
the Classes except Mammalia, VNUT has a YXXθ motif that is associated with 
internalization and/or targeting to synaptic vesicles or lysosomes, depending on post-
translational modification (Bonifacino & Traub, 2003; Guarnieri et al., 1993; Prado & 
Prado, 2002). In most Classes of organisms, sialin, the VGLUTs, VAChT, and VMAT2 
have a @X{2,3}θθ motif in their C-terminus. This is in stark contrast to the mammalian 
VNUT C-terminus, which is conspicuously lacking any common vesicle-associated 
targeting motifs. Note that while VNUT does contain dileucine-like motifs, these positions 
are likely embedded within transmembrane domains. 
The C-terminus of mammalian VNUT does have a KDEL receptor-like endoplasmic 
reticulum (ER) retention motif (Fig 4.7). Note that the motifs in Table 4.1 correspond to 
the motifs shown in Figure 4.7, in which only motifs present within the C-termini are 
shown. The motifs shown in Table 4.2 were not commonly present in the C-termini of the 
assessed transporters. Differences in the length of the C-termini for each transporter 




Figure 4.7 Signaling motifs in the C-terminus of SLC17 and 18 family members 
The presence of a variety of targeting sequences, denoted by the right-hand Y-axis, are noted by a dot. Each dot is colour-coordinated with a 
Class of animals as listed in the legend on the left. The size of the dot or circle corresponds to the frequency of the motif within the species of that 
Class. The location of the motif is shown on the x-axis, which shows the amino acid position relative to the C-terminal end of the amino acid 
sequence. The two red motifs were identified as being unique to VNUT. Motifs from Table 4.1 not listed here were either rarely found or not found 
at all in any of the C-termini or Classes. Abbreviations: Endo, endosome; TGN, trans-Golgi network; ER, endoplasmic reticulum; SynVes, synaptic 




Table 4.1 Targeting motifs found in the literature and C-termini of VNUT, sialin, VGLUT1, VGLUT2, VAChT, and VMAT2 
Motif Common Name Target Protein(s) References 
FW Diaromatic motif Endosome to TGN CD-MPR Bonifacino, J.S, & Traub, L.M., 2003. 
(K/H)@@θ KDEL motif Golgi to ER Calreticulin, Ubiquitin Teasdale, R.D. & Jackson, M.R., 1996; Raykhel, I., et al, 2007. 
(F/L)(L/I/V)XX(R/K) FLIXR motif Golgi Glycosyltransferases Banfield, D.K., 2011; Pandey, K.N., 2009. 









Colgan, L., et al, 2007; Li, H., et al, 2017; Prado, 
V.F, & Prado, M.A.M., 2002; Bonifacino, J.S, & 
Traub, L.M., 2003; Varoqui, H., & Erickson, J.D., 
1998; Pandey, K.N., 2009. 
@XXθθ  TGN to Endosome Sortilin 
Prado, V.F, & Prado, M.A.M., 2002; Bonifacino, 





Peroxisome Thiolase I Kiel, J.A.K.W., et al, 2004. 
YXXθ Tyrosine motif Synaptic Vesicle, Lysosome VAChT, LAMP-1 
Colgan, L., et al, 2007; Guarnieri, F.G., et al, 1992; 
Varoqui, H., & Erickson, J.D., 1998; Bonifacino, 





Table 4.2 Targeting motifs found in the literature but not in C-termini of VNUT, sialin, VGLUT1, VGLUT2, VAChT, and VMAT2 
Motif Common Name Target Protein(s) References 
YθYYθX Non-classical tyrosine motif Synaptic Vesicle VAChT 
Colgan, L., et al, 2007; Varoqui, H., & Erickson, 
J.D., 1998. 
NPXY NPXY motif Internalization LCL receptor Bonifacino, J.S, & Traub, L.M., 2003; Pandey, K.N., 2009. 
@@{6,9} Acidic cluster motif Endosome to TGN VMAT2 Bonifacino, J.S, & Traub, L.M., 2003. 
Y{3,7} Y-rich motif Endosome to TGN CD-MPR Bonifacino, J.S, & Traub, L.M., 2003. 










Lange, A., et al, 2007. 
K(K/R)X(K/R)  Nucleus (Monopartite) SV40 Large T-antigen, C-Myc Lange, A., et al, 2007. 
LIKAKKGGKSKL Peroxisome localization sequence (PLS) Peroxisome Firefly Luciferase 





4.2. Evolutionary Changes to VNUT 
VNUT has undergone major evolutionary changes from fish to birds. Figure 4.8 is a 
segment of the tree of life, which illustrates the widespread expression of SLC17A9 
(stars). A brief note about Class Ascidiacea: the protein sequence for Phallusia 
mammillata (NBI accession number CAB3266123) is the only sequence of this Class 
that has been submitted to the NCBI library. Further, this sequence has not been 
validated, thus the sea squirts were not denoted as having SLC17A9 in their genome 
(Fig 4.8), but other sea squirts may express SLC17A9.  
 
Figure 4.8 Evolutionary tree of Kingdom Animalia 
This tree is set up in dichotomous fashion to make evolutionary relationships between Classes of 
animals easier to trace. Where known, the timepoint of divergence is indicated (“OneZoom Tree 
of Life Explorer,” n.d.). Starred Classes have SLC17A9. Abbreviations: Ma, millions of years ago. 
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The alignment analysis in Figure 4.9 shows a charged residue-rich motif of @AβRVDI@-
XXKXR(Y/H)HNIHI that is present in fish (β represents a positively-charged, polar amino 
acid), with some exceptions such as Arctic char, croaker, and zebrafish. This conserved 
sequence, which contains a possible YXXθ motif (blue highlighting in Fig 4.9), changes 
as VNUT likely experiences a deletion event between Actinopterygii and Classes 
Amphibia, Mammalia, Reptilia, and Aves, approximately 430 million years ago. The DNA 
nucleotides that were likely deleted are highlighted in Figure 4.10. As a result, the C-
terminus length changes from ~19 amino acids in bony fish to ~14 amino acids in the 
other Classes. The deletion of these nucleotides may have resulted in a dileucine-like 
motif that is not present in fish (Chondrichthyes and most Actinopterygii), while an 
alternative tyrosine motif appears to have been retained in amphibians, reptiles, and 
birds (Fig 4.9).  
The 14 amino acid length of the C-terminal domain was unchanged in mammals, yet 
different mutations occurred. Of particular interest are the last four residues, which seem 
to undergo an evolutionary change from the tyrosine (YXXθ) motif found in analyzed 
representatives of the other Classes to a predominant HEDL sequence in mammals (Fig 
4.9). This HEDL motif bears strong resemblance to the KDEL receptor recognition motif.  
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Figure 4.9 Conservation of VNUT C-termini across Kingdom Animalia 
The C-terminus of VNUT is shown for one cartilaginous fish, eleven bony fish, two amphibians, 30 mammals, seven reptiles, and eleven 
birds, from top to bottom. Grey: the last transmembrane domain in selected species. Green: dileucine-like motif where present in the C-
terminal domain of each sequence. Blue: Tyrosine motifs were present within the C-terminal domains of each sequence. The numbers to 
the right of each sequence denote the number of amino acids shown. To the left of each sequence is the common name of the animal 




Figure 4.10 C-terminal deletion of VNUT in reptiles, aves, amphibians and mammals 
Nucleotide alignment of mammalian, avian, amphibian, and fish VNUT. Nucleotides are coloured such that thymine is red, guanine is black, 
adenine is green, and cytosine is blue. The blue highlighting indicates the predicted deletion, based on homology alignment.
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4.3. Possible Golgi-Targeting Motif in the C-terminal 
Domain of Mammalian VNUT 
A comparison of human SLC17 family members further illustrates the uniqueness of the 
C-terminal domain of a representative mammalian VNUT, Figure 4.11. All other twelve 
transmembrane domain SLC17A transporters have a dileucine-like motif in their C-
terminal domains, indicated in green in Figure 4.11. An important note is that the 
dileucine-like motifs alone do not dictate the subcellular location of these transporters, 
which is varied. For example, the VGLUTs traffic to vesicles (Haiyan Li et al., 2017), 
NPT1 is mainly found on the plasma membrane (Reimer, 2013) and sialin sorts to 
lysosomes (Wreden, Wlizla, & Reimer, 2005). Where VNUT lacks a synaptic vesicle 
targeting dileucine-like motif, it bears a KDEL-like HEDL motif at the very end of the C-
terminus, shown in yellow (Fig 4.11). The KDEL motif is specifically responsible for 
Golgi-to-ER cycling of ER resident proteins. The resemblance of the HEDL motif to the 
KDEL receptor motif and the flexible recognition ability of KDEL receptors (Raykhel et 
al., 2007) jointly point to the HEDL motif being a functional KDEL receptor ligand. 
Further, the YθDL motif seen in reptiles and birds (Fig 4.9) might be a moderately 
functional ligand for the reptilian and avian equivalent of the KDEL receptor, suggesting 
possible divergent evolution of VNUT into an ER/Golgi ATP transporter. 
A comparison of VNUT to human SLC18A family members VAChT and the VMATs also 
hints to the importance of the C-terminus in determining the subcellar location of VNUT. 
Figure 4.12 shows the monoamine transporters having acidic cluster motifs in addition to 
a dileucine-like motif. Acidic cluster motifs target prohormone processing enzymes to the 
TGN when phosphorylated (Bonifacino & Traub, 2003). The acetylcholine transporter 
also has a secondary motif in addition to the dileucine-like motif seen in both SLC17 and 
18 transporters. Two tyrosine motifs are critical for targeting VAChT to synaptic vesicles 
(Colgan et al., 2007). Using CLC Genomics Workbench, the C-termini of the transporters 








Figure 4.11 Predicted structures of human SLC17A transporters 
The grey rectangles represent lipid bilayers. Green represents dileucine-like motifs, yellow shows predicted ER retention 
motifs.  
Figure 4.12 Comparison of VNUT with the monoamine and acetylcholine transporters 
The grey rectangles represent lipid bilayers. Green represents dileucine-like motifs, red represents acidic cluster 




Figure 4.13 Alignment of 12-transmembrane domain transporters of the SLC17A and SLC18A families 
The common name of each transporter is shown on the right side of each sequence. The twelfth transmembrane domains of each transporter is highlighted in grey. Dileucine-like motifs are highlighted in green, acidic cluster motifs in red, and 
tyrosine motifs in blue. The KDEL-like motif is highlight in yellow. The numbers on the right correspond to the number of amino acids in each sequence. The NCBI accession numbers for each sequence, in descending order, are: Q9P2U7, 
Q9P2U8, Q8NDX2, Q9NRA2, Q14916, Q9BYT1, Q05940, P54219, and Q16572. 
In the electric organ of the Pacific Ray, the VAChT colocalizes with VNUT, VGLUT1, and VGLUT2 to synaptic vesicles (Huinan Li & Harlow, 2014). California torpedo is a member of Class Chondrichthyes. Figure 4.14, a 
simplified version of Figure 4.7, compares the mammalian and cartilaginous fish transporters that colocalized in the Pacific Ray. The VNUT sequence of the Pacific Ray is not available on NCBI. Two Chondrichthyes 
representatives were available, the elephant shark (XP_007909316) and the thorny skate (XP_032897284). A total of two VNUT and one of each VGLUT1, VGLUT2, and VAChT Chondrichthyes sequences were analyzed. 
Due to a lack of cartilaginous fish representatives, the bony fish (Actinopterygii) were included in the comparison. For Class Actinopterygii, 58 VNUT sequences were analyzed alongside one VGLUT1 sequence, 18 
VGLUT2 sequences, and 10 VAChT sequences. Similarly, 63 mammalian VNUT sequences were compared to their fish counterparts (cartilaginous and bony), in addition to 56 sequences of VGLUT1, 44 sequences of 
VGLUT2, and 57 VAChT sequences. 
The tyrosine and dileucine-like motifs are present in the C-terminus of fish and mammalian VAChT, VGLUT1, and VGLUT2. Of the 58 species of Actinopterygii for which VNUT sequences could be found, only one had a 
dileucine-like motif in the C-terminal domain of VNUT (Fig 4.14). The dileucine-like motif was absent from all other sequences. Neither of the Chondrichthyes representatives had a tyrosine motif, but 15 Actinopterygii 
species did have a C-terminal tyrosine motif. No mammalian VNUT sequence contained a tyrosine motif in the C-terminal domain (Fig 4.14). These data further highlight the unique and conspicuous absence of a C-terminal 
targeting motif in mammalian VNUT. 
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Figure 4.14 Comparison of Classes Chondrichthyes and Mammalia 
The presence of each motif is indicated by dots or circles, with the symbol size illustrating the 
frequency of the motif within each class. Light blue, Chondrichthyes. Dark blue, Actinopterygii. 
Black, Mammalia. Note that the size of the dot indicating the presence of a dileucine-like motif in 
Actinopterygii corresponds to a single species. 
4.4. Unique Regions of Mouse, Rat, and Human VNUT 
Having noticed the unique lack of targeting motifs in the C-terminal domain of VNUT, I 
checked for homology between the C-terminal sequence of human, rat, and mouse 
VNUT and the proteome corresponding to each species using NCBI’s Protein BLAST. 
My goal was to identify any transporters or receptors to which the VNUT C-terminal 
domain bore resemblance, hinting to possible trafficking locations. For each BLAST, 
unverified sequences such as models (XM/XP), non-redundant RefSeq proteins (WP), 
and uncultured or environmental sample sequences were excluded. In each proteome, 
VNUT self-matched with no other hits. The C-terminal tails of each VGLUT isoform only 
returned hits for the other isoforms of VGLUT. In contrast, the C-terminal sequences of 
sialin and the NPTs returned a variety of non-specific hits such as mitochondrial inner 
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membrane protease subunit 2, dual specificity protein kinase CLK4, plasma membrane 
calcium transporting ATPase, epidermal growth factor receptor substrate 15, and 
echinoderm microtubule-associated protein-like 2. The lack of specificity of sialin and the 
NPT C-termini is not surprising considering their lengths of 7 amino acids 
(SLC17A2/NPT3) and 16 amino acids (SLC17A4/NPT2, SLC17A3/NPT4, 
SLC17A1/NPT1, and SLC17A5/sialin). Amongst the SLC18A family, the C-termini are 
specific for each protein, with VAChT self-matching and the VMAT isoforms matching 
themselves and each other. These results indicate that transporter C-terminal domains 
are highly specific, except when the C-terminal length is short. 
I analyzed the remaining cytosolic regions of VNUT, which were non-specific except for 
the loop between the sixth and seventh transmembrane domains (S6-7 loop). Some off-
target hits included proteins like RUFY3, general transcription factor 3C, syntaxin 6, 
dynein heavy chain 5, 8, and 9, myosin 15, angiopoietin 1, and Timeless. Appendix C 
shows supplemental data that summarizes some of the results from the Protein BLAST 
analysis of mouse VNUT (NCBI accession Q8VCL5). The S6-7 loop appeared to be 
highly specific to VNUT. The mouse S6-7 loop did not have any significant homology to 
other mouse proteins. The S6-7 loops of the other SLC17 transporters were also 
specific. For example, the VGLUT isoforms only showed homology with each other, 
while sialin was homologous to itself and the sodium-dependent phosphate transporter 
isoforms 1-4 (SLC17A1-4). Additionally, the adjacent sixth and seventh transmembrane 
domains were highly conserved amongst all SLC17 transporters, Figure 4.15.  
In comparison, the SLC18 transporters do not have unique S6-7 loops, likely due to their 
short lengths. VAChT and VMAT1-2 returned numerous non-specific hits that included 
proteins like sickle tail protein, apolipoprotein L3, endothelial transcription factor GATA-
2, cadherin 23, and dystonin. The alignment shown in Figure 4.15 illustrates the variation 
of the S6-7 cytosolic loops of SLC17 and 18 transporters. The specificity of the S6-7 
loop was characteristic of the SLC17 but not the SLC18 transporters. The C-termini of 
the VMATs and VAChT have additional targeting motifs, such as acidic cluster and 
tyrosine motifs, that are not present in the C-termini of the SLC17A family members. The 
specificity of the S6-7 loop in conjunction with the increase in size (and perhaps 
accessibility for regulatory proteins) present a possible secondary location for targeting 
motifs for the SLC17A family members. 
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An example of a secondary targeting motif can be found in the S6-7 loop of sialin. The five amino acid residues SSL(R/K)N at positions 268-272 are important for targeting to lysosomes (Wreden et al., 2005). These 
residues are highlighted in orange in Figure 4.15. Further, mutational analysis of a dileucine motif in the cytoplasmic amino (N) terminal domain of sialin also disrupts lysosomal targeting by preventing interactions with other 
lysosomal proteins (Wreden et al., 2005). Figure 4.15 also shows the NPTs having a motif similar to the SSL(R/K)N motif found in sialin, although it is not clear if these motifs target the NPTs to lysosomes. These data 
illustrate the role of secondary targeting motifs in cytoplasmic domains other than the C-terminus in protein trafficking. It would be interesting to test what role, if any, the S6-7 loop has on VNUT targeting. Assessing 
additional cytosolic domains other than the C-terminus could provide insight into targeting motifs, like those seen in sialin. While mutational studies are needed to assess the importance of the S6-7 loop in VNUT trafficking, 
a conserved dileucine-like motif might explain why a small portion of VNUT is sorted to vesicles. 
 
Figure 4.15 Alignment of the cytosolic 6-7 loop sequences 
Transmembrane domains are indicated by grey arrows overlaid on each sequence. The sequence in between each of the transmembrane domains is the 6-7 loop, which is considerably shorter in the SLC18 transporters compared to the SLC17 
transporter loops. The VNUT 6-7 loop is shorter than those of other SLC17 family members and lacks the level of homology seen between all other SLC17A family members. There is a conserved @X{2,3}θθ motif amongst the SLC17A family 
(green). Sialin also contains an SSLRN motif (orange). 
.
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Chapter 5.  
 
Discussion 
5.1. Subcellular Localization of VNUT in N2a Cells 
Inconclusive Based on Immunostaining Results 
5.1.1. VNUT does not Localize to Synaptic Vesicles 
Purinergic Synaptic Vesicles 
I originally predicted that VNUT would localize to purinergic synaptic vesicles. Previous 
research in the Poburko lab demonstrated a correlation between synaptic vesicle 
proteins SV2a, synaptophysin, and synaptotagmin 1 (Syt1) with the monoamine 
transporter VMAT2 in rat tail artery. On the contrary, VNUT-containing blobs did not 
associate with these proteins in rat tail artery (Kalkhoran et al., 2019). Colocalization 
analyses in hippocampal neurons support a lack of colocalization between 
immunoreactive VNUT with Syt1 and synaptophysin (Larsson et al., 2012). A similar lack 
of colocalization between synaptophysin and VNUT was seen in cerebellar granule 
neurons (Menéndez-Méndez et al., 2017). VNUT, synaptophysin, and VGLUT were co-
expressed in murine retinal tissue, but the tissue-scale staining does not lend insight to 
subcellular colocalization of these proteins (S. Moriyama & Hiasa, 2016).  
The subcellular localization of VNUT may differ between cell types, in which there seems 
to be varying levels of colocalization between VNUT and synaptic vesicle proteins. A 
separate study using N2a cells found partial overlap of fluorescent signals corresponding 
to synaptophysin and Myc-tagged VNUT (Menéndez-Méndez et al., 2015). I argue that 
the density of the synaptophysin and Myc-tagged VNUT puncta overestimated the true 
extent to which these proteins colocalized, especially in the soma. Based on the 
predicted functional relationship of facilitating neurotransmitter release, these proteins 
should show a high degree of colocalization in the parts of the cell associated with 
vesicular release. For this reason, VNUT colocalization was assessed by cell part. 
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In the studies of this thesis, VNUT did not colocalize with markers of synaptic vesicles, 
secretory vesicles, catecholaminergic vesicles, or lysosomes with any degree of 
consistency, as summarized in Figure 5.1. The randomization trial of VNUT, LAMP-1, 
and VMAT2 colocalization calculated the frequency of NN puncta randomly residing 
within their reference VNUT puncta to be 8-10% (Table 3.12). The analysis of VNUT with 
LAMP-1 (Fig 3.6) and VMAT2 (Fig 3.10) resulted in marginal colocalization, illustrated by 
the NN puncta residing within VNUT at a slightly higher-than-random frequency of about 
11-12% (Table 3.13). After subtracting the rate of randomness, the frequency of NN 
within reference was further reduced to 2-4%. Considering the rate of random 
colocalization of VNUT with LAMP-2 and VMAT2, we assume that synaptotagmin 
isoforms 1 (5-7%), 2 (3-5%), and 5/9 (1-3%), synaptophysin (5-7%), synaptobrevin (0%), 
and the synaptic vesicle-associated protein synapsin (3-5%) exhibit sparse 
colocalization with VNUT.  
 
Figure 5.1 Graphical summary of colocalization analyses  
Markers are described in Figure 3.1. Red crosses denote proteins that were not consistent 
markers of VNUT-containing compartments. Created with Biorender.com. 
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Of the tested markers, the best candidates for colocalization based on NN within 
reference VNUT puncta frequencies were ELKS and SV2a. ELKS puncta coincided with 
VNUT at a frequency of 22.5% in neurites and 19.8% in terminal varicosities (Table 3.3), 
with a collective average of 20.2% in neurites and all varicosities. ELKS localizes to 
active zones, where it serves as a scaffold within a multiprotein apparatus that helps 
tether readily releasable vesicles to sites of calcium entry (Held & Kaeser, 2018). An 
influx of calcium triggers vesicle fusion and subsequent neurotransmitter release. While 
ELKS was not a definitive molecular marker of VNUT-containing organelles, 1 in 5 
VNUT-containing puncta contained an ELKS-labeled puncta in the cell parts that are 
most likely to contain active zones. ELKS 
tethering suggests that these VNUT-
containing puncta could represent a form 
of releasable vesicle.  
Since ELKS is not an integral 
transmembrane protein like VNUT, 
VMAT2, or LAMP-1, its 
subplasmalemmal dynamics are not 
confined to the circumference of a vesicle 
membrane. ELKS interacts with 
cytoskeletal elements and is present 
within the cytosol throughout the active 
zone, Figure 5.2. Of the numerous 
vesicle populations, ELKS would mostly interact with the readily releasable pool, which 
is the closest to the plasma membrane. Due to differences in localization and dynamics, 
extrapolating the VNUT-VMAT2-LAMP-1 randomization frequency of 8-10% is likely not 
as application to ELKS as it is for other markers that exhibit punctate staining and 
density similar to VNUT. Instead, colocalization analyses using VMAT2 and ELKS would 
provide better statistical comparisons. Further, ELKS-associated proteins such as Rab3-
interacting molecules, Munc13 proteins, and bassoon also participate in temporary 
tethering (Held & Kaeser, 2018). Future studies could test the colocalization of these 
active zone proteins with VNUT. 
SV2a is a 12 transmembrane domain protein that is thought to have a role in vesicle 
priming and/or fusion competency (Bartholome et al., 2017). The exact role of SV2a is 
Figure 5.2 ELKS and associated proteins 
are diffuse throughout the active zone 
VNUT localization is constrained to the vesicle 
membrane, resulting in punctate staining 
patterns. ELKS is found throughout the cytosol 
in active zones. Created with BioRender.com. 
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not known, but hypotheses include regulating the recruitment of Syt1 and/or the 
assembly polypeptide adaptor complex 2 (AP-2) (Bartholome et al., 2017). In addition to 
recruiting clathrin to the vesicle coat, adaptor proteins are cargo-specific, loading specific 
substrates into vesicles by recognizing acidic cluster/dileucine and tyrosine motifs (Kelly 
et al., 2014). The recruited clathrin helps shape vesicles during endocytosis and, in 
coordination with the adaptor protein complexes, participates in vesicle targeting. In mice 
pups, SV2a knockout was lethal within 1-2 weeks of birth, although the brain physiology 
remained unchanged (Bartholome et al., 2017). Thus, SV2a was not important for 
development in utero but its function was critical to post-birth survival. Its role in 
neurotransmission was established by knockout studies, in that spontaneous and 
evoked postsynaptic currents are reduced in the absence of SV2a (Bartholome et al., 
2017). If VNUT localizes to synaptic vesicles, SV2a should be a consistent marker of 
VNUT-containing vesicles. However, the majority of VNUT puncta do not have SV2a 
puncta within their borders, and vice versa (Fig 3.6H and K). ELKS and SV2a were not 
consistent markers of VNUT-containing organelles despite having the highest 
frequencies of NN puncta within the perimeter of VNUT reference puncta of the synaptic 
vesicle markers. 
Catecholaminergic Synaptic Vesicles 
ATP is co-released from sympathetic nerves that release norepinephrine. ATP release is 
rapid with short-term post-junctional effects (i.e., twitch contractions). Conversely, 
norepinephrine is primarily released in response to stronger stimuli. In addition to its 
release being sustained during longer periods of stimulation, norepinephrine induces 
post-junctional responses of greater amplitude and duration than ATP (Todorov et al., 
1999; Westfall et al., 1996). ATP and norepinephrine also have different, yet co-
dependent, pre-junctional regulatory mechanisms (Todorov et al., 1999). These 
differences in release kinetics suggest different populations of ATP- and norepinephrine-
containing vesicles. Immunohistochemical staining of rat tail artery identified anti-
colocalization of VNUT-containing puncta from puncta stained for the catecholamine 
transporter VMAT2 (Kalkhoran et al., 2019). I predicted that VNUT-containing vesicles 
were responsible for quantal release of ATP in N2a cells and further hypothesized that 
these quanta were molecularly distinct from catecholaminergic vesicles.  
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Accounting for the random likelihood of VMAT2 NN puncta residing within their reference 
VNUT of 10.3% (Table 3.13) and the assessed frequency of 11.1% (Table 3.3), VMAT2 
colocalization was negligible with frequency of NN within VNUT of 0.8%. I was not 
expecting VNUT to co-reside with VMAT2, based on my colleagues’ observations in rat 
tail artery (Kalkhoran et al., 2019) and the differences in ATP and NE release reported in 
sympathetic nerves (Kennedy, McLaren, Westfall, & Sneddon, 1996; Todorov et al., 
1996). This N2a cell-based research corroborates previous findings in rat tail 
sympathetic nerves that VNUT is not localized to catecholaminergic synaptic vesicles. 
The localization of VNUT may be cell line or tissue specific. Immunoelectron microscopy 
illustrates VNUT localization in a minority of secretory vesicle-like chromaffin granules in 
PC12 cells (Sawada et al., 2008). 
5.1.2. Chromogranin A is not a Marker of VNUT-Containing Organelles 
In bovine chromaffin cells, ATP is thought to be an important component of dense cored 
secretory vesicles (Estévez-Herrera et al., 2016). In sympathetic neurons, ATP is co-
released with NE, which is typically released from small dense cored vesicles. The 
electron density of these organelles is due to the presence of chromogranins (Hearn, 
1987; Hoon Huh, Hoo Jeon, & Hyun Yoo, 2003), which are also present in large dense 
cored secretory vesicles that typically release neuropeptides (Merighi, 2018). To rule out 
VNUT localization to peptidergic secretory vesicles, I assessed VNUT colocalization with 
chromogranin A (CGA). Immunolabeled CGA and genetically encoded CGA-GFP did not 
colocalize with VNUT in N2a cells. The NN puncta for each marker resided within their 
assigned VNUT reference puncta with an average frequency of 12.7% and 7.4% (Table 
3.3). Assuming the random colocalization frequency of 8-10% results in non-random 
frequencies of approximately 3-5% and 1-3% for CGA and CGA-GFP, respectively. I did 
not expect CGA to be a consistent constituent of VNUT-containing vesicles due to the 
lack of colocalization with catecholaminergic vesicles, some which also contain CGA 
(Kloukina-Pantazidou et al., 2013).  
5.1.3. VNUT does not Localize to Lysosomes in N2a Cells 
VNUT localization to lysosomes might be dependent on cell line. Reports studying 
kidney epithelial cells, myocytes, astrocytes, and glial cells suggested some degree of 
colocalization between VNUT and LAMP-1 (Cao et al., 2014; Oya et al., 2013; Zhong et 
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al., 2016). Studies of stria vascular marginal cells of rat cochlea also suggest VNUT 
localization to lysosomes (J. Liu et al., 2016). It is worth noting that ATP release from 
lysosomes has been identified in the central nervous system. Cerebellar granule 
neurons and primary cultures of dorsal root ganglion neurons exhibit calcium-induced 
lysosomal ATP release (Menéndez-Méndez et al., 2017; Miras-Portugal et al., 2019). 
VNUT localization to lysosomes and lysosomal ATP release have not been assessed in 
sympathetic nerves.  
I hypothesized that VNUT would not localize to lysosomes in N2a cells. The degree of 
colocalization between immunoreactive LAMP-1 and exogenously expressed LAMP-1-
RFP constructs with immunolabeled VNUT and N- and C-terminal EGFP-conjugated 
VNUT was comparable. The punctate pattern of VNUT and LAMP-1 
immunofluorescence is the N2a cells was consistent with their localization to small, 
membrane bound organelles. The observation that localization of LAMP-1 NN puncta fell 
within the bounds of VNUT ROIs and vice versa was only 4-7% above that seen for 
randomly distributed puncta suggests that these two markers are not colocalized in N2a 
cells. Although shRNA or isolation of primary cell culture from SLC17A9 deficient mice 
are the gold standard of assessing antibody specificity, the former technique could not 
be completed due to time constraints (Appendix B). However, the exogenously 
expressed constructs produced the same punctate patterns of fluorescence as the 
immunostaining, which was promising evidence of antibody specificity. Further, the 
degree of colocalization between the fluorophore-conjugated LAMP-1 and VNUT was 
similar to the immunolabeled counterparts. For overexpressed and native VNUT, 
fluorescence imaging data indicate that VNUT is not consistently localized to lysosomes. 
The reader might ask why I did not use LysoTracker, a common molecular probe for 
lysosomes. As discussed in Chapter 3, this fluorescent probe stains lysosomes based 
on the principle of pH-trapping lipophilic weak bases in acidic compartments. However, 
synaptic vesicles, endosomes, and multivesicular bodies are also acidic organelles that 
range in pH from 4 to 5.5 (Ahdut-Hacohen, Duridanova, Meiri, & Rahamimoff, 2004; 
Vacca, Scott, & Gruenberg, 2016). Due to pH-dependent accumulation, LysoTracker is 
unable to differentiate between lysosomes and other acidic organelles. Conversely, 
LAMP-1 is a canonical marker of lysosomes that is less likely to falsely label non-
lysosomal compartments. However, LysoTracker Red staining of cells that express 
EGFP-VNUT could provide information about the proportion of VNUT that is localized to 
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acidic compartments. For example, if VNUT is primarily localized to the ER/Golgi but 
also resides in synaptic vesicles or lysosomes, this would be observed by a greater 
proportion of VNUT reference puncta not containing a LysoTracker Red NN puncta 
within their perimeter.  
5.1.4. VNUT Might be a Golgi/ER Protein 
My data point to two possible configurations for the subcellular location of VNUT. A very 
small portion of VNUT-containing organelles might be synaptic vesicles, indicated by the 
range of frequencies of NN puncta within VNUT puncta of 2-20% for all synaptic vesicle 
proteins (not accounting for random colocalization). This theory does not account for the 
greater fraction of VNUT puncta that do not associate with canonical synaptic vesicle 
proteins or indeed the differences in puncta size and clustering in the soma compared to 
the neurites. A second explanation that accounts for the larger proportion of VNUT blobs 
in the soma is VNUT localization to a synaptic vesicle-adjacent compartment, but not 
synaptic vesicles themselves. These compartments may be trafficking compartments 
containing enzymes that hydrolyze ATP to metabolize their substrates. These organelles 
may include fragments of ER or Golgi, such as endoplasmic-reticulum-Golgi 
intermediate compartments (ERGICs), Golgi outposts and smaller satellites.  
Unlike the typical imagery shown in textbooks, the ER forms continuous tubular 
networks that extend into axons (Öztürk, O’Kane, & Pérez-Moreno, 2020) and dendrites 
(Mikhaylova, Bera, Kobler, Frischknecht, & Kreutz, 2016). Segments of the Golgi, called 
Golgi outposts tend to reside at the base of dendrites while smaller satellite segments 
interact with the ERGICs and endosomes (Mikhaylova et al., 2016). Like the main body 
of the ER and Golgi, the smaller counterparts are thought to allow protein modifications, 
lipid synthesis, and protein sorting. These compartments allow faster protein recycling 
and export to the plasma membrane by reducing the trafficking distance, although they 
are not fully functional like the major organelles (Mikhaylova et al., 2016; Ori-McKenney, 
Jan, & Jan, 2012; Öztürk et al., 2020). The ERGICs, Golgi outposts, and satellites all 
share membrane components with endosomes through the close cycling of proteins. 
Endosomes also participate in phagocytic processes involving fusion with multivesicular 
bodies and lysosomes. The recycling of membrane components of the endocytic 
recycling and phagocytosis processes would explain weak partial colocalization of VNUT 
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with synaptic vesicle proteins, VMAT2, secretory vesicle proteins, and lysosomes. In this 
theory, VNUT is vital in recruiting ATP for enzyme function in addition to vesicle loading. 
5.1.5. Limitations 
Antibody Specificity 
Due to the heavy reliance on antibodies throughout my research, the most obvious 
limitation is antibody specificity. The gold standard techniques for assessing antibody 
specificity are interfering RNA or a knockout animal model. I designed short hairpin RNA 
(shRNA) constructs that would knock down VNUT and firefly luciferase (FFL), shown in 
Appendix B. The FFL construct would have been the negative control, as there is no 
luciferase in mouse N2a cells. Unfortunately, time constraints due to the COVID-19 
pandemic prevented my undergraduate assistant and me from building and validating 
these constructs. Our lab is currently working on validating commercially produced 
shRNA constructs, but these constructs are failing to knock down VNUT mRNA 
expression. Our lab continues to work on VNUT knock down studies, however we are 
reasonably confident in our anti-VNUT antibody for two reasons. First, a second anti-
VNUT antibody was purchased from Alomone Labs to replenish our dwindling supply of 
Santa Cruz rabbit polyclonal antibody, which can no longer be purchased due to Santa 
Cruz having lost their license to use animals. The Alomone antibody exhibits a similar 
staining pattern as the Santa Cruz antibody (data not shown). Secondly, the EGFP-
conjugated VNUT probe also presents a similar pattern of fluorescence to the Santa 
Cruz antibody. Other than stronger perinuclear staining, the over-expressed EGFP-
VNUT fusion proteins stained the neurites and varicosities in a similarly punctate manner 
as the immunolabeled native proteins.  
Randomization of ROIs 
The regions of interest (ROIs) outlining each VNUT puncta were randomly re-located 
within the confines of 8 cells using the Poburko Lab’s Randomization macro in 
ImageJ/Fiji. This method uses an algorithm to assign each VNUT ROI a new x and y 
coordinate that cannot exceed the boundary of the cell outline. Although the random 
number generator does result in a random distribution of the VNUT ROIs, the ROIs were 
not homogenously distributed across the area of the cell. Small clusters of randomized 
ROIs may artificially increase the frequency of nearest neighbour colocalization within 
105 
VNUT ROIs. Analyzing multiple randomization replicates would help average out such 
an effect of small clusters, improving the evenness in the distribution of VNUT ROIs. The 
resultant mean frequencies of colocalization across all replicates would be a more 
statistically robust measure of random colocalization. One round of VNUT ROI 
randomization was completed for the LAMP-1 and VMAT2 colocalization analysis, the 
results of which were extrapolated to the colocalization analyses of the other markers. 
Ideally, multiple replicates of VNUT ROI randomization would have been performed for 
each marker. Due to time constraints, this was not possible. However, the analyzed 
images were typical of the N2a cells in which these markers were consistently labelled 
with a high degree of density throughout the cells.  
The constrained volume of neurites and varicosities and density facilitates the proximity 
of the markers and VNUT such that the greatest probability of colocalization should 
happen in these cell parts. Of all assessed markers, VNUT-EGFP/LAMP-1-RFP had the 
highest proportion of VNUT reference puncta containing a NN LAMP-1-RFP puncta 
(~24% in terminal varicosities, before considering the randomized colocalization 
frequency; Table 3.6) along with some of the highest density of puncta throughout the 
cells. Conversely, most markers with low frequencies of colocalization exhibited 
marginally higher NN colocalization indices within the confines of the neurites and 
varicosities. Since the volume of these cell parts is limited, the high density of puncta 
likely results in an overestimation of colocalization. This suggests that most of the 
colocalization seen is random. Further, the images were acquired using z-stacks which 
were compressed into a single z-plane, resulting in a best-focus image. This 
compression would flatten two puncta that were separated along the z-plane into a 
single image, resulting in false colocalization. If a marker was physiologically associated 
with VNUT such that the proteins consistently shared that same geographical space, this 
phenomenon should result in highly colocalized puncta that should be particularly 
apparent in the neurites and varicosities. However, inferences from the density of the 
ROIs for each marker suggests that most of the observed colocalization was random 
and that none of the markers tested are consistent markers of VNUT-containing 
compartments.  
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5.2. Understanding VNUT through Bioinformatics 
The C-terminus of mammalian VNUT is unique compared to the other SLC17A and 18A 
transporters. The VNUT tail lacks a dileucine-like motif that is shared between NPT1, 
sialin, the VGLUTs, the VMATs, and VAChT. Further, VAChT and VMAT2 have 
additional tyrosine-based and acidic cluster motifs, respectively, that likely allow 
differential localization of these co-expressed proteins (Varoqui & Erickson, 1998). While 
these transporters contain vesicle-associated targeting motifs, the C-terminus of VNUT 
lacks common vesicle targeting motifs, such as dileucine-like and tyrosine motifs.  
I identified a potentially evolutionary loss of a C-terminal tyrosine motif that is present in 
bony fish, reptiles, and avians but is not present in mammals. Further, reptiles have a 
dileucine-like motif also not present in the C-terminal domain of mammalian VNUT 
(Figure 4.9). I sought to compare the C-terminus of VNUT with those of the other solute 
carriers that colocalize in synaptic vesicles of the Pacific Ray, Figure 4.14 (Huinan Li & 
Harlow, 2014).  
The electric organ of Torpedo californica expresses VAChT and VNUT, as well as 
VGLUT1 and VGLUT2, resulting in a promising model for studying transporter 
localization. Immunocytochemical analyses identified colocalization between VAChT, 
VGLUT1, VGLUT2, and VNUT in the cholinergic neurons of the electric organ of the 
Pacific Ray (Huinan Li & Harlow, 2014). In addition to releasing acetylcholine, these 
neurons are capable of releasing ATP. Corelease of these neurotransmitters occurs as a 
result of shared vesicles, with 69% of VAChT-labeled vesicles being co-labeled for 
VNUT in isolated vesicles (Huinan Li & Harlow, 2014). In addition to colocalizing with 
VNUT, the 59% of VAChT vesicles co-labeled for VGLUT1 and 61% co-labeled for 
VGLUT2 (Huinan Li & Harlow, 2014). The shared localization of these neurotransmitter 
transporters suggested that they might share a common targeting motif in T. californica, 
a member of Class Chondrichthyes. The C-terminal tail of the VAChT is necessary and 
sufficient for targeting to synaptic vesicles, containing a dileucine-like motif and a YXXθ 
tyrosine motif (Colgan et al., 2007; Varoqui & Erickson, 1998). The C-termini of the 
VGLUTs contain a dileucine-like motif that drives synaptic vesicle targeting and recycling 
(Haiyan Li et al., 2017). I wondered which motifs were present in the Pacific ray VNUT 
sequence. Although the VNUT peptide sequence of T. californica was not available in 
the NCBI database, I analyzed a total of 60 VNUT, 2 VGLUT1, 19 VGLUT2, and 11 
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VAChT sequences from fish alongside 63 mammalian VNUT, 56 VGLUT1, 44 VGLUT2, 
and 57 VAChT sequences. I compared the presence of the dileucine-like and tyrosine 
motifs in the C-termini of these transporters (Fig 4.14). The VNUT C-termini of some 
bony fish contained a tyrosine motif that might play a role in vesicular targeting, like the 
VAChT tyrosine motif. Although the Chondrichthyes representatives did not have 
synaptic vesicle targeting motifs in the C-terminus, it would be premature to suggest that 
this Class does not have any C-terminal signaling motifs based on a small sample size 
of two representatives. Future research would benefit from acquiring the VNUT 
sequence for T. californica and additional Chondrichthyes to assess for motifs that drive 
synaptic vesicle targeting. The comparison between fish and mammalian VNUT C-
termini further illustrates the lack of synaptic vesicle targeting motifs in mammals. These 
results suggest that the motif(s) responsible for targeting VNUT to synaptic vesicles in 
mammals may reside on a different cytosolic domain other than the C-terminus, such as 
the S6-7 loop. 
It would be interesting to test if the pattern of VNUT staining and colocalization with 
VGLUT1-2 and VAChT is corroborated in reptiles and birds. Future studies could 
investigate changes in VNUT localization by removing the C-terminus and comparing the 
frequency of colocalization with VAChT in T. californica. Another experiment uses a 
mammalian-fish VNUT chimera in a mammalian cell model. The C-terminus of the 
mammalian VNUT would be swapped for the fish tail, like the VAChT and VMAT2 
chimera experiment (Varoqui & Erickson, 1998). The results of these experiments would 
clarify if the VNUT C-terminus is required for trafficking to synaptic vesicles in the Pacific 
Ray. If so, a previously unknown targeting motif may be present, or VNUT trafficking 
could be regulated by an alternative regulatory mechanism (e.g., the pH-sensitive ER-
Golgi cycling of the KDEL receptor). Conversely, continued sorting of the truncated 
VNUT to vesicles would support a trafficking motif in another cytosolic domain. 
5.3. VNUT Localization to the ER-Golgi Complex 
In my mammalian cell line, colocalization between VNUT and synaptic vesicle markers, 
large secretory vesicle markers, and lysosomes (some of which may participate in 
secretion) was weak. Some possible reasons for the lack of consistent localization 
include VNUT being cycled between compartments, VNUT localization to certain 
compartments in a development- and tissue-dependent manner, or VNUT having a 
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versatile, multifunctional role. The immunocytochemical and bioinformatic evidence 
presented in this thesis point to VNUT possibly localizing to the ER-Golgi complex, two 
organelles that require future analysis. Two main observations drive this hypothesis. 
Firstly, VNUT immunolabeling produces larger blobs in the nuclear and perinuclear 
space, which bears morphological resemblance to the ERGIC and Golgi. Secondly, the 
extreme end of the VNUT C-terminus possesses a KDEL-like HEDL motif in mammals. 
The HEDL motif will be examined in detail in Section 5.3.1. 
Immunocytochemistry studies in rat epithelial kidney cells identified pre-Golgi structures 
using immunolabeled p58, a marker of intermediate compartments between the ER and 
Golgi apparatus (Ying, Flatmark, & Saraste, 2000). The rat p58 is homologous to the 
human ERGIC marker, ERGIC53. The immunoreactive p58 resulted in punctate 
perinuclear staining to which the VNUT immunolabeling bears resemblance. A GFP-
conjugated ERGIC53 as well as antibody stained ERGIC53 and GM120, and Golgi 
marker, also exhibit punctate staining with enriched signal in the perinuclear space of 
HEK293 cells (Farhan et al., 2008). It is worth noting that the ERGIC53 fluorescence 
looked more similar to the VNUT immunofluorescence and VNUT-EGFP signal than 
GM130. This marker is particularly localized to the proximal areas of the perinuclear 
space (Davids et al., 2016; Farhan et al., 2008).  
A more widespread staining pattern that is most concentrated to around the nucleus, like 
I observed in my colocalization experiments, appears to be characteristic of the ERGIC. 
Indeed, this observation was confirmed by looking at immunofluorescent images of anti-
ERGIC53 antibodies, such as Santa Cruz (SC-365158), Sigma Aldrich (E1031), and 
ProteinTech (13364-1-AP). A study using primary rat hippocampal neurons 
demonstrates the presence of ER exit sites and Golgi outposts in dendrites (Horton & 
Ehlers, 2003). ER exit sites are discrete locations on the ER membrane where cargo is 
concentrated for secretion. This study supports ER and Golgi functionality in dendrites, 
although Golgi functionality was absent from axons. If VNUT primarily localizes to the 
ER-Golgi complex, it would conceivably cycle between the ER, ERGIC, and Golgi 
outposts of the N2a neurites.  
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5.3.1. Bioinformatic Evidence of ER-Golgi Localization of VNUT 
My bioinformatics research identified dileucine-like motifs and tyrosine motifs in non-
mammalian VNUT C-termini, but no such localization motifs in the mammalian 
counterpart. Mammals appeared to be unique in that they lost the dileucine-like and 
tyrosine motifs and instead contain a C-terminal HEDL sequence. While the driving force 
behind the evolution of this change is not clear, the presence of the HEDL motif 
suggests a shift in VNUT localization from primarily synaptic vesicles (as seen in T. 
californica) to the ER-Golgi complex. Experimental observations show VNUT localization 
to the perinuclear space. Without conducting C-terminal mutation experiments, it is 
unclear if the HEDL sequence is responsible for targeting VNUT to this region of the cell. 
Thus, the question is whether the HEDL sequence could reasonably retain VNUT in the 
ER-Golgi complex.  
In HeLa cells, the KDEL receptor was capable of recognizing conservative mutations in 
the KDEL motif, such as HDEL, KEEL, HADL, HEEL, and KEDL (Raykhel et al., 2007). 
The recognition rates of these variants were on par with the original KDEL sequence 
with ~80% ER localization and ~20% remaining in the Golgi (Raykhel et al., 2007). 
Although the HEDL sequence seen in the C-terminal tail of mammalian VNUT was not 
strictly included in this mutation study, based on the flexibility of the KDEL receptor 
recognition, I postulate that the KDEL receptor should be able to recognize the HEDL 
variant. Specifically, recognition of the KEDL and HDEL variants support the likelihood of 
the HEDL motif being a functional ligand for the KDEL receptor. 
Studies in N2a, COS7 and HEK293 cells provide evidence for HEDL-driven ER-Golgi 
localization of novel ER resident cysteine-rich with EGF-like domains 2 (CRELD2) (Oh-
hashi et al., 2009; Oh-hashi, Kunieda, Hirata, & Kiuchi, 2011). N2a cells stably 
expressing a Myc-tagged CRELD2 construct exhibit perinuclear staining (Oh-hashi et al., 
2009) that looks similar to what I observed in the immunolabeled and EGFP-conjugated 
VNUT colocalization analyses. Modifications to the C-terminal HEDL motif, such as a 
deletion of all four residues or the addition of tags like hemagglutinin or Myc/His, altered 
the localization of CRELD2. Instead of primarily residing within the ER-Golgi complex 
with occasional spontaneous secretion, C-terminal alterations to CRELD2 significantly 
increased secretion (Oh-hashi et al., 2011). The four C-terminal residues (R/H)EDL in 
the CRELD2 C-terminus are highly conserved amongst human, bovine, murine, rat, 
110 
chicken, xenopus, and zebrafish (Oh-hashi et al., 2011). The (R/H) variation of the -4 
position was also seen in mammalian VNUT (Fig 4.9). In COS7 cells, immunoreactive 
CRELD2 colocalized with ER and Golgi markers calnexin and GM130, respectively, 
although colocalization with the latter was partial (Oh-hashi et al., 2011). In N2a cells, 
the ER-Golgi complex marker BODIPY-conjugated brefeldin A colocalized with Myc-
tagged or EGFP-conjugated CRELD2 (Oh-hashi et al., 2009). These results further 
support ER-Golgi localization of this HEDL motif-bearing protein.  
The flexibility of KDEL receptor recognition (Raykhel et al., 2007) seems to allow various 
permutations of the KDEL motif in the four terminal residues of ER residents, such 
EDEL, KVEL, KEEL, and QEDL (Oh-hashi et al., 2011). Even greater permutations of 
the KDEL motif may be functional. For example, ER resident mesencephalic astrocyte-
derived neurotrophic factor (MANF) has a C-terminal R(T/S)(DE)L sequence, although 
KDEL motif variants are not as efficient as the KDEL motif itself (Gerondopoulos et al., 
2021; Oh-Hashi, Norisada, Hirata, & Kiuchi, 2015). When the REDL sequence of mouse 
CRELD2 was replaced with RTDL, CRELD2 secretion was dramatically increased. In 
comparison, replacing the HEDL sequence with the canonical KDEL motif largely 
eliminated secretion of CRELD2 (Oh-Hashi et al., 2015). The KDEL motif greatly 
improves the efficacy of the KDEL receptor retention of ER residents, yet the HDEL motif 
variant has greater affinity for the KDEL receptor than the KDEL motif (Gerondopoulos et 
al., 2021). An explanation for the KDEL receptor recognition flexibility might be explained 
by the sheer abundance of some proteins and the relative scarcity of others.  
The sheer amount of KDEL-bearing proteins, about 5-10 µM, results in competition for 
available KDEL2 receptors, the concentration of which is approximately 0.2-0.3 µM in 
HeLa cells (Gerondopoulos et al., 2021). With a five-fold greater concentration of 
proteins compared to the HDEL and RDEL variants, less abundant ER proteins can 
better compete with the KDEL-bearers by bearing a motif with a greater affinity for KDEL 
receptors, HEDL (Gerondopoulos et al., 2021). Differences in receptor affinity did not 
change the localization of the receptors. As long as ligands bore the HDEL, KDEL, or 
RDEL motif variations (ordered from highest affinity to lowest), the KDEL receptors were 
largely localized to the ER (Gerondopoulos et al., 2021). However, the flexibility of KDEL 
receptor recognition has limits. DDEL and ADEL motif variants have far lower affinities 
for the KDEL receptor. The presence of ligands bearing these sequences does not 
stimulate KDEL receptor-driven retrieval to the ER, instead resulting in KDEL receptor 
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accumulation in the Golgi (Gerondopoulos et al., 2021). Collectively, the KDEL motif and 
receptor studies of N2a, COS7, HEK293, and HeLa cells suggest the HEDL motif in the 
C-terminal tail of VNUT could be a functional ligand for the KDEL receptor. 
5.3.2. Molecular Evidence of VNUT Localization to the ER-Golgi 
Complex 
Throughout our experiments, my lab members and I noticed VNUT puncta in the 
perinuclear space. My experiments used anti-VNUT antibodies and genetically encoded 
EGFP-VNUT. N- and C-terminally tagged EGFP-VNUT constructs allowed visualization 
of differences in localization in case the conjugated EGFP impaired VNUT trafficking. 
Compared to the variability of the N-terminus, the risk of impaired trafficking seemed 
greater with the C-terminal EGFP-VNUT construct since mammalian C-termini are highly 
conserved in sequence and length (Fig 4.5A). However, both constructs were 
successfully expressed and trafficked in a similar manner to immunolabeled VNUT. The 
EGFP-VNUT clustered in the perinuclear space (Fig 3.16B,C). While some ER-Golgi 
aggregation of the overexpressed protein could be explained by limited availability of 
cellular transport machinery, I did not expect to see a similar degree of clustering in the 
immunocytochemistry-based experiments (Fig 3.16A). Other lab members noticed 
similar subcellular localization patterns of VNUT in their live-cell imaging experiments 
using VNUT-pHluorin.  
Intense, perinuclear fluorescent signals were observed in live-cell imaging 
experiments using VNUT-pHluorin. Our lab developed several VNUT-pHluorin 
constructs to study real-time, stimulated vesicle release. Instead of seeing brief 
instances of signal corresponding to vesicular fusion and release events, other members 
of the Poburko lab noticed consistent, relatively stable fluorescence within the N2a cells. 
During live-cell imaging of N2a cells, the VNUT-pHluorin expression product aggregated 
primarily near the nucleus (Fig 3.17B). The intensity of the pHluorin emission signal 
intensifies with increasing pH (Grillo-Hill, Webb, & Barber, 2014). The correlation 
between pH and intensity allows general inferences to be made about the localization of 
the pHluorin. Largely diffuse labeling was observed throughout the cell in a compartment 
of near neutral pH, and a localized accumulation o the reporter in nucleus-adjacent 
compartments that had a slightly acidic pH (~6.5). These compartments were acidified 
with sodium butyrate, quenching the VNUT-pHluorin probe (Fig 3.17B). De-quenching 
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occurred with ammonium chloride, resulting in a maximal fluorescent signal. 
Approximations based on the normalized change in fluorescence relative to the range of 
fluorescence intensity suggests the pH of the VNUT-pHluorin-containing compartment 
ranges from pH 6-7 (Gastaldello & Poburko, 2021; unpublished observations). The ER 
has a pH of approximately 7.2 while the Golgi apparatus ranges from a pH of 6 to 6.7 
(Rivinoja, Pujol, Hassinen, & Kellokumpu, 2012). The higher pH of these compartments 
could explain the intensity of the pHluorin in the perinuclear space, supporting the 
localization of VNUT to the ER-Golgi complex (Fig 3.17). 
In contrast, when the Poburko Lab fused the red pH-sensitive fluorescent protein pHuji 
into the luminal S1-2 loop of VMAT2, this probe was largely localized to highly acidic 
vesicles. Some portion of the pHuji probe was externalized, indicated by rapid quenching 
with acidic MES buffered saline (pH 5.5) and dequenching with alkaline TRIS buffered 
saline (pH 8.2). However, a greater proportion of VMAT2-pHuji exhibited peak 
fluorescence when the cells were exposed to ammonium chloride buffered saline (Fig 
3.17B). The relative differences between the initial-quenched intensity and the initial-
maximal intensity indicated localization of most of the VMAT2-pHuji probe to acidified, 
fusion competent compartments. These observations are a stark contrast to the VNUT-
pHluorin localization and responses, suggesting that VNUT is not localized to readily 
releasable, fusion competent compartments. Instead, VNUT-pHluorin is retained within 
the cell in compartments of slightly acidic to near neutral pH, which is most compatible 
with the ER-Golgi complex. 
5.4. Future Studies and Concluding Remarks 
To validate my findings of VNUT localization to the ER-Golgi complex, I identified 
several future experiments. Firstly, I suggest experiments to confirm the identity of the 
compartments as ER or Golgi. VNUT colocalization analyses using ER and/or Golgi 
markers are absent from my thesis due to time constraints, but this research would 
benefit from immunostaining of these compartments or transfecting cells with 
fluorescently tagged, genetically encoded markers. Examples of ER markers include the 
calcium binding chaperone calreticulin, synthesis chaperone binding immunoglobulin 
protein (BIP), and the enzyme protein disulphide-isomerase (PDI). Our lab has recently 
acquired the mDsRed-Golgi-7 Golgi-localizing fluorescent probe from Dr. Michael 
Davidson (Addgene plasmid # 55832). Colocalization analyses between ER and Golgi 
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markers and VNUT, as described in this thesis, would allow the quantification of the 
frequency of VNUT localization to these compartments. 
Additional experiments using molecular techniques would complement immunolabeling. 
One such experiment would replicate the VMAT2-VAChT chimera experiments seen in 
the literature (Varoqui & Erickson, 1998). The Poburko lab has shown VMAT2 
localization to highly acidified fusion competent compartments, likely synaptic vesicles, 
in N2a cells using genetically encoded VMAT2-pHuji. This construct functions in a 
similar manner to VNUT-pHluorin (B. Kim, 2019). I propose an experiment in which the 
C-terminal domains of the VMAT2-pHuji and the VNUT-pHluorin constructs are 
swapped. I predict the VNUT-pHluorin chimera with the VMAT2 C-terminal region would 
traffic to synaptic vesicles, while the VMAT2-pHuji chimera would exhibit perinuclear 
localization indicative of the ER-Golgi complex. This experiment serves to identify the C-
terminal domain as being necessary and sufficient for targeting VNUT to the ER-Golgi 
complex. An additional experiment, which follows the same avenue of investigation, has 
two components. The first component involves truncating VNUT-pHluorin or the N-
terminal, EGFP-tagged VNUT construct. Removing the HEDL portion of the C-terminus 
should alter targeting from the ER-Golgi complex. As shown in COS7 and HEK293 cells 
(Oh-hashi et al., 2011), altering the C-terminal HEDL sequence should result in 
increased secretion of VNUT. The second component of this experiment involves 
mutating the amino acids within the HEDL sequence, similar to the KDEL sequence 
mutation study (Raykhel et al., 2007). Mutations in the HEDL motif should result in a loss 
of ER-Golgi localization and most likely increased secretion. The use of N-terminal, 
EGFP-tagged VNUT or the VNUT-pHluorin is recommended due to the fluorescent 
probes residing well away from the C-terminal domain. Combined with the 
immunocytochemical analyses, these data could provide promising evidence of VNUT 
localization to the ER-Golgi complex. 
In brief, my thesis work sought to identify the molecular fingerprint of a VNUT-containing 
vesicle. I predicted VNUT would localize to purinergic synaptic vesicles in my neuron-like 
N2a cell model. Immunolabeling and exogenous expression techniques identified sparse 
VNUT localization to vesicles. Large clusters of VNUT puncta were observed in the 
perinuclear space, possibly indicating the native trafficking pattern of VNUT to an 
organelle near the nucleus. Since perinuclear enrichment was observed with antibodies 
and genetically encoded probes, the accumulation of VNUT at the perinuclear space is 
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not due to sequestration of the fluorescent probe nor due to non-specific binding of the 
anti-VNUT antibodies. Bioinformatics-based studies identified a lack of synaptic vesicle 
targeting sequences in the C-terminal domain of VNUT, unlike other synaptic vesicle-
associated transporters. Further, the C-terminus of mammalian VNUT contains an HEDL 
motif that bears a striking resemblance to the KDEL recognition motif responsible for 
retrieval of escaped ER proteins from the Golgi. Due to time constraints and COVID-19-
related complications, I was unable to test my first sub-hypothesis that VNUT-mediated, 
Ca2+-dependent ATP release from N2a cells is vesicular. I was able to do some 
troubleshooting identifying the optimal concentration of the calcium ionophore 4Br-
A23187 (AbCam, cat# 142244), which I have described in Appendix A. In conclusion, 
the distribution of VNUT and pattern of colocalization with diverse marker proteins is 
most compatible with localization to the ER-Golgi complex in N2a cells. VNUT may be 
involved in indirect ATP-loading of synaptic vesicles by establishing an ATP-rich 
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Appendix A.   
 
VNUT-Mediated, Ca2+-Dependent ATP Release from 
N2a Cells is Vesicular 
This sub aim sought to corroborate literature findings by visualizing A23187-induced 
ATP release in real-time using the novel GRAB-ATP1.0 sensor, as shown in Figure A.1. 
Further, I planned to assess relative changes in GRAB-ATP1.0 response when the cells 
were exposed to pharmacological agonists of VNUT, the SNARE complex, and pannexin 
channels using clodronate, NEM, and probenecid, respectively. As discussed in Section 
1.2.1, clodronate is a selective inhibitor of VNUT, unlike Evans Blue or DIDs. Clodronate 
has been used to study VNUT-mediated purinergic signaling involved in neuropathic 
pain (Mihara et al., 
2018; Y. Moriyama & 
Nomura, 2017). NEM is 




sensitive factor (NSF) 
that has been in use 
since the 1980s 
(Abeliovich, 2019). 
Probenecid has been 
used to study the role of 
Panx1 during 
neuritogenesis in N2a 
cells as well as primary 
neural stem and progenitor cells (Wicki-Stordeur et al., 2012; Xu et al., 2018). The 
calcium ionophore A23187 has been used to induce ATP release in rat hippocampal 
neurons (Kato et al., 2017; Larsson et al., 2012). Figure A.2 illustrates predicted effects 
of each inhibitor. The first step in setting up an experimental protocol for assessing 
changes in the relative amounts of ATP release in response to the describe inhibitors 
was identifying the optimal concentration of 4-Br-A23187 for inducing ATP release. 
Figure A.1 Overview of ATP release mechanisms and 
GRABATP1.0 activation 
Created with BioRender.com. 
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Subsequently, the optimal concentrations of each inhibitor would be determined. 
Complications due to the COVID-19 pandemic reduced my ability to troubleshoot my 
protocol, however I was able to elicit an intracellular calcium response to 4-Br-A23187. 
Methods and Materials 
In preparation for live-cell experiments, N2a cells were seeded at 5 K cells per well of a 
96-well plate (Greiner Bio-One, cat# 655090). The cells were stored in a humidified cell 
culture incubator that maintained an internal environment of 37°C, 5% CO2, and 95% air. 
One day post-seeding, the cells were transfected with the GRAB-ATP1.0 sensor at a 1:2 
ratio of DNA to jetPRIME reagent using the jetPRIME DNA transfection kit and protocol 
from Polyplus (cat# 114-07). After the four-hour transfection incubation time, the 
transfection media was replaced with fresh, warmed GM. Cells were allowed to recover 
for one day prior to differentiation. After two days of differentiation in DM (described in  
Section 2.1.1), the cells were imaged. The cell preparation methodology is summarized 
in Figure A.3. 
Figure A.2 Predicted changes in GRAB-ATP1.0 fluorescence in response during 
application of ATP release inhibitors 
Created in Part with BioRender.com. 
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Transfected cells were incubated for 30 minutes in GM containing 3 µg/mL Hoeschst-
33342 (Invitrogen Molecular Probes, cat# H3570). To visualized calcium dynamics, 
CalBryte was loaded into untransfected cells with a CalBryte loading solution containing 
2.5 µM CalBryte-520L AM from a 1 mM stock in DMSO (AAT Bioquest, cat# 20640), 
0.1% pluronic F-127, and 3 µg/mL Hoeschst-33342 in GM. After a 30-minute incubation 
at 37°C, the loading solutions for transfected and untransfected cells were replaced with 
100 µL HEPES buffer (140 mM 
NaCl, 5 mM KCl, 10 mM HEPES, 
2 mM CaCl2, 1.5 mM MgCl2, 10 
mM glucose, pH 7.4), as shown in 
Figure A.4.  
Unless otherwise stated, 
perfusion solutions were prepared 
in HEPES buffer and delivered 
onto the cells manually using a 
pipet. Successive acquisition of 
the GFP (488 nm) and mCherry 
(510 nm) signals from the 
genetically encoded GRABATP1.0 
probe used QD480 and QD560 
dichroic mirrors, respectively. The 
mCherry signal stably identified 
transfected cells, while the GFP signal was only visible when the receptor bound to a 
ligand (ATP). CalBryte signals were acquired using the same settings as GFP 
Figure A.3 Cell preparation for live-cell imaging of GRAB-ATP 
Created with BioRender.com. 
Figure A.4 Pre-imaging DNA staining and 
calcium dye loading 
Created with BioRender.com. 
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acquisition. Time-lapse data were acquired using the same microscope and camera 
equipment as described in Section 2.3. Twice concentrated working solutions of 4-
Bromo-A23187 was prepared at concentrations ranging from 2 µM to 10 mM. To induce 
a maximal GRAB-ATP1.0 response, a 3X concentrated working solution of 300 µM was 
prepared from a 100 mM stock in HEPES buffer. The 4-Br-A23187 and ATP were added 
sequentially to the 100 µL HEPES already present in the wells, resulting in a 1X 
concentration of each reagent. The 4-Br-A23187 was added to the cells 10 seconds into 
acquisition, followed by ATP at approximately 70 seconds into acquisition. Each round of 
acquisition was 90 seconds. The acquisition set-up is illustrated in Figure A.5.  
Results 
The calcium sensing dye CalBryte confirmed increased levels of intracellular calcium in 
response to 200 µM 4-Br-A23187, shown in Figure A.6. The CalBryte signal steadily 
increased after addition of the calcium ionophore, followed by maximum fluorescence 
when 100 µM ATP was added to the well.  
The GRAB-ATP1.0 sensor did not show a response to concentrations of 4-Br-A23187 
ranging from 1 µM to 200 µM final well concentration. The sensor was functional, 
indicated by immediate, robust responses to the manually added ATP as shown in 
Figure A.7. Further troubleshooting is needed to optimize the concentration of 4-Br-
A23187 needed to illicit ATP release. 
Figure A.5 Acquisition of GRAB-ATP1.0 and CalBryte 
responses to application of 4-Br-A23187 and ATP 
Created with BioRender.com. 
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Figure A.6 Changes in CalBryte signal in response to 200 µM 4-Br-A23187 and 
ATP 
Scale bar = 10 µM. 
 
Figure A.7 Representative images and trace of GRAB-ATP1.0 response to 4-Br-
A23187 and ATP 
Scale bar = 10 µM. Emission of mCherry at 510 nm not shown. 
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Appendix B.  
 
Testing Anti-VNUT Antibody Specificity using 
shRNA-Mediated Knockdown of VNUT 
To test if the anti-VNUT polyclonal antibody was specific for VNUT, I designed shRNA 
constructs using pEGFP-C1 RPEL1-EGFP-3XNLS gifted from Dr. Dyche Mullins 
(Addgene plasmid # 58469). This plasmid encoded a nuclear localized EGFP, which 
identified successfully transfected cells. Based on the pEGFP backbone, I designed two 
recombinant plasmids. The first contained a firefly luciferase (FFL) shRNA sequence 
and served as a negative control for VNUT knock down (5’- 
CTGACGCGGAATACTTCGA -3’) and the second contained a VNUT shRNA sequence 
(5’-GAACAAGAAGGAGGCTGGTATCGTGCTCA-3’) (Menéndez-Méndez et al., 2015). 
The shRNA sequences were designed as gBlocks Gene Fragments (IDT) to allow future 
use in other plasmids. The gBlocks included priming sequences, Esp3I TypeIIS 
restriction enzyme consensus sequences (New England BioLabs, cat# R0734S), and an 
H1 promoter sequence. The backbone and gBlocks were assembled using a Golden 
Gate Assembly-based protocol. 
The first step of assembling the recombinant pEGFP construct was linearizing of the 
backbone. Using primers that would simultaneously insert complementary Esp31 
sequence onto either end of the backbone, the plasmid was linearized after the third 
nuclear localization sequence and before the SV40 poly(A) signal via PCR. The 
backbone and gBlocks were combined using same-reaction restriction and ligation using 
Esp3I and T4 DNA ligase (New England BioLabs, cat# M0202S). Figure B.1 illustrates 
the molecular workflow for constructing the recombinant VNUT shRNA and firefly 
luciferase shRNA constructs, referred to as pEGFP-C1 EGFP-3XNLS-VNUTshRNA and 
pEGFP-C1 EGFP-3XNLS-FFLshRNA, respectively. Unfortunately, the constructs failed 
to ligate successfully despite multiple cloning attempts. Sequencing data indicated no 
insertion of the gBlocks into the backbone. To troubleshoot, plasmid DNA extracted from 
DH10ß Escherichia coli cells thought to be transformed with linearized plasmid was 
digested with DpnI restriction enzyme (New England BioLabs, cat# R0176S), which 
digests methylated DNA such as the non-linearized backbone plasmid. The DpnI-treated 
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PCR products should have cleaved all parent plasmid. Due to COVID-19 related 
complications, this project was not completed. 
 
Figure B.1 Molecular workflow to build shRNA constructs using an EGFP-
expressing backbone and gBlock gene fragments coding for VNUT and FFL 
Top grey box shows the generation of sticky ends on the pEGFP construct, while the lower grey 
box shows the same process for the gBlock containing the VNUT shRNA sequence. At the center 
of the figure, both components are ligated via their complementary sticky ends to generate the 
pEGFP-3xNLS-shRNA-VNUT construct.  
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Appendix C.  
 
Summary of Protein BLAST Results for the Predicted Cytosolic Domains of 
Murine VNUT  
Table C.1 summarizes series of NCBI protein BLAST results for the cytosolic domains of mouse VNUT (NCBI accession number 
Q8VCL5). A subset of each BLAST analysis is shown, of which the matched proteins share 100% identity with VNUT. Notes were 
made for this subset of the BLAST results using the corresponding UniProt and NCBI descriptions. Where multiple isoforms of a 
protein matched with VNUT, only one isoform was described to compact the table. Some protein names were too long to fit into the 
.txt results file that was downloaded from NCBI and are incomplete in the table, as denoted by ellipses (…).  
Table C.1 Summary of NCBI protein BLAST results  
Cytosolic 
Domain Protein Name NCBI Accession 
Subcellular Location 
(typical or predicted) Gene 
Notes on Function/Structure 
(from UniProt) 
N-terminus      
 protein 4.1 isoform 2 NP_001122078.1 Cytoplasm EPB41 
major structural element of 
erythrocyte membrane 
skeleton; interacts with 
spectrin and actin filaments; 
calmodulin binding 
 protein RUFY3 isoform 4 NP_001346137.1 Cytoplasm RUFY3 
neuronal plastificty & axon 




Domain Protein Name NCBI Accession 
Subcellular Location 
(typical or predicted) Gene 
Notes on Function/Structure 
(from UniProt) 
 complement component C1q 
receptor precursor NP_034870.1 Plasma Membrane CD93 
receptor for C1q; might be 
involved in phagocytosis 
(monocytes and 
macrophages) and cell 
adhesion; calcium binding 
 general transcription factor 3C 
polypeptide 4 isoform 2... NP_001159505.1 Nucleus GTF3C3 
involved in RNA III mediated 
transcription; DNA binding 
S2-3 loop      
 neurogenic locus notch homolog 
protein 2 precursor NP_035058.2 
Nucleus, Plasma 
Membrane, Golgi NOTCH2 
receptor for ligands related to 
cell fate determination; 
calcium binding 
 alanine-tRNA ligase, 
cytoplasmic NP_666329.2 Cytoplasm AARS1 
catalyzes attachment of 
alanine to tRNA(ala) 
 lysine-specific histone 
demethylase 1B NP_758466.1 Nucleus KDM1B 
corepressor of epigenetic 
transcriptional activation; 
demethylates Lys-4 of histone 
H3 
 E3 ubiquitin-protein ligase 
SMURF1 isoform 1 NP_001033716.1 Plasma Membrane SMURF1 
promotes ubiquitination of 
TRAF family members; role in 










phosphodiesterase 3 NP_067466.1 Golgi, Plasma Membrane SMPD3 




Domain Protein Name NCBI Accession 
Subcellular Location 
(typical or predicted) Gene 
Notes on Function/Structure 
(from UniProt) 
 zinc finger protein Eos isoform 1 NP_035902.2 Nucleus IKZF4 




 tripartite motif-containing protein 
43A isoform 1 NP_001344616.1 Cytoplasm Trim43a 
ubiquitin protein ligase; zinc 
binding; regulation of gene 
expression 
 SPRY domain-containing 
protein 3 NP_001028449.2 Cytoplasm SPRY3 
inhibits neurite 
growth/arborization 




STX6 intracellular vesicle trafficking 
 rab11 family-interacting protein 
1 isoform 1 NP_001074282.1 
Endosomes, Phagosomes, 
Cytoplasm RAB11FIP1 
involved in endosomal 
recycling; Rab11 effector 
 actin-binding protein IPP NP_032415.2 Cytoplasm IPP 
might be involved in 
cytoskeletal organization 
(actin); actin binding 
 dystonin isoform 1 NP_001263693.1 Cytoplasm, Nucleus, ER DST 
cytoskeletal linker protein; 
integrator of intermediate 
filaments, actin, and 
microtubules; calcium binding 
 dynein heavy chain 8, axonemal NP_038839.2 Cytoplasm DNAH8 motor protein; ATPase; involved in sperm motility 
140 
Cytosolic 
Domain Protein Name NCBI Accession 
Subcellular Location 
(typical or predicted) Gene 
Notes on Function/Structure 
(from UniProt) 
 dynein heavy chain 5, axonemal NP_579943.3 Cytoplasm DNAH5 
motor protein; ATPase; 
involved in cilium assembly, 
cardiac development, and 
left/right symmetry 
 ATP-binding cassette sub-family 
A member 2 isoform 2... NP_001355553.1 Endosomes, Lysosomes ABCA2 
cholestrol sequestration into 
late endosomes/lysosomes; 
ATPase activity; ATP binding 
 multiple PDZ domain protein 
isoform 1 NP_001292213.1 Plasma Membrane MPDZ 
NMDAR signalling complex 
member (may have a role in 
AMPAR potentiaton and 
synaptic plasticity; promotes 
clustering of (5)HT2RC (i.e., 
serotonin receptors) at cell 
suface 
 sodium channel protein type 5 
subunit alpha isoform 1... NP_067519.2 
Plasma Membrane, 
Nucleus, ER SCN5A 
mediates permeability to Na+ 
ions in a voltage-dependent 
manner 
 sodium channel protein type 1 
subunit alpha isoform 1... NP_001300926.1 
Nuclear Body, Plasma 
Membrane, SCN1A 
mediates permeability to Na+ 
ions in a voltage-dependent 
manner 
 sodium channel protein type 2 
subunit alpha isoform 2... NP_001333608.1 Plasma Membrane SCN2A 
mediates permeability to Na+ 
ions in a voltage-dependent 
manner 
 sodium channel protein type 3 
subunit alpha isoform 1... NP_001342095.1 Plasma Membrane SCN3A 
mediates permeability to Na+ 
ions in a voltage-dependent 
manner 
S4-5 loop      
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Cytosolic 
Domain Protein Name NCBI Accession 
Subcellular Location 
(typical or predicted) Gene 
Notes on Function/Structure 
(from UniProt) 
 myosin-15 NP_001159682.1 Cytosol MYO15 
intracellular movement; actin 
binding; ATPase activity; ATP 
binding; calmodulin binding 
 dynein heavy chain 9, axonemal NP_001093103.1 Cytosol DNAH9 force generating protein for cilia beating; ATP binding 
 rab11 family-interacting protein 
5 isoform 1 NP_001003955.1 
Endosomes, Golgi, 
Mitochondria RAB11FIP5 
Rab effector; protein trafficking 
from recycling endosomes to 
plasma membrane 
 angiopoietin-1 isoform 2 
precursor NP_001272991.1 Extracellular ANGPT1 
binds and activates TEK/TIE2 
receptor; regulation of 
angiogenesis, endothelial cell 
survival, proliferation, 
migration, adhesion, and cell 
spreading, reorganization of 
action cytoskeletion, 
maintenace of vascular 
quiescence 
S6-7 loop      
 VNUT Q8VCL5 Vesicles SLC17A9 involved in vesicular storage and release of ATP 
S8-9 loop      
 G protein-activated inward rectifier potassium channel 2 
isofo... Plasma Membrane KCNJ6 influx of potassium 
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Cytosolic 
Domain Protein Name NCBI Accession 
Subcellular Location 
(typical or predicted) Gene 
Notes on Function/Structure 
(from UniProt) 
 retinoic acid receptor RXR-
gamma isoform 1 NP_033133.1 Nucleus RXRG 
receptor for retinoic acid; 
involved in differentiation 
 glycosyltransferase 6 domain-
containing protein 1 precursor... NP_001034184.1 
Golgi, possibly Vesicles 
and Plasma Membrane GLT6D1 
transferase activity (glycosyl 
and hexosyl groups) 
 roundabout homolog 2 isoform 6 
precursor NP_001345423.1 Plasma Membrane ROBO2 
receptor for SLIT2 and maybe 
SLIT1 (SLITs are possible 
molecular guidance cues for 
cellular migration); axonal 
navigation; differentiation from 
neural tube during 
development 
 receptor-type tyrosine-protein 
phosphatase delta isoform 6... NP_001355921.1 Plasma Membrane PTPRD 
bidirectional induction of pre- 
and post-synaptic 
differentiation of neurons 
S10-11 loop      





cytoskeletal component; actin 
binding; maintains organellar 
organization; might interact 
with dynein-dynactin motor 
complexes 
 protein argonaute-2 NP_694818.3 Cytoplasm AGO2 involved in RNAi; endoribonuclease activity 
 protein argonaute-3 NP_700451.2 Cytoplasm AGO3 involved in RNAi; endoribonuclease activity 
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Cytosolic 
Domain Protein Name NCBI Accession 
Subcellular Location 
(typical or predicted) Gene 
Notes on Function/Structure 
(from UniProt) 
 protein timeless homolog 
isoform 3 NP_001157552.1 Nucleus TIMELESS 
DNA repair, circadian clock, 
genome stability; stabilizes 
replication forks; DNA binding 
 cordon-bleu protein-like 1 
isoform 2 NP_081501.1 Extracellular COBLL1 actin binding; cadherin binding 
 A-kinase anchor protein 11 
isoform 1 NP_001157975.1 Cytosol AKAP11 
binds and anchors type II 
regulatory subunits of PKA 
 unconventional myosin-XVIIIa 
isoform 4 NP_001278143.1 Cytosol, Golgi MYO18A 
may link Golgi membranes to 
cytoskeleton; participate in 
tensile force for vesicle 
budding from Golgi; may have 
a role in Golgi membrane 
trafficking; ATP/ADP binding; 
DNA binding; RNA binding; 
actin filament binding 
 ATP-binding cassette sub-family 
A member 13 NP_839990.2 
Plasma Membrane, 
Lysosome ABCA13 
ATP binding; ATPase-coupled 
transporter 
C-terminus      
 VNUT Q8VCL5 Vesicles SLC17A9 involved in vesicular storage and release of ATP 
 
